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ABSTRACT 
 
This PhD thesis focuses on the development of “greener” synthetic 
methodologies in organic synthesis. Turning chemical production into a more 
sustainable industry - by reducing the waste generated and the electricity 
consumption - is highly desired in a world with limited resources and 
increasing population.  
This thesis, in particular, focuses on three of the ‘12 Principles of Green 
Chemistry’, reducing the amount of solvent and energy consumption in a 
chemical process, and the use of catalytic reagents instead of stoichiometric.  
In the first chapter of this thesis, a greener synthetic route for the 
preparation of the antidepressant fluoxetine (Prozac) was developed. The 
use of ball milling allowed a decrease of the solvent used in the process, 
furthermore, microwave assisted heating provided a more efficient method 
compared to the traditional heating using an oil bath. Fluoxetine was 
synthesised with 47% yield through two different synthetic routes (3 and 4 
steps respectively). In addition, the scope of the developed methodologies 
was tested by the attempted synthesis of the antidepressant duloxetine. 
The second chapter of this thesis focuses on the catalytic enantioselective 
synthesis of chiral alcohols. More specifically, two different methodologies for 
the catalytic enantioselective addition of organolithium reagents to aldehydes 
were successfully developed, achieving excellent yields and 
enantioselectivities. Furthermore, a new methodology for the use of 
organozirconium reagents as nucleophiles in the catalytic enantioselective 
1,2-addition of alkenes to aldehydes was also developed. Last, the 
implementation of a catalytic enantioselective step to the previous syntheses 
of fluoxetine was attempted. 
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The Earth has gone through many environmental changes along the years; 
however, the planet has remained stable for the last 12,000 years in a period 
that geologists refer as the Holocene.1 This period of stability that started 
after the last ice age, is now facing some major and irreversible 
consequences. Human activities are now leading Earth towards a brand new 
area called the Anthropocene.2, 3 This geologic chronological term, which was 
first used by Eugene F. Stoermer in the late 1980s, defines our current 
epoch in which human actions are the main cause of global environmental 
change. 
It is well known that the chemical industry has an important role in the 
current environmental changes, mainly due to the millions of tonnes of 
waste that chemical manufacturing generates every year. Therefore, it has 
become a priority to eliminate or minimize the impact of the chemical 
industry towards the environment. The ideal solution to avoid waste would 
be to prevent its formation in the first place.4, 5 
Since the risk associated with a chemical process can be expressed as:6 
Risk = Hazard x Exposure 
by reducing or eliminating the hazard, it is possible to minimize the risk 
involved in any chemical reaction. 
As a result of expanding this idea, the concept of Green Chemistry was 
formulated at the beginning of the 1990s.7 Its most common and widely 
accepted definition is “the design, development and implementation of 
chemical processes and products to reduce or eliminate substances 
hazardous to human health and the environment”.6 
Few years later, continuing with the aim of achieving sustainability, Paul 
Anastas and John Warner expanded its definition by formulating the 12 
principles of Green Chemistry (which are shown below).6 
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The 12 principles of Green Chemistry 
1. It is better to prevent waste than to treat or clean up waste after it is 
formed. 
2. Synthetic methods should be designed to maximize the incorporation of all 
materials used in the process into the final product. 
3. Wherever practicable, synthetic methodologies should be designed to use 
and generate substances that possess little or no toxicity to human health 
and the environment. 
4. Chemical products should be designed to preserve efficacy of function 
while reducing toxicity. 
5. The use of auxiliary substances (e.g., solvents, separation agents, and so 
forth) should be made unnecessary wherever possible and innocuous when 
used. 
6. Energy requirements should be recognized for their environmental and 
economic impacts and should be minimized. Synthetic methods should be 
conducted at ambient temperature and pressure. 
7. A raw material or feedstock should be renewable rather than depleting 
wherever technically and economically practicable. 
8. Unnecessary derivatization (blocking group, protection/deprotection, 
temporary modification of physical/chemical processes) should be avoided 
whenever possible. 
9. Catalytic reagents (as selective as possible) are superior to stoichiometric 
reagents. 
10. Chemical products should be designed so that at the end of their 
function they break down into innocuous degradation products and do not 
persist in the environment. 
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11. Analytical methodologies need to be developed further to allow for real-
time in-process monitoring and control pior to the formation of hazardous 
substances. 
12. Substances and the form of a substance used in a chemical process 
should be chosen so as to minimize the potential for chemical accidents, 
including releases, explosions, and fires. 
 
Sheldon’s Environmental Impact Factor (E Factor) is used to determine the 
environmental acceptability of a manufacturing process.8 
The E Factor is defined as the mass ratio of waste to desired product (kg 
waste/kg product). In other words, it is the actual amount of waste 
produced during a chemical process.  
Table 1 summarizes the E factors for some segments of the chemical 
industry. The higher the E factor is, the greater negative impact to the 
environment.8 
Table 1 – E factors for some segments of the chemical industry 
Industry segment Product tonnage E Factor (kg waste/kg product) 
Oil refining 106 - 108 < 0.1 
Bulk chemicals 104 - 106 < 1 - 5 
Fine chemical industry 102 - 104 5 - 50 
Pharmaceutical industry 10 - 103 25 - 100 
 
Data in Table 1 shows that the E factor rises dramatically as we move from 
oil refineries and the bulk chemical industry to the fine chemicals and 
pharmaceutical industries. The main reasons why the pharmaceutical 
industry displays the highest E factor are that it is normally based on multi-
step syntheses that frequently involve large quantities of solvents, and the 
use of stoichiometric reagents instead of catalytic ones.9 A lot of efforts are 
now being made in order to turn the pharmaceutical industry into a 
sustainable industry. 
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Amongst all the strategies that constitute the 12 principles of Green 
Chemistry, this thesis focuses on principles 5, 6 and 9.  
Principle 5 states that the use of solvents should be made unnecessary 
wherever possible. We will address this by the use of mechanochemistry or 
ball milling techniques, which allow the performance of chemical reactions in 
the absence of solvent.  
Principle 6 targets the minimization of energy requirements for a chemical 
process. This issue will be addressed by replacing traditional heating (i.e. oil 
baths, isomantels, etc) by mechanochemistry and microwave assisted 
heating. 
More in particular, the first chapter of this thesis is based on the use of ball 
milling techniques and microwave assisted reactions in order to develop 
greener synthetic routes for the preparation of the active pharmaceutical 
ingredients fluoxetine and duloxetine, both antidepressant drugs. 
Regarding the principle 9, the second chapter of this thesis covers the use of 
catalytic reagents (instead of stoichiometric ones) for the development of 
new catalytic asymmetric processes. In particular, we have addressed the 
enantioselective addition of different organometallic reagents to carbonyl 
compounds.  
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Part of the research described in this chapter has been published: 
 
1. Solà, R.; Sutcliffe, O. B.; Banks, C. E.; Maciá, B. ‘Ball mill and microwave 
assisted synthetic routes to Fluoxetine’. Sustainable Chemistry and Pharmacy 
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1.1. Introduction 
Pharmaceutical manufacturing is the most solvent-intensive and the least 
efficient of all chemical industries in terms of waste generated per unit of 
product. Statistics compiled across the industry point to an average waste-
to-product ratio of 200 times. In other words, factories generate 200 
kilograms of waste for every kilogram of active pharmaceutical ingredient 
produced. In particular, 90% of more than 500 million tons of toxic waste 
that pharmaceutical companies generate each year, is solvent.10 
According to a recent study carried by GlaxoSmithKline,11 85% of the total 
mass of chemicals that are involved in pharmaceutic manufacturing consists 
of solvents. Although the typical recovery efficiencies are 50-80%, most of 
the solvent is incinerated for power, thus contributing to CO2 formation. 
Recent studies have identified three “green” approaches that could help the 
pharmaceutical industry to reduce its ecological impact. 
- Alternative feedstocks: use the waste generated in a process as a 
feedstock or reagent for the next one.12  
- Non-solvent reactions,13, 14 and alternative solvents (e.g. utilisation 
of water,15 ionic liquids16, 17 and supercritical fluids (SCF)18). 
- Alternative synthetic pathways: usage of catalysts instead of 
stoichiometric reagents, and their recovery and reutilisation after 
they have been used. 
Taking into consideration that solvents are the major cause of waste in the 
pharmaceutical industry, non-solvent reactions will constitute a relevant area 
of interest in this work. 
1.1.1. Non-solvent reactions 
The main role of solvents is to provide homogeneity in a chemical reaction. 
When all the components in a reaction are dissolved, the approach between 
molecules is favoured, which promotes the interactions between reagents at 
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a molecular level. Furthermore, solvents can also favour the formation and 
stability of certain intermediates formed during the reaction, thus allowing 
the thermodynamic and kinetic control to happen over a chemical process. 
In addition, solvents can also act as a heat trap, absorbing and dissipating 
the heat generated during the reaction. When heating is needed for the 
process, solvent provides additional safety and control since the chemicals 
will never be heated above the solvent’s boiling point. 
Despite all the advantages mentioned before, the use of solvents is 
expensive in production scale. It is not only about the cost of the solvent 
itself, the disposal and the subsequent treatment are also expensive 
processes. For this reason, pharmaceutical industry aims to reduce the 
amount of solvent used in every process. Ideally, the best situation would be 
a reaction in which no solvent is used at all.           
In a reaction without solvent, the challenge is to guarantee a good mixing of 
the reagents and achieve a homogeneous phase, so the molecules can 
interact between each other and the reaction can take place. 
Mechanochemical activation (as simple as grinding two reactants in a pestle 
and mortar) can facilitate this approach between molecules. 
Mechanochemical processes can be automated with the use of ball mills, 
which have the advantage over the pestle and mortar of requiring no 
physical effort, supplying greater power and being programmable.  
During the last decade, numerous protocols have been published using ball 
milling technologies for the synthesis of many valuable compounds.19, 20 This 
powerful method, based on the absorption of mechanical energy, has drawn 
the attention of many chemists as no solvent is required to carry out the 
reaction. 
Mechanochemistry has already been used for the synthesis of some active 
pharmaceutical ingredients (APIs) (see some examples in Figure 1.1).21-25 
Even though the number of reported mechanochemical syntheses of APIs is 
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still modest, there is a growing number of mechanochemical procedures for 
generating pharmaceutically relevant fragments and functionalities.26 
  
Figure 1.1 – Mechanochemically synthesised APIs 
More interestingly, it has been recently reported that some reactions are only 
possible under mechanochemical conditions.27 For example, in 2013, Friscic 
et al. reported a new single-step procedure for the preparation of 
sulfonylguanidines through grinding in a ball mill.25 Despite all the attempts 
of his research team at McGill University in Montreal, it was not possible to 
replicate the process in solution conditions.  
However, despite all the recent work on mechanochemistry and solventless 
chemical transformations, the transition from traditional wet technologies to 
dry methods for the synthesis of pharmaceuticals is a highly desirable but 
unexplored area that needs further investigation.28 
1.1.2. Ball Mill 
According to IUPAC, a mechanochemical reaction is defined as “a chemical 
reaction that is induced by the direct absorption of mechanical energy”.29 Its 
simplest case is grinding two reagents with a pestle and mortar. However, 
the process can be automatized with the utilisation of ball mills, which can 
provide greater power and avoid the use of physical energy at the same 
time. 
Ball mills are common equipment in industry, but their applications are 
usually limited to the grinding of solid materials in order to make thin 
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powders. However, the idea of using ball mills as efficient reaction vessels 
for the synthesis of pharmaceuticals has recently become very popular as a 
possible cleaner technology in the pharmaceutical sector.30 
Mechanosynthetic methods – grinding of (solid) reactants in a ball mill26 – 
avoid the use of solvents and at the same time utilise mechanical energy 
from the grinding for the formation/breaking of new bonds.13, 21-26, 31, 32 No 
solvent would be needed to carry out reactions and the energy required for 
the formation/breaking of new bonds would be provided by 
mechanochemical means (grinding). 
There are mainly two different kinds of ball mills commercially available for 
laboratory-scale synthesis, the shaker and the planetary ball mill. The shaker 
ball mill (Figure 1.2), based on a rapid horizontal shaking motion, is provided 
with a metal ball inside the reaction vessel that impacts against the sides of 
the grinding jar. The mechanical energy generated in the process is 
transferred to the reactants and allows the reaction to take place.  
 
 
Figure 1.2 – Shaker mill 
In the planetary ball mill, on the other hand (Figure 1.3), the grinding jar 
mimics the orbit of the planets around the sun (both rotation and revolution 
movements). It can work either on friction mode (the balls move around the 
walls of the grinding jar) or impact mode (the balls jump across the grinding 
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jar and impact against the walls) depending on the relative speeds of the 
rotation and revolution movement. Planetary mills generally have a lower 
impact frequency than shaker mills,33 however the oblique collisions and 
friction of the balls in the grinding jar produce higher temperatures (higher 
energy output), which can be beneficial for the reaction.34   
 
Figure 1.3 – Planetary ball mill 
Besides the type of ball mill that can be used to perform mechanochemical 
reactions, there are some parameters that can influence the yield of the 
reaction and have to be borne in mind: the revolutions per minute (rpm), the 
grinding time (t), the number and size of the milling balls, and the material 
both the grinding balls and grinding jar are made of. 
The main purpose of the ball mill when performing a mechanochemical 
reaction is to achieve the biggest energy input possible, so to evaluate the 
impact of each parameter a reference to the classical equations of kinetic 
energy (Ek) can be done (Equations 1.1 and 1.2).
35, 36 
    
 
 
                                      Equation 1.1 
                   
 
 
                                 Equation 1.2 
The angular velocity ( ) can be expressed as        , so it is easier to 
understand how frequency ( ) is related to the kinetic energy (  ). 
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The frequency     is the most determining parameter, so the rpm is going to 
have major contribution to the reaction. The faster the grinding balls move, 
the greater energy will be provided to the reaction mixture.  
On the other hand, the mass     depends on the number and the size of the 
grinding balls used. In other words, it comprises the total surface of grinding 
material involved in the reaction. Not only the number of balls is important, 
but the size of them.36 
The milling material (for both the grinding balls and jar) is also important, as 
the moment of inertia     (Equation 1.2) depends on the mass    , therefore 
the density of the material is also involved when calculating the kinetic 
energy (  ). The higher the density of the milling material, the greater 
energy is transferred to the reaction mixture.   
Despite this, it would be wrong to state that a greater energy input will 
always lead to a higher yield. The activation energy of the reaction and its 
mechanism have to be considered as well.37    
If we order all the parameters regarding their influence during the milling 
process, the sequence would follow this trend: rpm > milling time (t) > size 
of milling balls > number of milling balls > grinding material.36 
There are two types of mechanical actions in a ball mill: impact (collision of 
the grinding ball into the wall) and shear (the layers of the substance are 
laterally shifted in relation to each other).38 Impact is the predominant action 
taking place in the shaker mill, while shear is more distinctive of the 
planetary mill. 
While trying to understand the relationship between these types of 
mechanical action, it has been observed that two unique zones of different 
reactivity are present inside the grinding jar.38, 39 Samples at the milling jar 
ends (where impact prevails) may have a different concentration than 
samples from the walls (where shear is the predominant action). 
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It is also believed that increasing the number of balls in the grinding jar can 
change the motion of the media,40 reducing the number of impacts while 
increasing the shearing action. By using that technique, it would be possible 
to decrease the number of impacts of a shaker mill and increase the 
shearing, which is more characteristic of the planetary mill.  
In relation to the different types of mechanical action, the phenomenon of 
tableting or sintering can affect the progress of the reaction during the 
grinding. This phenomenon is characterised by the formation of a compact 
layer of the reaction mixture, which consists of particles incapable of further 
motion.36, 39 This tablet formed will initially be characterised by large 
amounts of shearing stress. Nevertheless, as the space between the particles 
is reduced, a densely packed tablet will be formed in which impact action is 
going to be dominant. 
In order to evaluate which kind of mechanical action is better for a particular 
reaction, all the reactions carried out during this thesis will be performed in 
both shaker and planetary ball mills. 
1.1.2.1. Mechanism at molecular level 
Although many efforts have been done in the area, and many models have 
been proposed, the mechanism of a mechanochemical reaction is still far 
from being understood up to date. Each mechanistic model developed has a 
limited area of applicability, whilst more than one may apply to a given 
reaction.13  
Early approaches to understand the mechanism of mechanochemical 
reactions were based on thermal effects. In particular, it was believed that 
the chemical reactions were the result of local heating. The most popular 
mechanisms based on local heating are the hot spot theory and the magma-
plasma model. 
The hot spot theory, developed by Bowden, Tabor and Yoffe during the 
1960’s,41 is based on friction processes for 10-4 – 10-3 s that can generate 
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local temperatures of over 1000 K between two surfaces of about 1 µm2. In 
the case of more brittle (fragile) materials, this process occurs at the tip of 
the propagating crack.13, 41 
The magma-plasma model, developed by Thiessen in 1967, is also based on 
the dramatic increase of the temperature in specific points, but focused on 
impacts rather than friction between surfaces. It is defined as an energetic 
impact between two particles that generates a plasma-like state 
characterized by the emission of electrons and photons. This state, which 
lasts less than 10-7 s, results in local temperatures that can reach more than 
104 K.13, 41, 42  
Despite this, the above-mentioned phenomena are too brief and/or too 
localized to define the entire course of the reaction. Further models have to 
be developed to understand the processes occurring in areas larger than 1 
mm2.13  
Recent studies have been carried out in order to enlighten the mechanism at 
molecular level behind solid/solid organic reactions. Some of the reactions 
studied include: aldol condensations, Baeyer-Villiger oxidation, esterification 
of alcohols, etc.43 It has been suggested that those organic reactions, in 
which a new covalent bond is formed, occur through a liquid eutectic 
intermediate phase that subsequently solidifies once the product is formed.43 
This liquid phase involves the formation of a low-melting eutectic mixture 
that provides particles with the necessary mobility to allow collisions between 
the two solid reagents. In the cases where heating is required for the phase 
change, local heating effects could provide the necessary temperature 
increase.43 
1.1.2.2. Liquid Assisted Grinding (LAG) 
In contrast to conventional chemical synthesis, where the energy dispersion 
and the transport of chemicals are assured by the action of solvents, the 
challenge in solvent-free reactions is to achieve good contact between the 
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different reagents (ideally, a homogeneous phase). In order to avoid the 
formation of areas of different reactivity, with the aim of achieving a 
homogeneous phase, liquid assisted grinding (LAG) is getting popular as a 
variation of neat grinding.44, 45 
LAG or solvent-drop co-grinding, as its name suggests, is based on the 
addition of a small amount of liquid phase within the grinding jar. The role of 
the liquid is still not fully understood, but several theories have been 
suggested including: influence the mixing of the reagents (dissolving one or 
more components), modify the surface properties (changing the interactions 
between the solids), or affecting the dielectric permeability which could 
induce the polarization of the components.46     
1.1.3. Non-conventional Energy Sources 
Non-conventional energy sources have gained popularity during the last 
years. The ones that are generating more interest within the field of organic 
chemistry are mechanochemistry (see ball mill section above), microwave 
assisted heating, ultrasound and photochemical activation. 
Traditional heating in organic synthesis usually involves the utilisation of an 
isomantle or an aluminium block, an oil or sand bath, or a jacketed reactor in 
case the reaction is done at bigger scale; that transfers heat to the solution 
by convection and conduction. However, these classical ways of heating are 
considered slow and inefficient as there is a temperature gradient within the 
reaction flask (heat is transferred from the glass to the solvent). A more 
efficient way of heating would reduce time and therefore costs in industrial 
processes. 
In this context, microwave heating has been reported to reduce reaction 
times dramatically, sometimes from hours to minutes, or even seconds.47 In 
addition, microwave heating is much more efficient than conventional 
heating as it heats the reagents and the solvent without heating the vessel.48 
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Comparative studies on the energy consumption from different technologies 
have been carried out. For example, in 2005, Macquarrie performed a study 
comparing the preparation of one mole of 4-methyl-1,1'-biphenyl via a 
Suzuki coupling reaction using conventional heating and microwave assisted 
heating.49 The results (shown in Table 1.1) indicate that microwave heating 
is more energy efficient than the oil bath. 
Table 1.1 – Energy consumption comparison in a Suzuki coupling 
 
Heating source  Solvent Time (h) 4-methyl-1,1'-biphenyl yield (%) Energy (kW/mol) 
Oil-bath               dioxane 24 56.6 
 
5830 
Microwave             dioxane 1 40.7 
 
1680 
 
Not only microwave irradiation provides a more efficient heating, but also it 
usually allows shorter reactions times, which ranks this technology as a low 
energy consuming method. For this particular reason, microwave assisted 
heating has become such an attractive technique for synthetic chemists 
during the last years.50 
Despite this, in case of low-boiling point solvents and comparatively short 
reaction times, classical heating techniques become more energy efficient.49 
1.1.3.1. Microwave Assisted Heating 
Microwaves are a form of electromagnetic radiation that lies between 
infrared and radio frequencies. Microwave wavelengths range from 1 mm to 
1 m, corresponding to frequencies between 30 GHz to 300 MHz. The 
frequency     indicates the number of oscillations of the electric or magnetic 
field in one second, and is inversely proportional to the wavelength (    (see 
equation 1.3 below). 
    
 
 
                       Equation 1.3 
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In case of electromagnetic radiation, the phase speed is the speed of light 
   . In order to avoid interfering with radar transmissions, domestic 
microwaves are required to operate at 2.45 GHz (12.2 cm).51 
Microwave domestic ovens have been used to heat food for more than 50 
years, the first microwave oven was invented by Percy Spenser in 1946. 
Despite this, they did not become popular in the field of organic chemistry 
until middle 90s, due to the lack of reproducibility of the reactions in 
domestic ovens. Some research groups were using modified microwave 
domestic ovens and they did not provide the necessary reaction parameters 
to reproduce the same reaction conditions.52 Furthermore, there was also a 
lack of understanding of the microwave dielectric heating.  
Nowadays, the dielectric heating process is fully understood and the 
utilization of monomode irradiation provides the necessary reproducibility for 
microwaves to become a successful alternative heating technique for organic 
chemistry. 
1.1.3.2. Microwave dielectric heating 
Microwave dielectric heating is the ability of some substances to transform 
electromagnetic energy into heat.  
An electromagnetic wave, as its name suggests, has both electric and 
magnetic components. The electric field component is the responsible for the 
dielectric heating, which happens mainly through two different mechanisms: 
dipolar polarization and conduction.53 
1.1.3.2.1. Dipolar Polarization 
When a substance is irradiated with microwaves, if the molecule has a dipole 
moment it will rotate in order to align itself with the electric applied field. 
The oscillating field will force the molecule to try to realign constantly.52   
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Figure 1.4 - Water molecule trying to align in an alternating electrical field 
Microwave cannot be used to heat gases as the molecules are too spaced 
from each other and their rotation is fast. 
On the contrary, when a liquid is irradiated with an electromagnetic field, its 
ability to align with the field will depend on the frequency applied and the 
viscosity of the liquid. At low frequencies, the molecules will rotate in phase 
with the oscillating electric field generating low energy, while at high 
frequencies, the molecules will not have enough time to align with the field, 
so no rotation will occur.53 
The ideal situation is when the frequency applied is within the microwave 
region; low enough so the molecule has time to respond to the electric field 
and rotate, but not too high so rotation cannot follow the alternating field 
accurately. During this process energy is lost and transformed into heat 
because of molecular friction and collisions.  
It would be reasonable to think that more polar solvents absorb more 
energy, so the temperature increase is higher. However, with substances 
with similar dielectric constants     , the dielectric loss       has to be 
considered as well.50, 51 
The loss factor        is expressed as the quotient of both parameters.  
       
   
  
                                   Equation 1.4 
The dielectric loss       is the efficiency in which the electromagnetic 
radiation is converted into heat, and the dielectric constant      is the ability 
of the molecules to re-orientate in the electric field.  
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Depending on the loss factor       , a solvent can be classified as high 
          , medium                or low microwave absorbing       
    . 
Next table shows the loss factor        for some commonly used solvents.50 
Table 1.2 – Loss factor for some common solvents 
Solvent 
  
tan   
 
Solvent 
  
tan   
ethylene glycol 
 
1.350 
 
chloroform 
 
0.091 
ethanol 
  
0.941 
 
ethyl acetate 
 
0.059 
DMSO 
  
0.825 
 
acetone 
  
0.054 
2-propanol 
 
0.799 
 
THF 
  
0.047 
methanol 
 
0.659 
 
dichloromethane 
 
0.042 
DMF 
  
0.161 
 
toluene 
  
0.040 
water 
  
0.123 
 
hexane 
  
0.020 
 
1.1.3.2.2. Conduction 
Conduction, the second mechanism of heating, is the movement of ions 
through the solution because of the effect of the electric field. Therefore, 
energy is converted into heat because of the increase in collisions.  
This mechanism can be easily acknowledged when two samples of tap and 
distilled water are heated in the microwave. Under the same irradiation 
conditions, the tap water sample will reach higher temperature due to the 
presence of ions. 
This conductivity effect is of stronger magnitude than the dipolar effect 
because of its higher heat-generating capacity. This is the reason why ionic 
liquids are perfect solvents for microwave assisted synthesis.54  
1.1.3.2.3. Other thermal effects 
Apart from the above mentioned thermal effects (i.e. dipolar polarization and 
conduction) there are some other thermal effects associated with the 
dielectric heating of the microwave. 
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i) Superheating effect: It has been observed that at early stages of 
microwave heating, the temperature rise is localized in distinct parts 
of the reaction vessel and that most organic solvents are superheated 
above their boiling points.55 This effect is due to the presence of a 
vapour embryo trapped inside the bulk of the liquid that is 
subsequently released as a bubble. Most organic solvents are 
overheated 13-26 °C above their boiling point.55 
ii) Hot spots: Formation of hot spots with a temperature 100-200 °C 
higher than the bulk temperature, caused by an inhomogeneity of the 
electromagnetic field.56 
iii) Selective heating: Since only polar substances are heated while 
non-polar substances do not absorb radiation; solvents, catalysts or 
reagents can be heated selectively. 
iv) Molecular radiators: In case of non-absorbing solvents like 
benzene, carbon tetrachloride or dioxane, a highly absorbing solute 
can be added in the solution. This molecule will absorb the 
electromagnetic radiation and transfer the heat to the solution by 
convection.  
v) Elimination of wall effects: The inverted temperature gradient in 
the microwave causes the temperature of the whole volume to rise 
simultaneously. Contrary to conventional heating, the highest 
temperatures are achieved within the reaction volume. By using an oil 
bath, the reaction mixture in contact with the vessel wall is heated 
first and the highest temperatures are achieved on the glass and on 
the areas where no solvent is present.50 
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1.1.3.3. Specific Microwave Effects 
Specific or non-thermal microwave effects are defined as accelerations that 
cannot be achieved or duplicated by dielectric heating. This topic is still 
controversial and research has to be done in order to fully understand this 
phenomena. 
Some research groups state that microwaves are not energetic enough to 
induce chemical transformations, so it is reasonable to assume that chemical 
reactivity in microwave is driven exclusively by thermal effects.48, 57 This 
affirmation is based on the fact that the energy transferred by microwaves 
(<0.3 kcal/mol) is too low to induce any molecular activation and microwave 
irradiation (2450 MHz) cannot excite rotational transformations.58 
However, other authors have observed accelerations and selectivities that 
cannot be rationalized by thermal effects. In most cases, this specific MW 
effects are masked by the solvent absorption of the electric field, despite 
this, they can be clearly appreciated in non-polar solvents (in which MW 
absorption is low). 
Several theories have been postulated in order to understand the specific 
microwave effects.56, 59 
i) Microwave activation can change the energy of activation of a 
reaction by increasing the Arrhenius pre-exponential factor    . 
                                       Equation 1.5 
The pre-exponential factor     represents the probability of molecular 
impacts, and it is believed that by changing the orientation of polar 
molecules it is possible to influence  . 
ii) The activation energy      is largely reduced. It is predicted that 
the entropy      for the reaction may increase because of the dipolar 
polarization. That would result in a decrease of the activation energy. 
                                   Equation 1.6 
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iii) Reaction’s mechanism: It has been previously stated that 
increasing the polarity of a molecule would result in a higher 
temperature rise. Therefore the polarity changes during the reaction 
have to be considered as well. 
In case of two competing transition states (TS) with different 
polarities, the more polar TS will be favoured under microwave 
radiation, increasing the selectivity of the reaction. 
1.1.3.4. Irradiation method 
There are two different types of microwaves depending on the irradiation 
method that they use: monomode and multimode. 
All domestic microwaves use the multimode technique. When the radiation 
gets inside the cavity, microwaves are reflected by the walls generating 
different modes in order to distribute the radiation homogeneously. This 
prevents the formation of standing waves (a wave that remains in constant 
position) minimizing the generation of “hot and cold spots”. Its major 
advantage is that several samples can be irradiated at the same time. 
Despite this, the heating efficiency can change dramatically depending of the 
position of the sample inside the microwave cavity.53 
Monomode or single mode, on the other side, is based on a cavity that only 
allows one mode to be present. This results in a uniform radiation pattern 
that prevents the formation of “hot and cold spots”. Monomode microwave 
apparatus are used in organic chemistry as they allow the achievement of 
higher reproducibility and predictability.53 Their major drawback is that the 
reaction volume is fixed and it is relatively small. A flow microwave reactor 
has to be used in order to scale up reactions to industrial levels.60 
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1.2. Aim and objectives 
This chapter aims to the development of eco-friendly methodologies for the 
preparation of top selling and commercially available Selective Serotonin 
Reuptake Inhibitors (SSRIs), a very important class of antidepressants. 
According to the IMS Health, the antidepressant drugs duloxetine and 
aripiprazole (commercialized as Cymbalta and Abilify, respectively) were 
ranked 1st and 4th in a list of the top 100 prescribed medicines by U.S. 
National Sales in Q3 2013. The application of “greener” methodologies to the 
development of pharmaceutical processes could decrease the number of 
technological stages, leading to both the simplification of the procedure and 
the reduction of costs to the manufacturer and, ultimately, to the consumer. 
A well-known antidepressant, fluoxetine (commercialized as Prozac, Figure 
1.5), was set as a target molecule for the eco-friendly synthesis. The 
purpose of this research was to develop a new and efficient method for the 
synthesis of fluoxetine using solvent free conditions and microwave assisted 
techniques. Both ball mill and microwave technologies were tested in the 
development of an alternative “greener” strategy that could lead to a simple 
and more efficient synthesis of fluoxetine. 
In order to prove the scope of our synthetic strategy, the synthesis of the 
structurally similar antidepressant duloxetine (Figure 1.5) was also 
attempted under the optimized conditions. 
 
Figure 1.5 – Structures of fluoxetine and duloxetine 
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1.3. Synthesis of fluoxetine (Prozac)  
1.3.1. Background 
Fluoxetine, commercially known as Prozac, is a selective serotonin reuptake 
inhibitor (SSRI) widely used for the treatment of depression and anxiety.  
Although Prozac is currently sold in its racemic form, some studies have 
proved that both enantiomers have different activities and metabolic rates.61, 
62 In particular, Robertson et al. in 1988 established that there is a small 
stereospecificity when it comes to the interactions with the serotonin-uptake 
carrier, being (S)-fluoxetine the enantiomer with the most potent 
biochemical activity as a serotonin-uptake inhibitor.61  
Fluoxetine, in its racemic form, was synthesised for the first time by Bryan B. 
Molloy and Klaus K. Schmiegel in 1982 with an overall yield of about 32%.63 
The process, patented by Eli Lilly and Company, consists on the preparation 
of fluoxetine’s oxalate salt after 7 reaction steps, starting from the 
commercially available 3-dimethylamino-1-phenyl-propan-1-one 
hydrochloride (3) (Scheme 1.1). 
 
Scheme 1.1 – Fluoxetine’s first synthesis by Bryan B. Molloy and Klaus K. Schmiegel 
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Hydrochloride salt 3 is converted into the free amine 4 by reaction with 
aqueous sodium hydroxide. Aminoketone 4 is subsequently treated with 
diborane in THF to provide amino alcohol 5 in 88% yield. Next, compound 5 
is dissolved in chloroform saturated with gaseous hydrogen chloride and 
treated with thionyl chloride to afford 6 in 92% yield. Finally, the reaction of 
6 with p-trifluoromethylphenol and sodium hydroxide in methanol affords 7 
after heating under reflux for 5 days. The yield of this reaction is not 
provided in the original patent. Compound 7 can be stored as the 
corresponding oxalate salt, as shown in Scheme 1.1, or used directly in the 
next reaction steps. 
In the last part of the synthesis, N,N-dimethyl-3-(p-trifluoromethylphenoxy)-
3-phenylpropylamine (7) is reacted with cyanogen bromide to generate 8 in 
75% yield. The reaction of 8 with potassium hydroxide provides fluoxetine’s 
free amine (9) in 72% yield, which is stored as the corresponding oxalate 
salt. 
In 1987, Prozac was the first SSRI to hit the U.S. market. After earning $350 
million during 1989, Prozac became the country’s most prescribed 
antidepressant by 1990.64 
However, Eli Lilly’s patented synthetic route suffers from several 
disadvantages. The p-trifluoromethylphenol used for the nucleophilic 
substitution reaction is not only expensive and unstable, but also unreactive, 
which makes the O-arylation reaction very long (5 day at reflux in methanol). 
Furthermore, the N-demethylation step is difficult and involves the use of the 
highly toxic CNBr (Scheme 1.1). 
For these reasons, R. G. Shepherd filed a new patent in 1980 presenting a 
new alternative method for the etherification reaction, based on the 
deprotonation of alcohols 5 or 10 with sodium hydride followed by reaction 
with 1-fluoro-4-(trifluoromethyl)benzene (Scheme 1.2).65 This method avoids 
the use of the p-trifluoromethylphenol and reduces the reaction time of the 
O-arylation reaction from 5 days to overnight. 
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Scheme 1.2 – Shepherd’s patent on the etherification reaction of 5 and 10 
A few years later, Kairisalo et al. patented another synthetic route in which a 
catalytic hydrogenation followed by an etherification reaction using 1-chloro-
4-(trifluoromethyl)benzene and a milder base (i.e. potassium tert-butoxide) 
generates fluoxetine’s free amine (9) in 87% overall yield over these two 
last steps.66 The process is summarised in the scheme below (Scheme 1.3). 
The use of a N-protected benzyl derivative instead of a methyl one avoids 
the challenging demethylation step; the benzyl group being easily removed 
at the same time as the reduction of the ketone takes place.  
 
Scheme 1.3 – Kairisalo’s patent on the etherification reaction 
Although Robertson et al. described an early attempt at the N-demethylation 
process in 1987 that avoids the use of cyanogen bromide, the fluoxetine 
obtained required preparative HPLC for its purification.67 In that process, 
cyanogen bromide is replaced by the less toxic phenyl chloroformate and the 
mixture is refluxed in toluene for 3 h. The carbamate intermediate 11 is then 
reacted with sodium hydroxide to provide 12 in 67% yield (Scheme 1.4). 
Preparative HPLC is, nevertheless, a too costly purification technique to be 
carried out on industrial scale. 
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Scheme 1.4 – Robertson’s N-demethylation process 
It was not until 1993 that Schwartz et al. patented a more efficient 
methodology for the N-demethylation step, based on the reaction sequence 
depicted in Scheme 1.5.68 Thus, the reaction of 3-dimethylamino-1-phenyl-
propan-1-ol (5) with ethyl chloroformate and sodium bicarbonate under 
reflux of toluene for 5 h, provides 13 in 88% yield. This carbamate 
intermediate 13 is consequently treated with sodium hydroxide to afford 
amino alcohol 10 in 96% yield. Last, the reaction of 10 with sodium hydride 
and 4-chlorobenzotrifluoride provides fluoxetine hydrochloride salt (1) in 
73% yield, after reaction with hydrogen chloride gas in toluene. 
 
Scheme 1.5 – Schwartz’s N-demethylation process 
Amongst all the patented fluoxetine syntheses, the etherification step has 
probably been the most challenging and controversial one. Many research 
groups have argued about which method is the most suitable to carry out 
this transformation in industrial scale. The most prominent methodologies 
are detailed below. 
A Hungarian patent by K. P. Juhani in 1992 details the reaction of 10 with 4-
chlorobenzotrifluoride in N-methylpyrrolidone in the presence of potassium 
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tert-butoxide and potassium iodide to afford fluoxetine (1) in 85% yield 
(Scheme 1.6).69  
 
Scheme 1.6 – Juhani’s etherification process 
Two years later, R. G. Vegyészeti et al. published another method using 
potassium hydroxide as a base in dimethylsulfoxide.70 Despite of the long 
reaction time, they were able to use a milder base and obtain fluoxetine 
hydrochloride (1) in 87% yield (Scheme 1.7). 
 
Scheme 1.7 – Vegyészeti’s etherification process 
In 2004, Kumar et al. patented a new method for the O-arylation step with 
4-chlorobenzotrifluoride, using potassium hydroxide as a base. The reaction 
is performed in sulfolane as a solvent and additives such us poly(ethylene 
glycol)-6000 (a) or 18-crown-6 (b), that act as solubility enhancers, are 
needed (Scheme 1.8). This methodology allows high yields in short reaction 
times.71 
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Scheme 1.8 – Kumar’s etherification process 
Although the mechanism of the arylation reaction for the previous reactions 
has not been studied in much detail, it is believed to go via a nucleophilic 
aromatic substitution (SNAr).
72 The reaction of the alcohol with the base 
generates the corresponding alkoxide, which acts as a nucleophile towards 
the aryl halide to form the O-arylated product (Scheme 1.9 a). 
Despite this, in the cases where a strong base is used (e.g. sodium hydride), 
the formation of benzyne could be considered as well. The removal of the 
proton in ortho to the halide, followed by the elimination of the halide, 
generates an unstable benzyne intermediate, which is rapidly intercepted by 
the nucleophile (the hydroxyl group), to generate the corresponding O-
arylated product (Scheme 1.9 b).       
 
Scheme 1.9 – Mechanism of the O-arylation reaction 
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However, the fact that a loss of regioselectivity has never been observed, 
suggests that the SNAr is the most plausible mechanism. 
A more recent patent from Wang et al. in 2007 describes the copper (I) 
coupling reaction between the optically pure (R)-N-methyl-3-hydroxy-3-
phenylpropylamine ((R)-10) with 4-iodobenzotrifluoride, using cesium 
carbonate as a base (Scheme 1.10).73 
 
Scheme 1.10 – Wang’s Cu(I) coupling reaction 
The reaction can be carried out either in butyronitrile, using a catalytic 
amount of copper iodide (Scheme 1.10 a) or in xylene with stoichiometric 
amounts of copper bromide (Scheme 1.10 b). Once the coupling reaction is 
finished, after 16-24 h, the crude is dissolved in methyl tert-butyl ether and 
treated with a 20% hydrogen chloride solution in isopropanol to generate 
the corresponding hydrochloride salt (R)-1. 
The reaction mechanism for this copper catalysed coupling reaction can be 
rationalised via the Ullmann type reaction catalytic cycle (Scheme 1.11).  
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Scheme 1.11 – Ullmann type reaction catalytic cycle 
The reaction mechanism is believed to proceed through a Cu(I)/Cu(III) 
catalytic cycle as shown in the previous scheme. However, there are two 
possible mechanistic pathways that can take place (Scheme 1.11).74 In the 
first proposal (A), the halide on copper is exchanged for the nucleophile and 
an oxidative addition on the aryl halide forms the copper (III) intermediate. 
Finally, a reductive elimination step releases the coupling product and 
regenerates the catalyst. The second route (B) starts with the oxidative 
addition, followed by the exchange for the nucleophile and ends with the 
reductive elimination. 
Although the order of the first two steps is uncertain, recent literature 
favours route A, in which the reaction with the nucleophile takes places 
before the oxidative addition step.74    
Although this chapter focuses on the racemic synthesis of fluoxetine, many 
enantioselective syntheses have been described in the literature since 
fluoxetine’s first patent in 1982. A detailed discussion of those syntheses will 
not be covered in this thesis; however, some of the asymmetric steps are 
worth mentioning. 
The first chiral synthesis of fluoxetine was published by Brown at al. in 
1987.75 Brown’s group carried out the asymmetric reduction of haloalkyl aryl 
ketones using Ipc2BCl in THF at –25 °C (Scheme 1.12). 
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Scheme 1.12 – Brown’s asymmetric step for the synthesis of fluoxetine 
Both enantiomers of the corresponding chloro alcohol 15 can be accessed by 
using the diisopinocampheylchloroborane derived from (+)-α-pinene or (-)-α-
pinene. 
Later, Sharpless et al. published a new asymmetric synthesis of fluoxetine 
based on an asymmetric epoxidation followed by the selective reduction with 
Red-Al (Scheme 1.13).76, 77   
 
Scheme 1.13 – Sharpless’s asymmetric step for the synthesis of fluoxetine 
The asymmetric epoxidation of cinnamyl alcohol (16) with (+)-DIPT, 
titanium tetraisopropoxide and tert-butyl peroxide, leads to the optically pure 
(2S,3S)-2,3-epoxycinnamyl alcohol (17) in excellent yield and ee. Next, the 
subsequent reduction of 17 with Red-Al in DME at 0 oC allows the synthesis 
of 18 in high selectivity (22:1) and excellent yield. 
In 1989, Corey et al. reported another enantioselective route to fluoxetine 
which involves a CBS catalytic reduction process (Scheme 1.14).78 The 
reduction of 14 with borane (0.6 eq.) in the presence of catalytic amounts of 
(S)-oxazaborolidine (0.1 eq.), in THF at 0 °C, allows the synthesis of the 
corresponding alcohol 15 in excellent yield (99%) and enantioselectivity 
(94%). 
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Scheme 1.14 – Corey’s asymmetric step for the synthesis of fluoxetine 
Apart from the above mentioned methods, other procedures for the 
preparation of optically pure fluoxetine have been reported. Some of the 
most relevant asymmetric strategies include: enantioselective 
hydroxylation,79 enzymatic reduction of ketones and β-ketoesters,80, 81 
stereoselective coupling reaction,82 and enzymatic83 or chemical84 resolution 
of benzylic alcohols.    
1.3.2. Results and discussion 
Two different synthetic routes (A and B, Scheme 1.15)63, 85-87 were proposed 
for the synthesis of fluoxetine. Both pathways consist on: (i) a Mannich 
condensation, (ii) a carbonyl reduction and (iii) an O-arylation. In the case of 
Route A, an additional (iv) N-demethylation step is needed in order to obtain 
fluoxetine hydrochloride. (Scheme 1.15) 
 
Scheme 1.15 – Proposed synthesis for fluoxetine 
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1.3.2.1. Step 1 - Mannich Condensation 
The Mannich condensation between acetophenone (19) and dimethyl- or 
methylamine hydrochlorides in the presence of paraformaldehyde has been 
previously described under conventional heating conditions, to provide 
adducts 388-91 and 20,92 respectively.  
The analogous Mannich reactions were first attempted under 
mechanochemical conditions, using both shaker and planetary ball mills. A 
wide screening of various grinding parameters was performed; including 
size, number and material of grinding balls, reaction scale and solvent 
assisted grinding with EtOH and iPrOH. The reaction was also performed 
using different reaction conditions; changing the equivalents of hydrochloride 
salt and paraformaldehyde. Unfortunately, no conversion higher than 10% 
was achieved in any case for either 3 or 20.  
When the reactions were performed under microwave irradiation, they 
provided higher yields in shorter times than the corresponding reactions 
under conventional heating, which range from 29-86% with reaction times 
between 1-5 h (Table 1.3).88-92 Thus, the reaction of 19 with 1.25 eq. of 
dimethylamine hydrochloride and 1.50 eq. of paraformaldehyde in 
isopropanol, provided the hydrochloride salt 3 in 65% yield in only 1 h at 
110 oC (entry 1, Table 1.3). Longer reaction times did not improve the yield 
of the reaction (entry 2). Similarly, the synthesis of 20 was achieved in 40% 
yield, using ethanol as solvent and microwave assisted heating at 130 °C 
(entry 3). In this case, the yield of the reaction could be improved to 57% 
with longer reaction times (5 h, entry 4).  
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Table 1.3 – MW assisted Mannich reaction for the synthesis of 3 and 20. 
 
Entry Product HNRMe  
(eq.) 
HO(CH2O)nH  
(eq.) 
Solvent T  
(oC) 
Time 
(h) 
Yield 
(%)b 
1 3 HNMe2 (1.25) 1.50 
iPrOH 110 1 65 
2 3 HNMe2 (1.25) 1.50 
iPrOH 110 4 59 
3 20 H2NMe (1.10) 1.40 EtOH 130 2 40 
4 20 H2NMe (1.10) 1.40 EtOH 130 5 57 
a Reaction Conditions: 19 (1 eq.), HNRMe, paraformaldehyde, solvent, MW . b Isolated yield. 
 
1.3.2.2. Step 2 - Carbonyl Reduction 
Next, we studied the reduction of 3 and 20 to their corresponding alcohols 5 
and 10 (Scheme 1.16). 
 
Scheme 1.16 – Carbonyl reduction reaction 
James Mack et al. described a solvent-free method for the reduction of 
carbonyl compounds (aldehydes, ketones and esters) using high-speed ball 
milling (HSBM) technique, in 2007.93 Their method consisted of the use of 
NaBH4 as a reducing agent. High conversions (>95%) and isolated yields (up 
to 70%) for aromatic aldehydes and ketones were achieved under these 
conditions. In addition, this methodology also allows the reduction of 
aromatic esters (>90% conversion and up to 67% isolated yield) when 
lithium chloride is added to the reaction mixture, in order to generate lithium 
borohydride in situ (Scheme 1.17).94 
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Scheme 1.17 – Reduction of carbonyl compounds using HSBM by Mack et al. 
A similar method was developed by B. T. Cho et al. in a pestle and mortar, 
using NaBH4 as a reducing agent in presence of some activators (Scheme 
1.18).95 The results point out that the utilisation of solid acid-activated 
sodium borohydride shortens the reaction times for the reduction of both 
aromatic aldehydes and ketones, leading to high yields. However, the use of 
pestle and mortar requires physical effort and results are hard to reproduce 
as the energy supplied will depend on the person grinding. 
 
Scheme 1.18 – Carbonyl reduction in pestle and mortar using activated NaBH4 
Few years later, in 2010, H. Shalbaf developed a faster method for the 
reduction of aromatic aldehydes and ketones in a pestle and mortar. This 
methodology is based on the utilisation of NaBH4 as a reducing agent and 
Al2O3 as a solid support (Scheme 1.19).
96 Using alumina as a solid inorganic 
support to immobilize (probably by adsorption) the reagents, generates 
active sites that are homogeneously dispersed through the reaction mixture. 
An easy work-up allows the recyclability of this porous solid support.  
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Scheme 1.19 – Reduction of carbonyls in pestle and mortar using NaBH4/Al2O3 
Inspired by these methodologies described in the literature, we envisioned 
that the development of a ball milling methodology for the reduction of the 
fluoxetine precursors 3 and 20 under solvent-free conditions could be 
feasible. 
Thus, the reduction reaction of 3 and 20 was attempted in both a shaker 
and a planetary ball mill. Different parameters were optimised in order to get 
the highest yield and shorter reaction times: 
a) Type of ball mill: planetary and shaker mills were tested. 
We observed that it was harder to obtain a homogeneous phase in 
the planetary ball mill due to the large surface that the grinding balls 
had to cover. Furthermore, it was harder for larger grinding balls to 
reach the chemicals accumulated in the corners. On the contrary, the 
round shape of the shaker mill provided a most homogeneous 
reaction mixture, which, ultimately, led to higher yields compared to 
the planetary mill.  
b) Type of grinding jar/number, size and material of the grinding balls:  
In the case of the planetary ball mill, a 50 mL stainless steel grinding 
jar was used. Different sizes of stainless steel grinding balls were 
tested, as well as Zr grinding balls. The best results and most 
homogeneous phase was obtained when using a 2.5 and a 1.0 cm 
diameter stainless steel grinding balls simultaneously. 
The shaker mill was tested with both a 25 mL stainless steel grinding 
jar and a 2 mL plastic Eppendorf inserted in the corresponding holder. 
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Different combinations of stainless steel grinding balls were tested in 
the 25 mL stainless steel grinding jar. However, a single 2.5 cm 
diameter stainless steel grinding ball provided the best fit and the 
most homogeneous phase. 
The reaction in a plastic Eppendorf could only be carried out using Zr 
grinding balls, since stainless steel balls were damaging/breaking the 
Eppendorf. Even though we previously stated that the grinding 
material was the least important parameter in a milling process, in 
this case, plastic was not a suitable material to use together with 
stainless steel. This highlights the fact that the density of the 
materials used has to be considered always.   
Full conversion was only obtained when using a 2.5 cm diameter 
stainless steel grinding ball in the shaker mill. When smaller grinding 
balls were used in any kind of grinding jar, the reaction did not reach 
full conversion because the grinding balls got trapped in the reaction 
mixture. That hampered the grinding and prevented the reaction from 
continuing.  
c) Reaction scale: the best way to prevent the grinding balls from 
becoming fouled in the reaction mixture was to use the 25 mL steel 
grinding jar in the shaker with a single grinding ball of 2.5 cm 
diameter. Furthermore, the amount of reagents inserted in the 
grinding jar has to be limited so the grinding ball can move freely. We 
found out that the optimal amount of solid inside the grinding jar is 
132 mg (all reagents included). In case of our substrate 3, this equals 
to work in a 0.5 mmol scale.    
d) Solvent assisted reaction: the reduction of substrate 3 with 1.3 eq. of 
sodium borohydride in the presence of a small amount of MeOH (50 
µL per 107 mg of ketone) was tested in the shaker mill. 
Unfortunately, results were not better than under solvent free 
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conditions, and the reaction did not reach full conversion after 1 h of 
shaking at 20.0 Hz.  
e) Reaction work-up: when the crude reaction mixture from the 
reduction of 3 was simply dissolved in ethyl acetate and washed with 
water, a mixture of the desired product 5 and its corresponding 
boronate was obtained. An acid/base extraction work-up, however, 
allowed the hydrolysis of the boronate, and pure product 5 was easily 
obtained.  
The optimised reaction conditions for the racemic reduction of 3 (Route A) 
allowed the synthesis of 5 in the shaker mill, in 96% yield (Scheme 1.20). 
The reaction reached full conversion after grinding at 20.0 Hz for 25 min, 
using a 25 mL stainless steel grinding jar provided with one stainless steel 
grinding ball with a diameter of 2.5 cm. No additional reagents or additives 
were necessary, which allowed a simply purification of 5 by acid/base 
extraction. 
 
Scheme 1.20 – Optimised conditions for the racemic reduction of 3 
This new methodology reduces the reaction time to only 25 min of shaking, 
compared to 15 h reaction time in the solution-based reactions described in 
the literature.87, 97 Furthermore, no solvent has to be used for the reaction. 
Additionally, in order to know if the temperature was an important 
parameter for this reaction, an IR thermometer was used to measure the 
temperature of the grinding ball and the inside and outside walls of the 
grinding jar every 2 minutes until the reaction was finished. Results are 
represented in Graph 1.1 below. 
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Graph 1.1 – Temperatures of the ball, inside wall and outside wall of the grinding 
jar every 2 min of reaction. 
The average increase of temperature for the grinding ball and the inside and 
outside walls of the grinding jar during the 25 min of reaction is only 4.5 °C. 
We believe this increase is not significantly high and it is not a determining 
factor for the reaction. 
When the same reaction conditions (1.3 eq. of NaBH4, 20.0 Hz of frequency) 
were used for the reduction of 20 (Route B), using a 25 mL stainless steel 
grinding jar provided with one stainless steel grinding ball with a diameter of 
2.5 cm, the reaction reached full conversion after only 5 min of grinding, 
providing 83% yield after purification by acid/base extraction workup 
(Scheme 1.21).  
 
Scheme 1.21 – Optimised conditions for the racemic reduction of 20 
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The yield obtained through this new methodology is similar to the one 
reported in the literature (90%).92 However, the reaction time has been 
shortened from 1 h to only 5 min. Furthermore, our method has the 
advantage of not requiring any solvent for the reaction. 
1.3.2.3. Step 3 – O-Arylation 
In the search of new routes for fluoxetine’s syntheses, in 2002, Peter O’Brien 
developed a methodology to access 3-aryloxy-3-aryl-1-propanamines.98 This 
approach is based on the mesylation of the corresponding aminoalcohol 5, 
followed by an intramolecular substitution reaction that leads to an 
azetidinium ion intermediate. A second SN2 reaction where the corresponding 
phenol acts as nucleophile provides the O-arylated product (R)-7 in 33% 
yield and 85% ee, with overall retention of the configuration (Scheme 
1.22).98 The small loss of the enantiopurity is attributed to the ring opening 
of the azetidinium intermediate.98 
 
Scheme 1.22 – Synthesis of 3-aryloxy-3-aryl-1-propanamines via azetidinium ion 
intermediate 
We decided to investigate the effect of ball milling in this reaction, in an 
attempt to increase the yield. Due to the high toxicity of methanesulfonyl 
chloride (MsCl), p-toluenesulfonyl chloride (TsCl) was used instead in our 
experiments, using phenol as nucleophile for the preliminary tests (Scheme 
1.23).  
Both shaker and planetary mills were explored for this reaction, using 
different grinding ball sizes, shaking frequencies/rpm, and reaction times for 
both steps of the reaction sequence. In all experiments, the planetary mill 
was used with the 50 mL stainless steel grinding jar while the shaker mill 
was used with the 25 mL stainless steel grinding jar. The use of plastic 
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Eppendorfs as grinding jars was discarded and not tested in the shaker mill, 
based on the previous negative results during the reduction reaction.  
Different bases were also evaluated (Et3N, K2CO3, DMAP). After a through 
optimization process, the best conditions for the step 1 (Scheme 1.23a) 
resulted in the use of the shaker mill with the 25 mm diameter stainless steel 
grinding ball, triethylamine as base (1.2 eq.) and 1.1 eq. of p-toluenesulfonyl 
chloride. Full conversion was achieved (disappearance of 5 confirmed by GC-
MS) after 3 h of shaking at 20.0 Hz. Next, the grinding jar was opened and 
potassium carbonate and phenol were added. 
The optimization of step 2 (Scheme 1.23b) was therefore carried out in the 
shaker mill with the 25 mm diameter stainless steel grinding ball. Different 
bases (K2CO3 and NEt3) and equivalents of nucleophile (phenol) were tested. 
The optimal conditions found consisted of the use of potassium carbonate 
(2.0 eq.) and 5 eq. of phenol. The azetidinium ion intermediate is not visible 
by GC-MS, so it was not possible to track the progress of the reaction. An 
overall yield of 14% from 5 was obtained after 4 h of shaking at 20.0 Hz and 
purification by column chromatography.  
 
Scheme 1.23 – Tosylation reaction and reaction with phenol 
When the optimised conditions were applied using p-trifluoromethylphenol as 
arylating agent, the corresponding product 7 (fluoxetine’s precursor) was 
obtained in 8% overall yield from 5 after 6 h of milling at 20.0 Hz and 
purification by column chromatography (Scheme 1.24). Longer reaction 
times or different bases (NEt3) in the second step of the reaction were 
tested, but, unfortunately, higher yields could not be achieved. 
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Scheme 1.24 – Tosylation reaction and substitution with phenol derivative 
In spite of all our efforts, the yield of the fluoxetine precursor 7 was very low 
with this strategy, so we decided to explore new strategies for the O-
arylation step. 
Rej et al. reported, in 2013, a 9 steps asymmetric synthesis of fluoxetine 
using benzaldehyde as starting material, with 23% overall yield.99 Their O-
arylation step consisted on a Mitsunobu reaction, that leads to the 
corresponding arylated product with inversion of configuration and a yield of 
60-70% (Scheme 1.25).99  
 
Scheme 1.25 – Mitsunobu reaction with inversion of configuration 
This same strategy was explored in neat conditions using both planetary and 
shaker ball mills at different frequencies and rpm, testing several grinding 
ball sizes (Scheme 1.26). After optimisation of reaction times and equivalents 
of each reagent, we concluded that the best results were obtained in the 
shaker mill, using a single 2.5 cm diameter stainless steel grinding ball at 
20.0 Hz for 3h 30min. Thus, the use of triphenylphosphine (1 eq.), 
diisopropyl azodicarboxylate (1 eq.) and p-trifluoromethylphenol (1 eq.), 
provided 44% conversion and 25% isolated yield of 7, after purification by 
column chromatography). 
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As comparison, when the reaction was carried out in the planetary ball mill, 
using a 50 mL stainless steel grinding jar provided with both a 2.5 cm and a 
1.0 cm diameter stainless steel grinding balls at 250 rpm for 14 h, only 25% 
conversion of 7 was achieved (determined by GC-MS). Under analogous 
reaction conditions, liquid assisted grinding was also attempted in the 
planetary ball mill, using 100 µL of dichloromethane for 0.25 mmol of 
substrate. Only 15% conversion was obtained after 6 h of grinding at 250 
rpm. 
 
Scheme 1.26 – Mitsunobu reaction in the ball mill 
Although the yield of 7 obtained with this approach was higher than the 
previous tosylation strategy, it is still not satisfactory enough to use in a 
pharmaceutical synthesis. In addition, the fact that a purification by column 
chromatography is needed is not feasible in a commercially production scale. 
As a matter of fact, both previous methodologies generate considerable 
amounts of waste. In the case of the tosylation reaction, two reaction steps 
are required and a total of 5 reagents are involved in the reaction. On the 
other hand, the Mitsunobu procedure is based on stoichiometric amounts of 
reagents that generate undesired waste such us triphenylphosphine oxide. 
For this particular reasons, we decided to change the approach and look for 
a catalytic and more sustainable strategy.  
Amongst the O-arylation reactions present in the literature, the palladium 
catalysed coupling developed by S. L. Buchwald drew our attention for being 
a catalytic process with minimal generation of waste (Scheme 1.27).100, 101  
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Scheme 1.27 – Buchwald’s palladium catalysed coupling 
The coupling of primary and secondary alcohols with aryl halides is based on 
the utilisation of Pd(OAc)2, a phosphine ligand and Cs2CO3 as a base. The 
catalytic cycle for the process is represented in Scheme 1.28. 
 
Scheme 1.28 – Pd catalysed cycle for the O-arylation of secondary alcohols 
As reported by Buchwald et al., the success of this catalytic cycle depends on 
the ability of the alkoxide intermediate A to undergo a reductive elimination, 
avoiding a β-hydride elimination reaction that would lead to the oxidised 
product. The best way to prevent β-hydride elimination is the use bulky 
ligands (see some examples in Scheme 1.27) and activated aryl halides.101 
Scheme 1.28 below shows some results reported by Buchwald et al. using 
this methodology. The authors describe a 24 h reaction in tributylamine as 
solvent, cesium carbonate as base and palladium acetate/L1 as catalyst. The 
use of these conditions allows a low catalyst loading (2 mol%) and leads to 
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yields up to 92%. Satisfyingly, the use of the bulky phosphine L1 completely 
suppresses the formation of any β-hydride elimination product. Many 
functionalities are allowed in the aryl halide coupling partner, however, 
hindered alcohols provide lower yields. 
 
Scheme 1.28 – Buchwald’s methodology results for different secondary alcohols and 
aryl halides  
Inspired by these results, we tested the Pd catalysed O-arylation reaction for 
our substrate 5 in the ball mill under solvent free conditions. Different bases, 
Pd sources and phosphine ligands* were evaluated in both the shaker and 
planetary mill (see Table 1.4 for further details). In case of the shaker mill, a 
single 2.5 cm diameter stainless steel grinding ball was used, whereas in the 
planetary ball mill a 2.5 cm and a 1.0 cm diameter stainless steel grinding 
balls were used together.  
A through screening of different conditions and catalyst combinations was 
performed, but no product 7 was obtained in any case and the starting 
material was always recovered. 
 
 
 
 
                                                             
* None of the bulky Buchwald ligands were available in our laboratories and were not tested. 
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Table 1.4 – Pd based coupling reaction in solvent free conditions 
 
 
 
We were aware that the use of deactivated para-CF3 aryl halides as coupling 
partners was an extra challenge for this coupling reaction, that would 
hamper the oxidative addition step. For this reason, we also performed 
several reactions using iodobenzene as coupling partner instead, however, 
no O-arylation product was observed in any case either.  
Based on Ullmann’s ether synthesis,102, 103 Buchwald et al. developed another 
O-arylation methodology using CuI as a catalyst and 1,10-phenanthroline as 
a ligand (Scheme 1.29). Thus, the coupling reaction between an aliphatic 
alcohol (primary or secondary) and an aryl iodide is performed in neat 
alcohol, or, if the alcohol is a precious compound, the reaction can be carried 
out in toluene using only 2 eq. of the alcohol.104 Good yields are obtained 
using only 10 mol% of CuI and 20 mol% of phenanthroline, using cesium 
carbonate as base (2 eq.), as depicted in the examples in Scheme 1.29. 
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Scheme 1.29 – Results of the CuI methodology for different alcohols and aryl 
iodides 
A few years later, in 2009, Tao et al. extended this methodology to the use 
of both aryl bromides and chlorides as coupling partners, by using 3,4,7,8-
tetramethyl-1,10-phenanthroline as ligand.105 However, their scope only 
included the O-arylation of benzylic alcohols.  
Buchwald et al. also developed a ligand-free copper-catalysed arylation of β-
amino alcohols in which the reaction site could be controlled by tuning the 
reaction conditions.106 Thus, selective O-arylation of amino alcohols with 
several aryl iodides (1.2 eq.) can be achieved in the presence of CuI (5 
mol%), Cs2CO3 (2 eq.) in butyronitrile at 125 
oC (Scheme 1.30).  
 
Scheme 1.30 – Buchwald’s selective O-arylation of amino alcohols 
The reaction requires long reaction times (14-48 h), but the method does 
not require the use of any ligand and allows the synthesis of the O-arylated 
product in moderated to good yields (50-80%). Reactions with primary β-
amino alcohols (primary amine) exhibit higher N/O-arylation ratio and/or 
higher diaryl byproduct formation compared to the secondary ones.106  
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The absolute lack of reactivity of simple alcohols (e.g. 1-octanol) under these 
conditions points out that the presence of a neighbouring amine group is 
necessary for the activation of the alcohol.106 In fact, the selective ligand 
free arylation of amino alcohols is only possible because of the formation of 
a five-membered chelate ring (see Scheme 1.31, formation of products 24a 
and 24b).107, 108  
As represented in Scheme 1.31, the solvent plays a crucial role in regards 
the N/O-arylation selectivity of aminoalcohols where the formation of a five-
membered chelate ring is possible. For example, in the presence of CuI as 
catalyst, the substrate 22 undergoes N-arylation with 1-iodo-4-
methylbenzene (in good selectivity) when the reaction is carried in 
acetonitrile, while O-arylation is observed (in moderate selectivity) when the 
THF is used as solvent (Scheme 1.31).107  
For aminoalcohols where it is not possible to form a five-membered chelate 
ring (substrate 21, Scheme 1.31), the use of the ligands L2 and L3 allows 
the selective N- or O-arylation, respectively. 
 
Scheme 1.31 – Buchwald’s N- vs O-arylation of aminoalcohols catalysed by CuI 
With this background, we envisioned that the development of a copper 
catalysed O-arylation reaction for the fluoxetine synthesis could be a good 
approach and decided to evaluate the reaction with and without a ligand. 
We attempted the O-arylation reaction of 5 using ball milling techniques 
(Scheme 1.32) under solventless conditions. The reaction was attempted in 
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the shaker mill at 20.0 Hz using a 25 mm diameter stainless steel grinding 
ball, and in the planetary ball mill at 250 rpm using a 25 mm and a 10 mm 
diameter stainless steel grinding balls. Unfortunately, no product was 
obtained and starting material was recovered in all cases (0% conversion).  
 
Scheme 1.32 – CuI coupling reaction in the ball mill 
As a mode of comparison, we performed the O-arylation reaction of 5 under 
classical conditions (reflux in toluene, Scheme 1.33), using 1 eq. of the aryl 
iodide, 10 mol% of CuI, 20 mol% of 1,10-phenanthroline and 2 eq. of 
cesium carbonate. Surprisingly, we observed very low conversion (20%) 
after 5 days of reaction time (Scheme 1.33). 
 
Scheme 1.33 – CuI coupling reaction in solvent conditions 
However, we were pleased to find out that the reaction of 5 (0.1 M in 
toluene) and 1-iodo-4-(trifluoromethyl)benzene (1 eq), with 10 mol% of CuI, 
20 mol% of 1,10-phenanthroline and 2 eq. of cesium carbonate gave 75% 
conversion when carried out with MW assisted heating with only 3 h at 200 
°C (entry 1, Table 1.5). With this preliminary results in hand, we performed 
an extensive optimization screening in order to find the best conditions for 
this synthetic step (Table 1.5).  
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Table 1.5 – Optimisation of the O-arylation reaction in the MW 
 
 
 
 
Entry Aryl halide Catalyst Ligand Base Solvent Conc. of 5 Conv.
b
 
1 X =  I, R = CF3 CuI (10 mol%) 1,10-phenanthroline (20 mol%) Cs2CO3 toluene 0.1 M 75% 
2 X =  I, R = H CuI (10 mol%) 1,10-phenanthroline (20 mol%) Cs2CO3 toluene 0.1 M 60% 
3 X =  I, R = H CuI (10 mol%) 2,2'-bipyridine (20 mol%) Cs2CO3 toluene 0.1 M 73% 
4 X =  I, R = H CuI (10 mol%) 2,2'-bipyridine (20 mol%) KOH toluene 0.1 M 0% 
5 X =  I, R = H CuI (10 mol%) 2,2'-bipyridine (20 mol%) KOtBu toluene 0.1 M 0% 
6 X =  I, R = H CuI (10 mol%) 2,2'-bipyridine (20 mol%) Cs2CO3 o-xylene 0.1 M 96% 
7 X =  I, R = H CuI (10 mol%) 2,2'-bipyridine (20 mol%) Cs2CO3 1,2-dichlorobenzene 0.1 M 63% 
8 X =  I, R = H CuI (10 mol%) 2,2'-bipyridine (20 mol%) Cs2CO3 DMF 0.1 M 64% 
9 X =  I, R = H CuI (10 mol%) 2,2'-bipyridine (20 mol%) Cs2CO3 ethylbenzene 0.1 M 81% 
10 X =  I, R = CF3 CuI (10 mol%) 2,2'-bipyridine (20 mol%) Cs2CO3 o-xylene 0.1 M 98% 
11 X =  I, R = CF3 no catalyst no ligand Cs2CO3 o-xylene 0.1 M 10% 
12 X =  I, R = CF3 CuI (20 mol%) 2,2'-bipyridine (40 mol%) Cs2CO3 o-xylene 0.1 M 92% 
13 X =  I, R = CF3 CuI (5 mol%) 2,2'-bipyridine (10 mol%) Cs2CO3 o-xylene 0.1 M 90% 
14 X =  I, R = CF3 CuI (10 mol%) no ligand Cs2CO3 o-xylene 0.1 M 99% 
15 X =  I, R = CF3 CuI (10 mol%) no ligand Cs2CO3 xylene (isomer mixture) 0.1 M 80% 
16 X =  I, R = CF3 CuI (10 mol%) no ligand Cs2CO3 p-xylene 0.1 M 68% 
17 X =  I, R = CF3 CuI (20 mol%) no ligand Cs2CO3 o-xylene 0.1 M 99% 
18 X =  I, R = CF3 CuCl (10 mol%) no ligand Cs2CO3 o-xylene 0.1 M 99% 
19 X =  I, R = CF3 CuCl2 (10 mol%) no ligand Cs2CO3 o-xylene 0.1 M 74% 
20 X =  I, R = CF3 CuI (10 mol%) no ligand Cs2CO3 o-xylene 0.2 M 76% 
21 X = Br, R = CF3 CuI (10 mol%) no ligand Cs2CO3 o-xylene 0.1 M 51% 
22 X = Cl, R = CF3 CuI (10 mol%) no ligand Cs2CO3 o-xylene 0.1 M 1% 
a Reaction Conditions: 5 (1.0 eq.), aryl halide (1.1 eq.), base (2.0 eq.)  b Conversion determined by GC-MS after heating for 3h at 200 °C 
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Our optimization studies started by evaluating the reaction of 5 with 
iodobenzene using 1,10-phenanthroline and 2,2’-bipyridine as ligands 
(entries 2 and 3 respectively), using Cs2CO3 (2 eq.) as base in toluene. The 
later ligand, 2,2’-bipyridine, provided higher conversion (73%, entry 3, 
versus 60%, entry 2), so it was selected for the next reactions. 
Other bases such as KOH and KOtBu were tested (entries 4 and 5) but no 
product 7 was obtained at all. We also screened different solvents (entries 6-
9); o-xylene providing the highest conversion (96%, entry 6). The method 
seemed robust and similar result was obtained when 4-iodobenzotrifluoride 
was used as coupling parter (98% conversion, entry 10).  
In the absence of any copper salt and ligand, the O-arylation reaction of 5 
with 4-iodobenzotrifluoride led only to 10% conversion (entry 11). Higher 
loadings of CuI and ligand (20 and 40 mol%, respectively) did not improve 
the conversion of the reaction (entry 12) while lower CuI/ligand loadings (5 
and 10 mol%, respectively) lead to an small drop in conversion (entry 13).  
Gratifyingly, the O-arylation of 5 with 4-iodobenzotrifluoride worked in the 
presence of 10 mol% of CuI without any ligand (entry 14), reaching full 
conversion after 3 h.  
It is important to note that when an isomeric mixture of xylene was used as 
solvent, instead of o-xylene, the conversion was lower (80%, entry 15, 
versus 99%, entry 14), and when the reaction was performed in p-xylene, 
only a 68% conversion was obtained after 3 h (entry 16). We believe this 
could be due to the decrease of the dipole moment of the p-xylene 
compared to the other isomers of the molecule. 
Doubling the amount of CuI to 20 mol% did not shorten the reaction time 
(entry 17). 
In addition, we screened different copper sources (entries 18 and 19). CuCl 
proved to be as efficient as CuI (99% conversion, entry 17) whilst with CuCl2 
(entry 19), lower conversion was obtained (74%).  
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Next, we evaluated the concentration of substrate 5 in the reaction. 
Unfortunately, higher concentrations than the original 0.1 M led to lower 
conversions (entry 20). 
Last, we applied our optimised conditions for the O-arylation of 5 with 4-
bromobenzotrifluoride and 4-chlorobenzotrifluoride (entries 21 and 22 
respectively). However, low conversion (51%) was obtained in the case of 
the corresponding aryl bromide and no reaction took place when the aryl 
chloride was used as coupling partner. 
To summarise, the best conditions to carry out the O-arylation of 5 (Route 
A) are shown in the scheme below (Scheme 1.34). This methodology allows 
the synthesis of the fluoxetine’s precursor 7 in 99% conversion after 3 h of 
MW dielectric heating. 
 
Scheme 1.34 – Optimised conditions for the O-arylation reaction of 5 under MW 
irradiation 
When the analogous reaction, under the same conditions, was carried out in 
solution (using an oil bath) only 23% of conversion was reached after 3 h of 
heating to reflux at 145 °C (see Scheme below). This result points out the 
advantages of using MW assisted heating, supporting the higher rates of 
reaction previously described in the literature.47  
 
Scheme 1.35 – O-arylation reaction of 5 under traditional heating 
Next, we applied the optimised reaction conditions to the O-arylation of 10 
(Route B). Satisfyingly, the reaction reached full conversion after only 2 h of 
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microwave assisted heating and a simple filtration through a plug of Celite® 
allowed us to obtain 9 in a quantitative yield (Scheme 1.36). 
 
Scheme 1.36 - Optimised conditions for the O-arylation reaction of 10 
1.3.2.3.1. O-Arylation – Scope of the reaction 
Being aware of the potential of the methodology just developed, we decided 
to expand the scope of the reaction using different amino alcohols and aryl 
iodides. As a reference, the results would be compared to the ones 
previously described by Buchwald’s research group.106-108 
Our aim was to proof that MW assisted heating would decrease the long 
reaction times described by Buchwald and, at the same time, analyse if our 
methodology would lead to higher N/O selectivities.  
The O-arylation of 2-(methylamino)ethanol with 2-iodo-1,3-dimethylbenzene 
was chosen as model reaction (Scheme 1.38).  
Under Buchwald´s reaction conditions106 (5 mol% CuI, 1.2 eq. of aryl iodide 
and 2 eq. of cesium carbonate) the O-arylation of 2-(ethylamino)ethanol 
proceeds in 72% yield after 30 h, using butyronitrile as solvent, under 
classical reflux conditions (Scheme 1.37).  
 
Scheme 1.37 – Buchwald O-arylation reaction of 2-(ethylamino)ethanol under 
classical reflux conditions 
When our optimised conditions for the O-arylation reaction of 5 (Scheme 
1.34) were applied to our model reaction with 2-(methylamino)ethanol, 6% 
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conversion was obtained after 4 h of MW assisted heating (Scheme 1.38). 
Even though we only observed O-arylation product, the reaction was much 
slower compared to the one developed by Buchwald’s group (Scheme 1.37 
vs Scheme 1.38). 
 
Scheme 1.38 – O-arylation reaction of 2-(methylamino)ethanol under MW 
irradiation 
Next, we decided to examine the difference in the N/O-arylation ratio when 
using primary amines as substrates. We chose the coupling of ethanolamine 
with p-iodotoluene as model reaction (Scheme 1.40).  
Buchwald described the reaction between ethanolamine and p-iodotoluene 
under two different reaction conditions (Scheme 1.39).107 The ligand free 
reaction in dimethylformamide at room temperature leads to the N-arylated 
product in high yield (92%). However, when toluene is used as a solvent at 
90 °C, together with ligand L3 (Buchwald’s optimal conditions for O-
arylation) the desired O-arylation product is obtained with poor selectivity 
and low yield (16%, Scheme 1.39).  
 
Scheme 1.39 – Buchwald O-arylation reaction of ethanolamine under classical reflux 
conditions 
In an attempt to improve Buchwald´s results, we carried out the O-arylation 
reaction of ethanolamine using our coupling optimised conditions in the 
microwave. However, in spite of increasing our catalyst loading up to 10 
CHAPTER 1 
 
54 
 
mol%, no product was observed after 2 h of heating under MW conditions 
(Scheme 1.40).  
 
Scheme 1.40 – O-arylation reaction of ethanolamine under MW irradiation 
Next, we studied the reaction of 3-aminopropan-1-ol with p-iodotoluene. 
Under Buchwald´s conditions,107 the reaction, in the presence of L2 and 
dimethylformamide as solvent affords the corresponding N-arylated product 
in excellent yield and selectivity (96%, 45:1) at room temperature (Scheme 
1.41). When the same reaction is executed in toluene at 100 °C in the 
absence of any ligand, the O-arylated product is only obtained in moderate 
yield (64%) and low selectivity (2:1, Scheme 1.41). 
 
Scheme 1.41 – O-Arylation reaction of 3-aminopropan-1-ol under classical Buchwald 
conditions 
We attempted the same reaction conditions using MW assisted heating 
instead of classical reflux conditions (Scheme 1.42). Unfortunately, we 
obtained the same O/N-arylation selectivity (2:1) and lower conversion 
(31%, Scheme 1.42a) than Buchwald´s report.107 Interestingly, when o-
xylene was used as solvent, a switch in the N/O-arylation selectivity was 
observed (N/O 3:1), although the conversion for this reaction was only 58% 
(Scheme 1.42b).  
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Scheme 1.42 – O-Arylation reaction of 3-aminopropan-1-ol under MW irradiation 
The switch in N/O-arylation selectivity that the solvent provided is an 
interesting fact. With further optimization, and perhaps with the aid of some 
ligands, the reaction could reach good levels of selectivities under MW 
irradiation, in shorter reaction times than Buchwald´s methodology. More 
work needs to be carried out in this area.  
1.3.2.4. Step 4 - N-Demethylation 
In 1984, Olofson, Senet et al. described the use of -chloroethyl 
chloroformate for the selective N-dealkylation of tertiary amines.109 The 
tertiary amine reacts with -chloroethyl chloroformate, and the carbamate 
intermediate is subsequently treated with methanol. The mechanism of the 
process is described below (Scheme 1.43). 
 
Scheme 1.43 – Mechanism for the N-dealkylation reaction with -chloroethyl 
chloroformate 
Some years later, in 2000, R. Noyori et al. successfully applied this 
methodology to the N-demethylation of 7, leading to fluoxetine 
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hydrochloride (1) in 96% yield.110 The reaction conditions are described in 
Scheme 1.44 below. 
 
Scheme 1.44 – Reaction conditions for the N-dealkylation of 7 by R. Noyori 
Many attemps were done in order to reproduce Noyori’s reaction (Scheme 
1.44) but unfortunatelly none of them were successful.  
The demethylation of 7 with -chloroethyl chloroformate was first attempted 
in dichloromethane (0.1 M) under the above described reaction conditions, 
but only 2% conversion was observed after the treatment of the 
corresponding carbamate with methanol. 
The reaction was also attempted under reflux conditions. Unfortunately, 
refluxing a mixture of 7 and -chloroethyl chloroformate during 15 h in 
dichloromethane, followed by the addition of methanol and subsequent 
stirring at 50 °C for 1 h; did not improve the conversion (4%). When the 
concentration of 7 was increased to 0.5 M in dichloromethane, the reaction 
only reached 7% conversion. 
The reaction was then carried out in dichloroethane as solvent (0.1 M and 
0.5 M of 7), under the same conditions reported in the literature,110 but no 
improvement in conversion (c.a. 7%) was observed after 6 h of classical 
reflux. 
A neat reaction in 5 eq. of -chloroethyl chloroformate was also carried out, 
but the reflux of the mixture for 3 h only led to decomposition products. 
After these unsuccessfull attemps to carry out this reaction under classical 
heating conditions, ball milling technologies and microwave assisted 
reactions were also assayed. 
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The reaction was tried in the planetary ball mill using a 25 mm and a 10 mm 
diameter stainless steel grinding balls in the 50 mL stainless steel grinding 
jar. A mixture of 7, -chloroethyl chloroformate (1 eq.) and methanol (5 eq.) 
were ground for 21 h at 250 rpm, but the reaction only led to 3% 
conversion. 
Surprisingly, when the same reaction was performed with microwave 
assisted heating using 5 eq. of -chloroethyl chloroformate, 89% conversion 
was obtained after heating for 2 h in dichloroethane (1 h at 120 °C and 1 h 
at 150 °C), followed by the addition of methanol and subsequent heating for 
1 h at 120 °C. 
Longer reaction times with MW irradiation did not increase the conversion. 
After 1 h at 120 °C and 3 h at 150 °C in dichloroethane and 1 h at 120 °C in 
methanol, the conversion of 7 into 1 was still 88%. 
After the N-demethylation reaction, a recrystallisation in AcOEt:hexane led to 
76% yield of pure fluoxetine hydrochloride (1, 66 mg) (Scheme 1.45). 
 
Scheme 1.45 – N-Demethylation reaction with MW assisted heating 
1.3.3. Conclusions 
A greener synthesis of fluoxetine has been developed. Fluoxetine 
hydrochloride (1) has been obtained with an overall yield of 47% through 
both Routes A or B.  
The developed synthesis of fluoxetine through Route A is summarized below 
(Scheme 1.46). 
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Scheme 1.46 – Route A, greener synthesis for the preparation of fluoxetine 
hydrochloride 
 The Mannich condensation of acetophenone (19) led to the 
aminoketone 3 in 65% yield after only 1 h of heating in the 
microwave (Step 1). This shortens considerably the Mannich reaction 
times previously described in the literature.88-91 
 The carbonyl reduction of 3 in the ball mill afforded 5 in 96% yield. 
No solvent was needed for the reaction, which finished after only 25 
min of grinding in a shaker ball mill (Step 2). The reaction time of the 
solution based reaction described in the literature is 15 h.87, 97 
 The O-arylation reaction was fully optimised, reaching 99% yield after 
3 h of heating in the microwave (Step 3). When the reaction was 
done under classical reflux conditions, only 23% conversion was 
reached after 3 h. 
 Although it was not possible to replicate the literature reaction 
conditions110 for the N-demethylation of 7 in solution, the reaction in 
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the microwave proved to be reproducible and provided 1 in 76% yield 
after 3 h (Step 4). 
The developed synthesis of fluoxetine through Route B is summarized below. 
(Scheme 1.47) 
 
Scheme 1.47 – Route B, greener synthesis for the preparation of fluoxetine 
 The Mannich condensation of acetophenone (19) afforded 
aminoketone 20 in 57% yield after 5 h of microwave assisted heating 
(Step 1). Although this Mannich reaction proved to be harder than the 
one in Route A, the result is still an improvement when compared it to 
the 20 h reaction described in the literature.111  
 The carbonyl reduction of 20 in the ball mill afforded 10 in 83% yield 
(Step 2). The non-solvent reaction finished after only 5 min of shaking 
in the shaker mill. The reaction time of the solution based reaction 
described in the literature is 1 h.92   
 The O-arylation reaction was fully optimised, reaching >99% yield 
after 2 h of heating in the microwave (Step 3). 
In conclusion, the use of ball milling and microwave assisted heating 
represented a substantial improvement compared to the previously described 
synthetic methodologies based on conventional heating methods, not only by 
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allowing higher yields and shorter reaction times, but also by reducing the 
amount of solvent and diminishing the number of process operations. This 
leads to a potential reduction of the production costs of fluoxetine, that 
could ultimately decrease the price of the drug for the consumers. 
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1.4. Synthesis of duloxetine (Cymbalta) 
1.4.1. Results and discussion 
With the ball mill and MW optimised conditions for the synthesis of fluoxetine 
in hand, we decided to expand the scope of our synthetic strategy to the 
synthesis of duloxetine. Due to their structural similarities, we thought it 
would be feasible to carry out both synthetic routes (A and B) for the new 
target (Scheme 1.48). 
 
Scheme 1.48 – Proposed synthesis for duloxetine 
1.4.1.1. Step 1 – Mannich Condensation 
The reaction between acetylthiophene (25) and dimethyl- or methylamine 
hydrochlorides in the presence of paraformaldehyde was studied under MW 
assisted heating. The optimised conditions for the Mannich condensation 
used in the synthesis of fluoxetine (section 3.2.1 of this thesis) were chosen 
as our starting point for this new reaction. 
Mechanochemistry was not evaluated in this case because of the low 
conversions obtained in the condensation of acetophenone with dimethyl- or 
methylamine hydrochlorides (synthesis of fluoxetine, section 3.2.1). 
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Thus, under MW irradiation, the reaction of 25 with 1.25 eq. of 
dimethylamine hydrochloride and 1.50 eq. of paraformaldehyde in 
isopropanol, provided the hydrochloride salt 26 in 74% yield after only 1 h 
at 110 °C (entry 1, Table 1.6). The yield of the reaction could not be 
improved with longer reaction times (2h, entry 2). Similarly, the synthesis of 
29 was achieved in 44% yield, using ethanol as solvent and microwave 
assisted heating at 130 °C (entry 3). Longer reaction times did not lead to 
higher yields (entry 4). 
Table 1.6 – MW assisted Mannich reaction for the synthesis of 26 and 29. 
 
Entry Product HNRMe      
(eq.) 
HO(CH2O)nH 
(eq.) 
Solvent T  
(oC) 
Time 
(h) 
Yield 
(%)b 
1 26 HNMe2 (1.25) 1.50 
iPrOH 110 1 74 
2 26 HNMe2 (1.25) 1.50 
iPrOH 110 2 70 
3 29 H2NMe (1.10) 1.40 EtOH 130 4 44 
4 29 H2NMe (1.10) 1.40 EtOH 130 5 34 
a Reaction Conditions: 25 (1 eq.), HNRMe, paraformaldehyde, solvent, MW . b Isolated 
yield. 
 
1.4.1.2. Step 2 – Carbonyl Reduction 
The reduction of 26 and 29 was carried out in the shaker mill, using a 25 
mL stainless steel grinding jar provided with a 25 mm diameter stainless 
steel grinding ball. The reduction of 26 with 1.3 eq. of sodium borohydride 
for 25 min at 20.0 Hz led to the reduced product 27 in 88% yield (entry 1, 
table 1.7). The yield of the reaction could be improved to 92% with longer 
reaction times (entry 2). In an attempt to increase the yield even further, we 
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increased the equivalents of sodium borohydride to 2.0, obtaining 95% yield 
after 1 h (entry 3) and 97% yield after 2 h of reaction (entry 4). 
On the other hand, the reduction of ketone 29 with 1.3 eq. of sodium 
borohydride for 25 min, led to the corresponding alcohol 30 in 74% yield 
(entry 5). Unfortunately, in this case, increased amounts of sodium 
borohydride and longer reaction times did not improve the yield of the 
reaction (entry 6).  
Table 1.7 – Carbonyl reduction for the synthesis of 26 and 29. 
 
Entry Product NaBH4 (eq.) Time (min) Yield (%)
b 
1 27 1.3 25 88 
2 27 1.3 90 92 
3 27 2.0 60 95 
4 27 2.0 120 97 
5 30 1.3 25 74 
6 30 2.0 120 72 
a Reaction Conditions: 26 or 29 (1 eq.). b Isolated yield. 
 
1.4.1.3. Step 3 – O-Arylation 
The O-arylation reaction of both 27 and 30 with 1-iodonaphthalene was first 
carried out in the microwave reactor using the optimised conditions that 
were previously optimized for the O-arylation of fluoxetine (see section 
3.2.3). Unfortunately, the MW irradiation at 200 °C, in o-xylene as solvent, 
of the corresponding amino alcohol (27 or 30) and 1-iodonaphthalene (1.1 
eq.), in the presence of copper iodide (10 mol%) and caesium carbonate 
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(2.0 eq.), did not provide any O-arylated product 28 or 31 after 5 h (Table 
1.8, entries 1 and 2). 
Table 1.8 – O-Arylation reaction of 27 and 30 in the MW 
 
Entry R CuI (%mol) Base T (°C) Time (h) Conversion (%)b 
1 Me 10 Cs2CO3 200 5 - 
2 H 10 Cs2CO3 200 5 - 
3 H 30 Cs2CO3 200 2 - 
4 H 10 KOH 200 2 - 
5 Me 10 KOtBu 200 2 - 
6 Me 10 NaOH 200 2 - 
7 Me 10 NaOMe 200 2 - 
8 Me 10 K2CO3 200 2 2 
9 H 10 Cs2CO3 60 8 - 
a Reaction Conditions: 27 or 30 (1.0 eq.), 1-iodonaphthalene (1.1 eq.), base (2.0 eq.)  b Conversion 
determined by GC-MS. 
 
Higher catalyst loadings (30 mol% CuI), did not improve the conversion for 
the reaction with 30 (entry 3). Different bases (potassium hydroxide, 
potassium tert-butoxide, sodium hydroxide and sodium methoxide; entries 4-
7) were also screened, without any success. Only potassium carbonate gave 
2% conversion in the reaction of 30 after 2 h of MW irradiation at 200 oC 
(entry 8). 
Concerned about the idea that the starting material was decomposing at the 
reaction temperature (200 °C), we tested the reaction of 30 at lower 
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temperature (60 °C). Unfortunately, no conversion was observed after 8 h 
(entry 9). 
As a mode of comparison, we performed the reaction with 2-
iodonaphthalene as coupling partner. Surprisingly, the reaction of both 27 
and 30, in the presence of copper iodide (10 mol%) and cesium carbonate 
(2.0 eq.), reached full conversion under MW irradiation at 200 °C, using o-
xylene as a solvent, in less than 5 h (Scheme 1.49). 
 
Scheme 1.49 – O-Arylation reaction of 27 and 30 with 2-iodonaphthalene 
Furthermore, in order to rule out the possibility of 1-iodonaphthalene not 
being stable at high temperatures, we attempted the coupling reaction of 
fluoxetine precursor 5 with 1-iodonaphthalene. To our surprise, the reaction 
of 5 with 1-iodonaphthalene in the presence of copper iodide (10 mol%) and 
cesium carbonate (2.0 eq.), reached full conversion in 4 h under MW 
irradiation at 200 °C, using o-xylene as a solvent. (Scheme 1.50). The 
corresponding product 32 was obtained in 92% yield after purification by 
column chromatography. 
 
Scheme 1.50 – O-Arylation reaction of fluoxetine’s precursor 5 with 1-
iodonaphthalene 
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More work needs to be done to optimise the O-arylation reaction step in the 
synthesis of duloxetine. Different solvents, copper sources and ligands could 
be evaluated in the future. 
1.4.2. Conclusions 
It has not been possible to develop a complete synthesis for the preparation 
of the antidepressant duloxetine. The O-arylation of both intermediates 27 
and 30 was not possible under the optimised conditions for the previous 
synthesis of fluoxetine.  
The optimized first two steps in the synthesis of duloxetine through Route A 
are summarized below (Scheme 1.51). 
 
Scheme 1.51 – Route A, greener synthesis for the preparation of duloxetine’s 
precursor 
 The Mannich condensation of 2-acetylthiophene (25) led to the 
aminoketone 26 in 74% yield after only 1 h of heating in the 
microwave (Step 1). This shortens the reaction time of the Mannich 
reactions previously described in the literature (6-24 h of reaction), 
although the yield obtained is not as high as the ones reported (90-
94%).112, 113 
 The carbonyl reduction of 26 in the ball mill afforded 27 after 2 h, in 
97% yield. Both reaction time and yield are similar to the ones 
described in the literature (2-7 h, 90-95% yield),114, 115  but our 
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method has the advantage of avoiding the use of solvent for the 
reaction. 
The optimized first two steps in the synthesis of duloxetine through Route B 
are summarized below. (Scheme 1.52) 
 
Scheme 1.52 – Route B, greener synthesis for the preparation of duloxetine’s 
precursor 
 The Mannich condensation of acetophenone (25) afforded the 
aminoketone 29 in 44% yield after 4 h of microwave assisted heating 
(Step 1). Although this result shortens the 9 h reaction time of the 
procedure described in the literature,116 the yield obtained is much 
lower (44% cf. 71%). 
 The carbonyl reduction of 29 in the ball mill afforded 30 in 74% yield 
(Step 2). The non-solvent reaction finished after only 25 min of 
shaking in the shaker mill. Although the yield reported in the literature 
is slightly higher (86%),112 our method shortens considerably their 4 h 
reaction time and has the advantage of avoiding the use of solvent in 
the reaction. 
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1.5. Experimental Part 
1.5.1. General instrumentation 
TLC: Thin layer chromatography (TLC) was run on silica gel 60 aluminium 
sheets, 0.25 mm thick (F254 Merck KGaA®). The components were visualized 
by UV light (254 nm), phosphomolybdic acid or KMnO4 staining solutions.  
IR: IR spectra were recorded on Nicolet® 380 FT/IR – Fourier Transform 
Infrared Spectrometer. Only the most significant frequencies have been 
considered for the characterisation, and have been reported in cm-1.   
NMR: 1H NMR, 13C NMR and 19F NMR were recorded on a JEOL® ECS-400 
(400, 100.6 and 376.5 MHz, respectively) using CDCl3 or CD3OD as solvent. 
Chemical shift values are reported in ppm with TMS as internal standard 
(CDCl3: δ 7.26 for 
1H-NMR, δ 77.0 for 13C-NMR). Data are reported as 
follows: chemical shifts, multiplicity (s= singlet, br s = broad singlet, d= 
doublet, t= triplet, q= quartet, m= multiplet, br= broad), coupling constants 
(Hz), and integration. 
Flash chromatography: Column chromatography was carried out using 
Geduran® Silica gel 60, 40-63 microns RE.  
Melting points: Melting points were measured in a Stuart® SMP10 melting 
point apparatus and are not corrected. 
GCMS: Low resolution mass spectra were recorded on a GC-MS 
spectrometer (Hewlett Packard® HP 5890 Series II GC System) equipped 
with a DB-5 column (J&W Scientific®, 30 m × 0.32 mm), connected to a 
Hewlett Packard® HP 5972 Series Mass Selective Detector. Helium was used 
as carrier gas at 10 psi, and the samples were ionized by an electronic 
impact (EI) source at 70 eV. 
HRMS: High resolution mass spectra were obtained on a Agilent 
Technologies® 6540 Ultra-High-Definition (UHD) Accurate-Mass equipped 
with a time of flight (Q-TOF) analyzer and the samples were ionized by ESI 
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techniques and introduced through a high pressure liquid chromatography 
(HPLC) model Agilent Technologies® 1260 Infinity Quaternary LC system. 
Samples were eluted with mixture of MeOH and 0.1% formic acid, with a 
flow of 0.2 ml/min.  
Shaker ball mill: Reactions in the shaker ball mill were carried out in a 
Retsch® MM200 (shaker mill) using a 25 mL stainless steel grinding jar 
provided with one stainless steel grinding ball of 2.5 cm of diameter.  
Planetary ball mill: Reactions in the planetary ball mill were carried out in 
a Retsch® PM100 using a 50 mL stainless steel grinding jar and different 
sets of the grinding balls: (a) 2 stainless steel grinding balls of 1.5 cm 
diameter each, (b) 5 stainless steel grinding balls of 1 cm diameter each, (c) 
10 stainless steel grinding balls of 0.8 cm diameter each, (d) 10 stainless 
steel grinding balls of 0.7 cm diameter each, (e) 5 stainless steel grinding 
balls of 0.6 cm diameter each, (f) 10 stainless steel grinding balls of 0.4 cm 
diameter each, or (d) 20 zirconium-coated grinding balls of 0.3 cm diameter 
each. 
MW: The microwave irradiation was carried out in an Anton Paar® 
Monowave 300, Microwave Synthesis Reactor, using 10 and 30 mL glass 
vials sealed with a PTFE-coated silicone septum and closed with a snap cap 
made of PEEK. 
1.5.2. General methods and considerations 
All commercially available reagents were purchased from Aldrich, Acros, Alfa 
Aesar, Manchester Organics, Fisher and Maybridge and used without further 
purification, unless stated otherwise. 
Ball mill reactions: Before starting the grinding process, the grinding jar 
was flushed for 0.5 min with a stream of argon after all the reagents were 
added.  
MW reactions: A dry MW-glass vial was filled with argon and sealed with a 
rubber septum. All the chemicals were added under argon atmosphere. The 
CHAPTER 1 
 
70 
 
septum was quickly changed for a snap cap before inserting the vial inside 
the Microwave Synthesis Reactor. 
1.5.3. Experimental procedure and data of compounds 
1.5.3.1. Mannich reactions under MW irradiation 
3-(Dimethylamino)propiophenone hydrochloride 
(3).117 Concentrated HCl (40 µL, 0.5 mmol) was added 
dropwise to a solution of acetophenone (961 mg, 8.0 
mmol), dimethylamine hydrochloride (832 mg, 10.0 
mmol) and paraformaldehyde (360 mg, 12.0 mmol) in iPrOH (4 mL) at RT 
under Ar atmosphere, in a 30 mL MW glass tube. The mixture was heated in 
the MW to 110 °C for 60 min and a solid precipitated inside the glass tube. 
The resulting solid was removed by filtration, washed with acetone and dried 
under vacuum. Pure 3-(dimethylamino)propiophenone hydrochloride (3) was 
obtained as a white solid (1.10 g, 65%). Mp = 153–156 °C [lit.
118 Mp = 153–
154 °C]. IR (ATR) 3400 (br), 2946, 2662, 1674, 1334, 1222, 958 cm-1. 1H 
NMR (400 MHz, CD3OD) δ 8.80–7.20 (m, 5H), 4.45–2.25 (m, 4H), 3.75 (s, 
6H). 13C NMR (100.6 MHz, CD3OD) δ 198.3, 137.2, 135.0, 129.9, 129.3, 
54.4, 43.9, 34.2. Data in agreement with the literature. 
3-(Methylamino)-1-phenylpropan-1-one 
hydrochloride (20).111 Concentrated HCl (125 µL, 1.5 
mmol) was added dropwise to a solution of 
acetophenone (3.00 g, 25.0 mmol), methylamine 
hydrochloride (1.86 g, 27.5 mmol) and paraformaldehyde (1.05 g, 35.0 
mmol) in EtOH (12.5 mL) at RT under Ar atmosphere, in a 30 mL MW glass 
tube. The mixture was heated in the MW to 130 °C for 5 h. The solvent was 
then removed under vacuum and the crude product was purified by 
recrystallization (iPrOH/AcOEt) to afford pure 3-(methylamino)-1-
phenylpropan-1-one hydrochloride (20) as a white solid (2.82 g, 57%). Mp = 
113–118 °C [lit.111 Mp = 113–115 °C]. IR (ATR) 3390 (br), 2941, 2694, 
2448, 1679, 1373, 1223, 749 cm-1. 1H NMR (400 MHz, CD3OD) δ 8.10–7.45 
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(m, 5H), 3.58–3.35 (m, 4H), 2.77 (s, 3H). 13C NMR (100.6 MHz, CD3OD) δ 
198.6, 137.2, 135.0, 129.9, 129.3, 45.5, 35.5, 34.1. Data in agreement with 
the literature.  
3-(Dimethylamino)-1-(2-thienyl)-1-propanone 
hydrochloride (26).112 Concentrated HCl (40 µL, 0.5 
mmol) was added dropwise to a solution of 
acetylthiophene (864 mg, 8.0 mmol), dimethylamine 
hydrochloride (832 mg, 10.0 mmol) and paraformaldehyde (360 mg, 12.0 
mmol) in iPrOH (4 mL) at RT under Ar atmosphere, in a 30 mL MW glass 
tube. The mixture was heated in the MW to 110 °C for 60 min and a solid 
precipitated inside the glass tube. The resulting solid was removed by 
filtration, washed with acetone and dried under vacuum. Pure 3-
(dimethylamino)-1-(2-thienyl)-1-propanone hydrochloride (26) was obtained 
as a white solid (1.31 g, 74%). Mp = 184–187 °C [lit.
118 Mp = 184–185 °C]. 
IR (ATR) 3078, 2960, 2552, 2444, 1650, 1412, 1224 cm-1. 1H NMR (400 
MHz, CD3OD) δ 8.15–7.95 (m, 1H), 7.85–7.95 (m, 1H), 7.28–7.20 (m, 1H), 
3.62–3.50 (m, 4H), 2.95 (s, 6H). 13C NMR (100.6 MHz, CD3OD) δ 191.1, 
143.9, 136.3, 135.0, 129.7, 54.1, 43.9, 35.3. Data in agreement with the 
literature. 
3-Methylamino-1-thiophen-2-yl-propan-1-one 
hydrochloride (29).111 Concentrated HCl (125 µL, 1.5 
mmol) was added dropwise to a solution of 
acetylthiophene (3.16 g, 25.0 mmol), methylamine 
hydrochloride (1.86 g, 27.5 mmol) and paraformaldehyde (1.05 g, 35.0 
mmol) in EtOH (12.5 mL) at RT under Ar atmosphere, in a 30 mL MW glass 
tube. The mixture was heated in the MW to 130 °C for 4 h. The solvent was 
then removed under vacuum and the crude product was purified by 
recrystallization (iPrOH/AcOEt) to afford pure 3-methylamino-1-thiophen-2-
yl-propan-1-one hydrochloride (29) as a pale brown solid (2.28 g, 44%). Mp 
= 140–142 °C [lit.111 Mp = 139–141 °C]. IR (ATR) 3383 (br), 2970, 2736, 
2450, 1650, 1411, 755 cm-1. 1H NMR (400 MHz, CD3OD) δ 7.98–7.95 (m, 
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1H), 7.92–7.86 (m, 1H), 7.25–7.20 (m, 1H), 3.52–3.35 (m, 4H), 2.76 (s, 
3H). 13C NMR (100.6 MHz, CD3OD) δ 191.4, 143.9, 136.2, 134.9, 129.7, 
45.4, 35.7, 34.0. Data in agreement with the literature.  
1.5.3.2. Carbonyl reduction in the shaker mill 
3-Dimethylamino-1-phenylpropan-1-ol (5).119 
Aminoketone hydrochloride 3 (107 mg, 0.5 mmol) and 
NaBH4 (25 mg, 0.7 mmol) were added into a 25 mL 
stainless steel grinding jar with a 25 mm Ø stainless 
steel ball. The grinding jar was flushed with a stream of argon and the 
mixture was shaken at 20.0 Hz for 25 min. The reaction crude was dissolved 
with water and acetone and transferred into a separating funnel. 
Concentrated HCl (5 mL) was added and the aqueous layer was washed with 
CH2Cl2 (3  20 mL) and the organic layer was discarded. A solution of NaOH 
5 N (15 mL) was added to the aqueous layer, and was subsequently 
extracted with CH2Cl2 (4  25 mL). The combined organic layers were dried 
with MgSO4 and concentrated under vacuum. To afford pure 3-
dimethylamino-1-phenylpropan-1-ol (5) as a white solid (86 mg, 96%). Mp = 
45–47 °C [lit.120 Mp = 47–48 °C]. Rf (MeOH) = 0.25. IR (ATR) 3076 (br), 
2970, 2821, 1602, 1450, 1027, 700 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.40–
7.15 (m, 5H), 4.93 (dd, J = 7.6, 4.0 Hz, 1H), 2.68–2.44 (m, 2H), 2.30 (s, 
6H), 1.85–1.78 (m, 2H). 13C NMR (100.6 MHz, CDCl3) δ 145.1, 128.1, 
126.8, 125.5, 75.8, 58.4, 45.3, 34.5. Data in agreement with the literature.  
3-Methylamino-1-phenylpropan-1-ol (10).121 
Aminoketone hydrochloride 20 (105 mg, 0.5 mmol) 
and NaBH4 (39 mg, 1.0 mmol) were added into a 25 
mL stainless steel grinding jar with a 25 mm Ø stainless 
steel ball. The grinding jar was flushed with a stream of argon and the 
mixture was shaken at 20.0 Hz for 5 min. The reaction crude was dissolved 
with water and acetone and transferred into a separating funnel. 
Concentrated HCl (5 mL) was added and the aqueous layer was washed with 
CH2Cl2 (3  20 mL) and the organic layer was discarded. A solution of NaOH 
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5 N (15 mL) was added to the aqueous layer, and was subsequently 
extracted with CH2Cl2 (4  25 mL). The combined organic layers were dried 
with MgSO4 and concentrated under vacuum to afford pure 3-methylamino-
1-phenylpropan-1-ol (10) as a white solid (73 mg, 83%). Mp = 66–73 °C 
[lit.122 Mp = 50–60 °C]. Rf (AcOEt/MeOH 1:1) = 0.20. IR (ATR) 3281, 2927, 
2793, 1600, 1450, 1080, 1080 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.40–7.20 
(m, 5H), 4.94 (dd, J = 8.8, 3,2 Hz, 1H), 3.95 (br s, 1H), 2.94–2.83 (m, 2H), 
2.45 (s, 3H), 1.90–1.73 (m, 2H). 13C NMR (100.6 MHz, CDCl3) δ 145.1, 
128.2, 126.9, 125.6, 75.6, 50.5, 36.8, 36.0. Data in agreement with the 
literature. 
3-Dimethylamino-1-(2-thienyl)propan-1-ol 
(27).123 Aminoketone hydrochloride 26 (113 mg, 0.5 
mmol) and NaBH4 (39 mg, 1.0 mmol) were added into 
a 25 mL stainless steel grinding jar with a 25 mm Ø 
stainless steel ball. The grinding jar was flushed with a stream of argon and 
the mixture was shaken at 20.0 Hz for 2 h. The reaction crude was dissolved 
with water and acetone and transferred into a separating funnel. 
Concentrated HCl (5 mL) was added and the aqueous layer was washed with 
CH2Cl2 (3  20 mL) and the organic layer was discarded. A solution of NaOH 
5 N (15 mL) was added to the aqueous layer, and was subsequently 
extracted with CH2Cl2 (4  25 mL). The combined organic layers were dried 
with MgSO4 and concentrated under vacuum. To afford pure 3-
dimethylamino-1-(2-thienyl)propan-1-ol (27) as a white solid (89 mg, 97%). 
Mp = 71–73 °C [lit.
123 Mp = 71–73 °C]. IR (ATR) 3080, 2942, 2826, 1467, 
1076, 844 cm-1. 1H NMR (400 MHz, CDCl3) δ 7.24–7.18 (m, 1H), 7.00–6.94 
(m, 1H), 6.94–6.88 (m, 1H), 5.19 (dd, J = 8.0, 4.0 Hz, 1H), 2.70–2.51 (m, 
2H), 2.29 (s, 6H), 2.20–1.85 (m, 2H). 13C NMR (100.6 MHz, CDCl3) δ 149.8, 
126.5, 123.6, 122.2, 72.2, 58.1, 45.3, 34.5. Data in agreement with the 
literature. 
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3-methylamino-1-(2-thienyl)-1-propanol (30).121 
Aminoketone hydrochloride 29 (103 mg, 0.5 mmol) 
and NaBH4 (25 mg, 0.7 mmol) were added into a 25 
mL stainless steel grinding jar with a 25 mm Ø stainless 
steel ball. The grinding jar was flushed with a stream of argon and the 
mixture was shaken at 20.0 Hz for 5 min. The reaction crude was dissolved 
with water and acetone and transferred into a separating funnel. 
Concentrated HCl (5 mL) was added and the aqueous layer was washed with 
CH2Cl2 (3  20 mL) and the organic layer was discarded. A solution of NaOH 
5 N (15 mL) was added to the aqueous layer, and was subsequently 
extracted with CH2Cl2 (4  25 mL). The combined organic layers were dried 
with MgSO4 and concentrated under vacuum to afford pure 3-methylamino-
1-(2-thienyl)-1-propanol (30) as a white solid (64 mg, 74%). Mp = 58–61 °C 
[lit.111 Mp = 61–63 °C]. Rf (AcOEt/MeOH/NEt3 10:10:1) = 0.30. IR (ATR) 
3282, 2859, 2662, 1473, 1311, 1074 cm-1. 1H NMR (400 MHz, CDCl3) δ 
7.20–7.18 (m, 1H), 7.00–6.88 (m, 2H), 5.17 (dd, J = 8.8, 3.6 Hz, 1H), 4.00 
(br s, 1H), 2.98–2.80 (m, 2H), 2.41 (s, 3H), 2.02–1.80 (m, 2H). 13C NMR 
(100.6 MHz, CDCl3) δ 149.7, 126.5, 123.7, 122.3, 71.9, 50.1, 36.8, 35.9. 
Data in agreement with the literature.  
1.5.3.3. Carbonyl reduction in solution 
To a well stirred solution of the aminoketone hydrochloride (3, 20, 26 or 
29, 4.0 mmol) in H2O (25 mL) at 0 °C was added NaBH4 (201 mg, 5.2 mmol) 
in two portions. The solution was warmed to r.t. and stirred for 15-24 h. 
The solution was treated with acetone and concentrated HCl (5 mL). The 
aqueous layer was washed with CH2Cl2 (3 x 20 mL) and the organic layer 
was discarded. A solution of NaOH 5 N (15 mL) was added to the aqueous 
layer, and was subsequently extracted with CH2Cl2 (4 x 25 mL). The 
combined organic layers were dried with MgSO4 and concentrated under 
vacuum. The corresponding aminoalcohol 5, 10, 27 or 30, respectively, 
were obtained pure in excellent yields (90-99%). 
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1.5.3.4. Tosylation reaction and substitution in the shaker mill 
3-Dimethylamino-1-phenyl-propan-1-ol (5) (46 mg, 0.25 mmol), NEt3 (42 µL, 
0.30 mmol) and 4-toluenesulfonyl chloride (53 mg, 0.28 mmol) were added 
into a 25 mL stainless steel grinding jar with a 25 mm Ø stainless steel ball. 
The grinding jar was flushed with argon and the mixture was shaken at 20.0 
Hz for 3 h. After the 3 h, K2CO3 (69 mg, 0.50 mmol) and 4-
(trifluoromethyl)phenol (209 mg, 1.25 mmol) were added in the grinding jar, 
which was flushed with Ar again. The new mixture was shaken at 20.0 Hz for 
3 h. The content of the grinding jar was dissolved with Et2O (25 mL) and an 
aqueous solution of NaOH 2M (10 mL). The organic layer was washed with 
H2O (10 mL) and the aqueous layers were extracted with CH2Cl2 (4 x 15 
mL). The combined organic layers were dried with MgSO4 and concentrated 
under vacuum. The resulting crude oil was purified with column 
chromatography (CH2Cl2/MeOH 95:5) to afford 7 mg (8%) of 3-
dimethylamino-1-phenyl-1-(4-trifluoromethylphenoxy)propane (7, see 
analytical data below). 
1.5.3.5. Mitsunobu reaction in the shaker mill 
3-Dimethylamino-1-phenyl-propan-1-ol (5) (45 mg, 0.25 mmol), 
triphenylphosphine (69 mg, 0.25 mmol), diisopropyl azodicarboxylate (50 µL, 
0.25 mmol) and 4-(trifluoromethyl)phenol (42 mg, 0.25 mmol) were added 
into a 25 mL stainless steel grinding jar with a 25 mm Ø stainless steel ball. 
The mixture was shaken at 20.0 Hz for 3 h 30 min. The content of the 
grinding jar was dissolved with CH2Cl2 and concentrated under vacuum. The 
resulting crude oil was purified with column chromatography (CH2Cl2/MeOH 
95:5) to afford 21 mg (25%) of 3-dimethylamino-1-phenyl-1-(4-
trifluoromethylphenoxy)propane (7, see analytical data below). 
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1.5.3.6. MW assisted copper catalysed O-arylation  
3-Dimethylamino-1-phenyl-1-(4-
trifluoromethylphenoxy)propane (7).124 4-
Iodobenzotrifluoride (40 µL, 0.275 mmol) was added 
dropwise to a solution of amino alcohol 5 (45 mg, 
0.250 mmol), CuI (5 mg, 0.025 mmol) and Cs2CO3 
(163 mg, 0.500 mmol) in o-xylene (2.5 mL) at RT under Ar atmosphere, in a 
10 mL MW glass tube. The mixture was heated in the MW using the 
following heating program: 120 °C for 10 min, then 150 °C for 10 min and 
last 200 °C for 3 h. After that time, GC-MS analysis confirmed 99% 
conversion. The resulting solution was filtered through a plug of Celite® and 
eluted with EtOAc. After concentrating the solvent under vacuum, pure 3-
dimethylamino-1-phenyl-1-(4-trifluoromethylphenoxy)propane (7) was 
obtained as a brown oil (84 mg, 99%). Rf (CH2Cl2/MeOH 95:5) = 0.25. IR 
(ATR) 2946, 2768, 1614, 1517, 1323, 1248, 1108 cm-1. 1H NMR (400 MHz, 
CDCl3) δ 7.45–6.88 (m, 9H), 5.28 (dd, J = 8.4, 5.2 Hz, 1H), 2.50–2.36 (m, 
2H), 2.25 (s, 6H), 2.30–1.94 (m, 2H). 13C NMR (100.6 MHz, CDCl3) δ 160.6, 
141.1, 128.7, 127.8, 126.7 (q, J = 15.2 Hz), 125.8, 123.0, 122.7 (q, J = 
129.6 Hz), 115.8, 78.5, 55.7, 45.4, 36.7. 19F NMR (376.5 MHz, CDCl3) δ –
61.52. HRMS (+ESI): m/z calculated for C18H21NOF3 [M+H]
+: 324.1575. 
Found: 324.1572. Data in agreement with the literature.  
N-methyl-3-phenyl-3-[4-
(trifluoromethyl)phenoxy]propan-1-amine (9). 
125 4-Iodobenzotrifluoride (40 µL, 0.275 mmol) was 
added dropwise to a solution of amino alcohol 10 (41 
mg, 0.250 mmol), CuI (5 mg, 0.025 mmol) and 
Cs2CO3 (163 mg, 0.500 mmol) in o-xylene (2.5 mL) at RT under Ar 
atmosphere, in a 10 mL MW glass tube. The mixture was heated in the MW 
using the following heating program: 120 °C for 10 min, then 150 °C for 10 
min and last 200 °C for 2 h. After that time, GC-MS analysis confirmed full 
conversion. The resulting solution was filtered through a plug of Celite® and 
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eluted with EtOAc. After concentrating the solvent under vacuum, pure N-
methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine (9) was 
obtained as a yellow oil (81 mg, >99%). Rf (CH2Cl2/MeOH 95:5) = 0.25. IR 
(ATR) 2927, 2849, 1613, 1516, 1323, 1107 cm-1. 1H NMR (400 MHz, CDCl3) 
δ 7.37–6.82 (m, 9H), 5.27 (dd, J = 8.4, 4.8 Hz, 1H), 3.03 (br s, 1H), 2.82–
2.70 (m, 2H), 2.41 (s, 3H), 2.30–1.98 (m, 2H). 13C NMR (100.6 MHz, CDCl3) 
δ 160.3, 140.5, 128.8, 128.0, 126.8 (q, J = 15.2 Hz), 125.7, 122.9 (q, J = 
130.0 Hz), 115.8, 78.2, 47.8, 37.7, 35.7, 30.9. 19F NMR (376.5 MHz, CDCl3) 
δ –61.44. Data in agreement with the literature.  
N,N-dimethyl-3-(α-naphthyloxy)-3-
phenylpropylamine (32).126 1-Iodonaphthalene (40 
µL, 0.275 mmol) was added dropwise to a solution of 
amino alcohol 5 (45 mg, 0.250 mmol), CuI (5 mg, 
0.025 mmol) and Cs2CO3 (163 mg, 0.500 mmol) in o-
xylene (2.5 mL) at RT under Ar atmosphere, in a 10 mL 
MW glass tube. The mixture was heated in the MW using the following 
heating program: 120 °C for 10 min, then 150 °C for 10 min and last 200 °C 
for 4 h. After that time, GC-MS analysis confirmed full conversion. The 
resulting solution was filtered through a plug of Celite® and eluted with 
EtOAc.  
After concentrating the solvent under vacuum, the crude oil was dissolved in 
CH2Cl2 (20 mL) and transferred into a separating funnel. Concentrated HCl 
(1.5 mL) and water (25 mL) were added and the aqueous phase was 
extracted with CH2Cl2 (3 x 15 mL), the organic layer was discarded. A 
solution of NaOH 1 N (25 mL) was added to the aqueous layer, and was 
subsequently extracted with CH2Cl2 (4  25 mL). The combined organic 
layers were dried with MgSO4 and concentrated under vacuum. The product 
obtained was still not satisfyingly pure, so it was subsequently purified with 
column chromatography (AcOEt/MeOH 95:5) to afford 71 mg (92%) of pure 
N,N-dimethyl-3-(α-naphthyloxy)-3-phenylpropylamine (32). Rf (AcOEt/MeOH 
95:5) = 0.35. IR (ATR) 2940, 2764, 1576, 1461, 1264, 1095 cm-1. 1H NMR 
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(400 MHz, CDCl3) δ 8.48–6.60 (m, 12H), 5.45 (dd, J = 8.4, 4.8 Hz, 1H), 
2.60–2.52 (m, 2H), 2.27 (s, 6H), 2.40–2.05 (m, 2H). 13C NMR (100.6 MHz, 
CDCl3) δ 153.5, 141.8, 134.5, 128.6, 127.5, 127.5, 126.2, 125.9, 125.8, 
125.7, 125.1, 122.1, 120.0, 78.2, 56.1, 45.5, 37.0. Data in agreement with 
the literature. 
1.5.3.7. O-Arylation – Scope of the reaction 
General procedure: p-Iodotoluene or 2-iodo-1,3-dimethylbenzene (0.275 
mmol) was added dropwise to a solution of the corresponding amino alcohol 
(0.250 mmol), CuI (5 mg, 0.025 mmol) and Cs2CO3 (163 mg, 0.500 mmol) in 
toluene or o-xylene (2.5 mL) at RT under Ar atmosphere, in a 10 mL MW 
glass tube. The mixture was heated in the MW using the following heating 
program: 120 °C for 10 min, then 150 °C for 10 min and last 200 °C for the 
described reaction time. After that time, the conversion and the N/O-
arylation ratio was determined by 1H-NMR of the reaction crude. 
All the N/O-arylated products have been previously described in the 
literature by Buchwald et al.106, 107 
1.5.3.8. N-demethylation 
N-methyl-3-(4-trifluoromethylphenoxy)-3-
phenylpro pylamine hydrochloride / Fluoxetine 
hydrochloride (1).127 -Chloroethyl chloroformate 
(108 µL, 1.00 mmol) was added dropwise to a solution 
of 3-dimethylamino-1-phenyl-1-(4-
trifluoromethylphenoxy)propane (7) (81 mg, 0.25 mmol) in dichloroethane 
(2.5 mL) at RT under argon atmosphere, in a 10 mL MW glass tube. The 
mixture was heated in the MW at 120 °C for 1 h and at 150 °C for 1 h. The 
resulting solution was concentrated under vacuum and heated (MW) with 
MeOH (2.5 mL) at 120 °C for 1 h. The crude oil was purified by 
recrystallization (EtOAc/hexane) to afford of pure fluoxetine hydrochloride 
(1) (66 mg, 76%) as a white solid. Mp = 152–154 °C [lit.
128 MP = 156–158 
°C]. Rf (CH2Cl2/MeOH 95:5) = 0.30). IR (ATR) 2858, 2730, 2450, 1614, 
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1517, 1325, 1241, 1107 cm-1. 1H NMR (400 MHz, CDCl3) δ 9.69 (br s, 2H), 
7.45–6.85 (m, 9H), 5.46 (dd, J = 7.6, 4.0 Hz, 1H), 3.20–3.05 (m, 2H), 2.63 
(s, 3H), 2.58–2.37 (m, 2H). 13C NMR (100.6 MHz, CDCl3) δ 159.6, 139.0, 
129.0, 128.4, 126.8 (q, J = 15.2 Hz), 125.7, 123.3 (q, J = 129.6 Hz), 122.8, 
115.8, 76.9, 46.1, 34.5, 33.0. 19F NMR (376.5 MHz, CDCl3) δ –61.54. Data 
in agreement with the literature.  
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2.1. Introduction 
2.1.1. Background 
The enantioselective synthesis of chiral secondary alcohols is a recurring 
chemical transformation for both academia and industry.1-7 As a matter of 
fact, there is a countless amount of natural products and pharmaceutical 
compounds that incorporate this fragment in their structures (Figure 2.1).    
 
Figure 2.1 – Structures of top selling pharmaceuticals with a chiral secondary 
alcohol (or derivative) in their structure 
The enantioselective hydrogenation of ketones and the enantioselective 
addition of organometallic reagents to aldehydes are among the most 
popular catalytic approaches for the synthesis of non-racemic secondary 
alcohols.1, 2, 8-14 This chapter, however, will focus exclusively on the 
catalytic enantioselective addition of organometallic reagents to 
aldehydes. 
As stated previously in the 12 principles of Green Chemistry, “catalytic 
reagents are superior to stoichiometric reagents”. By using catalytic 
methodologies, it is possible to decrease the amount of waste generated 
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in a chemical transformation, in an effort to turn the chemical industry into 
a more sustainable sector. 
The catalytic enantioselective addition of organometallic reagents to 
aldehydes has been vastly studied for organometallic species of low to 
medium reactivity, such as organozinc reagents.15-28 It is known that 
organozinc compounds are unreactive towards aldehydes,29, 30 
nonetheless, the use of chelating ligands (e.g. aminoalcohols) can alter 
their geometry and increase their reactivity so the addition to the carbonyl 
group can take place.29 
The first catalytic enantioselective addition of organozinc reagents to 
carbonyl compounds was described by Noyori et al. in 1986.16 Their work 
focused on the asymmetric alkylation of aromatic aldehydes using 
diethylzinc as nucleophile, in the presence of catalytic amounts of the 
chiral amino alcohol ligand L1 (Scheme 2.1). 
 
Scheme 2.1 – Noyori’s addition of Et2Zn to aromatic aldehydes 
Following Noyori’s work and the success of the 3-exo-
dimethylaminoisoborneol (L1) as ligand, the transformation became very 
popular and a lot of research was done in that field. During the last 20 
years, more than 200 different ligands have been reported for the 
enantioselective addition of diethylzinc to benzaldehyde (see some 
representative examples in Figure 2.2).31-37  
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Figure 2.2 – Chiral ligands used for the enantioselective addition of Et2Zn to 
aldehydes 
Also, recently, Ar-BINMOL ligands have proven to be efficient in the 
addition of diethylzinc to aromatic aldehydes (Figure 2.3).38 
 
Figure 2.3 – Ar-BINMOL ligands (R,S)-L9 and (S,R)-L9 
Ar-BINMOL ligands were synthesised for the first time by Kiyooka et al. in 
1996,39 via a [1,2]-Wittig rearrangement. Although the ligands were 
obtained in excellent diastereoselectivities (up to >99% de) from 
enantiopure (R)- or (S)-BINOL, the yields reported were only moderate 
(up to 55% yield over 2 steps).  
It was not until 2011 that the synthesis of Ar-BINMOLs was improved by 
Xu and co-workers.40 The new optimised strategy was also based on a 
two-step sequence, starting from the commercially available enantiopure 
(S)-BINOL (Scheme 2.2). The benzylation of (S)-BINOL (L8) with an aryl 
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bromide, in the presence of potassium carbonate provides the 
corresponding ether intermediate I-A, which is subsequently treated with 
i-butyllithium to afford the corresponding Ar-BINMOL (L9) in excellent 
yield and diastereoselectivity. 
 
Scheme 2.2 – Xu’s synthesis of Ar-BINMOL ligands 
The second step of the transformation is a lithium-assisted [1,2]-Wittig 
rearrangement. The mechanism of this transformation is shown in Scheme 
2.3 below. 
 
Scheme 2.3 – Mechanism of the lithium-assisted [1,2]-Wittig rearrangement 
The intermediate I-A is deprotonated twice in the presence of i-
butyllithium, providing the dilithiated species I-B. A homolytic dissociation 
of the C-O bond in I-B generates intermediate I-C. Next, a radical 
recombination ([1,2]-Wittig rearrangement) takes place providing the 
corresponding Ar-BINMOL ligand (L9) via the intermediate I-D. The axial 
chirality from the (S)-BINOL starting material induces the radical 
recombination to happen in an enantioselective manner. The newly 
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formed sp3 chiral center holds, exclusively, (R) configuration (>99% de 
obtained in the process).  
As briefly mentioned above, Xu’s et al. successfully used Ar-BINMOL 
ligands in the catalytic addition of Et2Zn to aromatic aldehydes.
38 Excellent 
yields and enantioselectivities are reported in the presence of catalytic 
amounts of L10 and 1 eq. of titanium tetraisopropoxide (Scheme 2.4). 
 
Scheme 2.4 – Xu’s asymmetric addition of Et2Zn to aromatic aldehydes 
The exact mechanism for the transformation above is not known, 
however, authors propose that an alkyl group from the organozinc reagent 
must be transferred to one of the titanium atoms that, in coordination 
with the chiral ligand, are forming the catalytic complex.38 
Even though the results obtained by Xu et al. using this methodology were 
excellent, the use of organozinc reagents has several disadvantages. First 
of all, their atom economy is poor since only one of the alkyl groups is 
transferred into the product. Additionally, organozinc reagents are 
expensive and generally difficult to prepare and to handle.20 
The use of organometallic species of higher availability and lower cost 
would be a more attractive option to carry out this transformation. Both 
organomagnesium and organolithium compounds meet these 
requirements, but due to their higher reactivity and strong basicity, which 
leads to the loss of chemo-, regio- and enantioselectivity, they have been 
studied much less in the enantioselective additions to carbonyl 
compounds.  
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2.1.2. Catalytic enantioselective addition of Grignard 
reagents to carbonyl compounds 
2.1.2.1. Catalytic enantioselective addition of Grignard reagents 
to aldehydes 
The first Grignard reagent was prepared in 1900 by Françoise Auguste 
Victor Grignard, who was awarded the Nobel Prize for his work in 1912.41 
This world’s famous transformation has the ability of turning an 
electrophile (alkyl or aryl halide) into a nucleophile (alkyl or 
arylmagnesium halide) by the reaction with magnesium metal in the 
appropriate solvent. 
Organomagnesium or Grignard compounds can be divided into two 
different categories: i) complete compounds, like dialkyl or 
diarylmagnesium with the formula R2Mg and ii) mixed compounds, like 
alkyl or arylmagnesium halides with the formula RMgX. When a Grignard 
reagent is in solution, both species are in equilibrium (Schlenk equilibrium, 
Scheme 2.5).  
 
Scheme 2.5 – Schlenk equilibrium 
Grignard reagents are one of the cheapest and most commonly used 
organometallic reagents in both academic laboratories or industry. When 
compared to organozinc compounds, Grignard reagents have better atom 
economy, since all the R groups are transferred from the nucleophile to 
the product. Additionally, they offer other advantages like lower cost, 
wider commercial availability and being more tuneable and easier to 
prepare. 
Due to their high reactivity, the use of Grignard reagents in asymmetric 
catalysis has been limited. The enantioselective addition of Grignard 
reagents to aldehydes or ketones is difficult due to the competition with 
the background uncatalysed reaction that leads to the racemic alcohol.8, 42-
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44 Additionally, due to their high basic character, Grignard reagents can 
deprotonate enolizable aldehydes and ketones to form the corresponding 
enolate (Scheme 2.6). Furthermore, alkyl Grignard reagents with a 
hydrogen atom in the β-position easily undergo β-hydride elimination, 
causing the reduction of the carbonyl group in the starting material (see 
Scheme 2.6 below). 
 
Scheme 2.6 – Possible products of the Grignard reaction 
For these reasons, most of the enantioselective methodologies described 
in the literature for the addition of Grignard reagents to carbonyl 
compounds involve (super)stoichiometric amounts of a chiral ligand and 
very low temperatures (–78 to –110 °C).1-8, 42-44 Some of these ligands 
have been depicted in Scheme 2.7 below. 
 
Scheme 2.7 – Ligands used for the (super)stoichiometric addition of Grignard 
reagents to aldehydes (a) and ketones (b) 
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The first highly enantioselective addition of Grignard reagents to a 
carbonyl compound using catalytic amounts of ligand was reported in 
2008 by Harada et al.45 The reported method involves the initial treatment 
of an alkyl Grignard reagent with an excess of Ti(OiPr)4 at –78 °C, which is 
then slowly added to the reaction mixture at 0 °C. Only 2 mol% of the 
ligand L11 is needed to obtain excellent levels of enantioselectivity 
(Scheme 2.8). 
 
Scheme 2.8 – Harada’s enantioselective catalytic addition of alkyl Grignard 
reagents to aldehydes 
It is worth noting that the addition of the very valuable MeMgCl to 1-
naphthaldehyde using this methodology only provided a 28% ee of the 
corresponding methyl carbinol. As it will be explained later (section 2), 
methyl carbinol units are especially interesting for their abundance in 
natural products.  
For the addition of aromatic Grignard reagents to both aromatic and 
heteroaromatic aldehydes, the partially hydrogenated ligand L12 proved to 
be more efficient than L11 (Scheme 2.9).
46, 47 The only limitation of this 
reaction is the addition of PhMgBr to o-anisaldehyde, which only provides 
66% yield and 9% ee, probably due to steric problems. 
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Scheme 2.9 – Harada’s enantioselective catalytic addition of aromatic Grignard 
reagents to aldehydes catalysed by L12 
This methodology also allows the addition of functionalised Grignard 
reagents that have been prepared in situ using Knochel’s procedure.48 The 
reaction of the corresponding iodoarene with c-C5H9MgCl allows the 
formation of the corresponding Grignard reagent, which is subsequently 
treated with Ti(OiPr)4 at –78 °C. Next, the reaction mixture is slowly added 
to a solution of the aldehyde in the presence of L12 at 0 °C. The 
corresponding secondary alcohols are obtained in good yields and 
enantioselectivities (Scheme 2.10). 
 
Scheme 2.10 – Harada’s catalytic addition of in situ prepared Grignard reagents 
to 1-naphthaldehyde 
Alternatively, Grignard reagents can be prepared by reaction of an aryl 
bromide (more desirable precursor than iodoarenes since they offer 
greater stability, wider availability and lower price) with the commercially 
available iPrMgCl in THF.49-52 Nonetheless, in this particular case, the THF 
involved in the preparation of the Grignard reagent must be removed in 
vacuo and replaced with dichloromethane in order to obtain the desired 
secondary alcohols in good yields and enantioselectivities (Scheme 
2.11).53 Unfortunately, the reaction with aliphatic aldehydes, such as 
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cyclohexanecarbaldehyde, only leads to moderate yield (54%) and 
enantioselectivity (63%). 
 
Scheme 2.11 – Harada’s catalytic addition of in situ prepared Grignard reagents 
to aldehydes 
Da et al. have demonstrated that the catalytic use of (S)-BINOL as ligand, 
with stoichiometric amounts of bis[2-N,N-dimethylamino)ethyl]ether 
(BDMAEE) as additive, is a successful combination for the enantioselective 
addition of Grignard reagents to aldehydes.54, 55 The usage of this 
chelating additive, which is able to coordinate the metal (i.e. magnesium) 
and decrease its reactivity, improves the reaction conditions (temperature 
of 0 °C and lower amount of Ti(OiPr)4 required) compared to Harada’s 
methodology (Scheme 2.12).    
 
Scheme 2.12 – Da’s enantioselective addition of Grignard reagents to aldehydes 
As proposed by Da et al., and in corroboration with the studies of Bolm 
and Walsh,56, 57 BDMAEE is not only able to coordinate to the Grignard 
reagent and decrease its reactivity, but also to trap the magnesium salts 
(MgBr2 and/or Mg(O
iPr)Br) formed during the Schlenk equilibrium and/or 
the transmetalation process. The coordination of these salts to the oxygen 
atom of the carbonyl group in the substrate would promote the 
uncatalysed reaction, thus favouring the formation of the corresponding 
racemic alcohol.     
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The following Scheme 2.13 shows the Ti(OiPr)4 assisted addition of 
nBuMgBr to benzaldehyde in the presence and absence of BDMAEE.55 It is 
worth noting that BDMAEE not only increases of the enantioselectivity of 
the reaction up to 98% ee, but also allows a substantial reduction of the 
amount of Ti(OiPr)4 and Grignard reagent required to perform the 
transformation. 
 
Scheme 2.13 – Enantioselective addition of n-butylmagnesium bromide to 
benzaldehyde with and without the additive BDMAEE. 
In 2010, Da et al. reported a new methodology that allows the addition of 
aromatic Grignard reagents to aldehydes in excellent yields and 
enantioselectivities.58 The procedure involves the treatment of the 
corresponding Grignard reagent with AlCl3, to provide a less reactive 
triarylaluminium intermediate in situ. Next, ligand L13 is added, followed 
by Ti(OiPr)4 and the aldehyde in the last place (Scheme 2.14). The 
corresponding alcohols are obtained in good yields and 
enantioselectivities, working at higher and more convenient temperatures 
(0 oC) than Harada’s previous methodology (78 oC). 
 
Scheme 2.14 – Da’s enantioselective addition of aromatic Grignards to aldehydes 
in the presence of AlCl3 
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In 2011, our research group published a new methodology for the 
addition of Grignard reagents to aldehydes catalysed by Ar-BINMOLs 
ligands (Scheme 2.15).59 The methodology allows the direct addition of 
Grignard reagents to carbonyl compounds in a one-pot reaction and 
without the need of performing a slow addition of the nucleophile (main 
disadvantage of Harada’s methodology).45-47  
 
Scheme 2.15 – Maci  and Yus’ addition of Grignard reagents to aldehydes 
Even though the experimental procedure requires a large excess of 
Ti(OiPr)4 and low temperatures (–40 °C), the whole process can be done 
one-pot and good yields and enantioselectivities are obtained for the 
addition of the challenging methyl Grignard to aromatic aldehydes (85-
99% yield, 58-90% ee). The reaction has to be carried out in Et2O as THF 
causes a decrease in the enantioselectivities.   
The addition of PhMgBr to 2-naphthaldehyde proceeded in a very low 
enantioselectivity (16% ee) and the reaction with aliphatic aldehydes only 
provided moderate enantioselectivities (50-70% ee). A simple switch to 
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the chiral ligand (Sa,R)-L15, however, allows the addition of Grignard 
reagents to aliphatic aldehydes in good yields (61-99%) and 
enantioselectivities (60-99%) (Scheme 2.16).60 
 
Scheme 2.16 – Maci  and Yus’ addition of Grignard to aliphatic aldehydes 
This catalytic system described in Scheme 2.16 provides unprecedented 
yields and enantioselectivities for the synthesis of aliphatic chiral 
secondary alcohols under mild conditions. Additionally, ligand L15 can be 
easily recovered from the reaction mixture by a simple acid/base 
extraction (60% recovery yield) and subsequently reused without any loss 
of activity. 
Soon after this methodology was published by our group, Xu et al. 
reported the use of a new Ar-BINMOL ligand for the addition of MeMgBr to 
aromatic aldehydes.61 The utilisation of the ligand L16 allows the synthesis 
of chiral methyl carbinol products in excellent yields (91-96%) and 
enantioselectivities (85-90%). Furthermore, this new ligand allows a slight 
reduction in the amounts of MeMgBr (3.0 vs 3.8 eq.) and Ti(OiPr)4 (10.0 
vs 15.0 eq.), compared to our previous methodology (Scheme 2.17). 
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Scheme 2.17 – Xu’s addition of methylmagnesium bromide to aromatic aldehydes 
 
Xu and co-workers have also demonstrated that ligand L16 is effective for 
the addition of aryl Grignard reagents to aromatic aldehydes.61 The 
reaction in dichloromethane at –20 °C affords the corresponding chiral 
secondary alcohols in moderate yields (70-92%) and enantioselectivities 
(50-71%) (Scheme 2.18).  
 
Scheme 2.18 – Xu’s addition of aryl Grignard reagents to aromatic aldehydes 
2.1.2.2. Catalytic enantioselective addition of Grignard reagents 
to ketones 
The addition of Grignard reagents to ketones is a very challenging reaction 
due to the lower reactivity of ketones and the greater steric hindrance 
around the carbonyl group.  
In 2014, our research group published a titanium based methodology for 
the enantioselective addition of aromatic Grignard reagents to ketones.62 
The use of catalytic amounts of the Ar-BINMOL ligand L17, in the presence 
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of an excess of Ti(OiPr)4 (10 eq.), in ether at 0 °C, provides the 
corresponding chiral tertiary alcohols in moderate to excellent yields (35-
99%) and good enantioselectivities (46-92%). Unfortunately, the reaction 
with bulky substrates such as o-methylacetophenone, only leads to a 12% 
conversion (Scheme 2.19).   
 
Scheme 2.19 – Maci  and Yus’ addition of aromatic Grignard reagents to ketones 
In 2012, the groups of Harutyunyan and Minnaard developed the first 
catalytic enantioselective 1,2-addition of Grignard reagents to α-
substituted α,β-unsaturated ketones based on a copper (I)-diphosphine 
complex, without the use of any additive (Scheme 2.20).63 The desired 
chiral tertiary alcohols are obtained in high yields (81-96%) and 
enantioselectivities (42-96%) when CuBr·SMe2 and the ferrocenyl 
diphosphine rev-Josiphos (L18) are used as catalysts, in tert-butylmethyl 
ether as solvent (Scheme 2.20). Although the scope of the reaction is 
limited to bulky -branched Grignard reagents, this methodology is 
especially relevant, since it breaks the old paradigm that organocopper 
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compounds favour the 1,4-addition to electron-deficient carbonyl 
compounds.     
 
Scheme 2.20 – Harutyunyan’s 1,2-addition of Grignard reagents to α,β-
unsaturated ketones  
Harutyunyan and Minnaard’s research groups have also successfully 
applied this methodology to the alkylation of aryl alkyl ketones.64 The 
reaction affords the corresponding benzylic tertiary alcohols in high yields 
and excellent enantioselectivities (Scheme 2.21). As observed in the 
previous case, β-branched Grignard reagents lead to higher 
enantioselectivities, whilst linear Grignard reagents provide lower 
enantiomeric excesses. MeMgBr does not react. 
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Scheme 2.21 – Harutyunyan’s 1,2-addition of Grignard reagents to aryl alkyl 
ketones 
A similar catalytic system, based on CuBr·SMe2/Josiphos ligand L19 proved 
to be efficient for the alkylation of several aryl heteroaryl ketones (Scheme 
2.22).65 The access to tertiary aryl heteroaryl methanols is very attractive 
because of the presence of this motif in biologically active structures.66 In 
this case, however, a mixture of the Lewis acids BF3·OEt2/CeCl3 (1:1) is 
required in order to improve the reactivity and outcompete the undesired 
reduction product via Meerwein-Pondorf-Verley reaction. The role of the 
two Lewis acids is not clearly understood, but it would be reasonable to 
think that they prevent the coordination of the magnesium atom to the 
oxygen of the carbonyl group, which would promote the undesired β-
hydride transfer generating the reduction product. 
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Scheme 2.22 – Harutyunyan’s addition of Grignard reagents to aryl heteroaryl 
ketones 
The low stability of both the alkoxide and the diarylmethanol product leads 
to the formation of the dehydration product during the reaction and 
purification. For this reason, the yields obtained in this reaction are only 
moderate. Additionally, the difficult enantiodiscrimination provides low to 
moderate enantioselectivities (Scheme 2.22). Nevertheless, this is the first 
example of direct asymmetric alkylation of diaryl ketones reported in the 
literature. 
The alkylation of acyl silanes (relevant compounds in medicinal 
chemistry)67, 68 with Grignard reagents, has also been evaluated using this 
methodology.69, 70 The reaction affords excellent yields and an excellent 
enantiodiscrimination between the two moieties of the carbonyl group 
(Scheme 2.23).  
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Scheme 2.23 – Harutyunyan’s addition of Grignard reagents to acyl silanes 
Both the chemo- and enantioselectivity of this reaction depend strongly on 
the bulkiness of the silyl group. When the reaction was attempted with 
SiPh3 and SiEt3 ketones, only reduction product was obtained, whilst 
SiPh2Me or SiPhMe2 substituents afforded the desired 1,2-addition product 
with good yields and enantioselectivities. Additionally, the mixture of the 
two Lewis acids (BF3·OEt2/CeCl3 1:1) is necessary in order to obtain good 
enantiomeric excesses and chemoselectivities. The addition of iBuMgBr to 
phenylsilylketone using this boron/cerium system provides the desired 
tertiary alcohol in good chemoselectivity (5:1, carbonyl addition/reduction 
product) and 90% ee.69, 70   
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2.1.3. Catalytic enantioselective addition of 
organolithium reagents to carbonyl compounds 
Organolithium compounds were discovered by Wilhelm Schlenk in 1917.71 
Since then, organolithium reagents have become common bench 
chemicals in any organic synthetic laboratory. 
Their use in asymmetric synthesis is a very attractive option due to their 
great availability and low cost.72, 73 However, their high reactivity and 
strong basicity can often lead to the loss of chemo-, regio- and 
enantioselectivity. For these reasons, their application in enantioselective 
catalysis is challenging and it usually involves (super)stoichiometric 
amounts of a chiral ligand together with extremely low temperatures. 
The first catalytic enantioselective addition of organolithium reagents to 
aldehydes was reported by Seebach et al. in 1994.74 Their methodology 
describes the use of the chiral titanium TADDOLate L20 in toluene at –78 
°C (Scheme 2.24). When nBuLi is added to benzaldehyde in the presence 
of 1.2 eq. of ClTi(OiPr)3, only 60% ee is obtained. However, when the LiCl 
is removed from the reaction mixture, by a tedious filtration procedure, 
and the corresponding organotitanium compound isolated, the 
enantioselectivity increases to 98%. This fact proves that the lithium salts 
formed during the transmetallation step can act as Lewis acids and 
promote the undesired uncatalysed reaction. 
 
Scheme 2.24 – Seebach’s enantioselective addition of organolithium reagents to 
aldehydes  
In 2009, Walsh et at. developed a new methodology for the 
enantioselective addition of organozinc compound to aldehydes catalysed 
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by L21 (Scheme 2.25).
75 The organozinc compound is prepared by 
transmetallation of the corresponding organolithium reagent (prepared in 
situ by reaction of an aryl bromide and nBuLi) with ZnCl2. The use of 
TEEDA (0.8 eq.) is necessary to chelate the lithium salts formed during 
the transmetallation process. 
 
Scheme 2.25 – Walsh’s addition of aryllithium reagents to aldehydes 
In 2010, Harada et al. described a methodology for the enantioselective 
addition of Grignard reagents to aldehydes, catalysed by the BINOL 
derivative ligand L12 (Scheme 2.26).
76 Again, the Grignard reagent is 
prepared by transmetallation of the corresponding organolithium reagent, 
which is prepared from reaction between an aryl bromide and n-
butyllithium. An excess of Ti(OiPr)4 is necessary to achieve good 
enantioselectivities in the addition to different aldehydes.  
 
Scheme 2.26 – Harada’s addition of aryllithium reagents to aldehydes 
In 2014, Da et al. reported a procedure for the titanium assisted addition 
of organoaluminum reagents to aldehydes using the partially 
hydrogenated (S)-BINOL L13 as chiral ligand (Scheme 2.27).
77 The 
organoaluminum reagents are prepared by transmetallation of the 
corresponding aryllithium reagents with AlCl3. These aryllithium reagents 
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are generated in situ from an aryl bromide and n-butyllithium. The 
additive TMEDA is required in order to achieve good enantioselectivities. 
Authors postulate that the role of the TMEDA is to trap by chelation the 
lithium salts generated during transmetallation.  
 
Scheme 2.27 – Da’s addition of aryllithium reagents to aldehydes 
As described above, the use of organolithium reagents as nucleophiles in 
enantioselective catalysis is very challenging, and many groups have 
opted for their transmetallation into less reactive organometallic species, 
such as organotitanium, organoaluminum, organozinc or 
organomagnesium reagents.  
The first substoichiometric direct addition of an organolithium to an 
aldehyde was not achieved until 2011, by the group of Maddaluno.78 The 
direct addition of methyllithium to o-methylbenzaldehyde was carried out 
using a 33 mol% of the chiral ligand L22 and a 33 mol% of LiCl. The 
corresponding secondary alcohol was obtained in 80% yield and 80% ee 
(Scheme 2.27). 
 
Scheme 2.28 – Maddaluno’s enantioselective direct addition of MeLi to o-
methylbenzaldehyde 
In 2012, our research group published a new methodology that allows the 
direct addition of organolithium reagents to aldehydes by using catalytic 
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amounts of the Ar-BINMOL ligand (Sa,R)-L14 in the presence of an excess 
of Ti(OiPr)4 (Scheme 2.29).
79 
 
Scheme 2.29 – Maci  and Yus’ enantioselective addition of methyl lithium to 
aldehydes catalysed by (Sa,R)-L14 
In general, the addition of the very versatile methyllithium proceeds with 
good yields and enantioselectivities. The lower yield (78%) and 
enantioselectivity (62%) obtained for the reaction with o-
methylbenzaldehyde might be due to higher steric hindrance close to the 
carbonyl group. The reaction with aliphatic aldehydes, such as 
phenylacetaldehyde and pivaldehyde, provided low conversions. 
It is worth mentioning that no additives and no tedious salt filtrations or 
slow addition procedures are required with this methodology. 
Furthermore, no by-product formation is observed, and both the non-
reacted starting material and the ligand can be easily recovered from the 
reaction mixture. The recovered ligand L14 can be used in other reactions 
without any loss of its activity. 
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The methodology can be successfully extended to other alkyl lithium 
reagents using a wide range of aromatic aldehydes, providing the 
corresponding secondary alcohols in good yields (62-90%) and excellent 
enantioselectivities (92-96%) (Scheme 2.30).79  
 
Scheme 2.30 – Maci  and Yus’ enantioselective addition of alkyllithium to 
aromatic aldehydes catalysed by (Sa,R)-L14 
The main limitations of this methodology are (i) the addition of bulky 
organolithium reagents (e.g. iBuLi only provides 8% yield and 62% ee in 
the addition to benzaldehyde, together with considerable amounts (40%) 
of the reduction product phenylmethanol), (ii) the addition of aryllithium 
reagents (e.g. phenyllithium affords high yields (92-96%) but low 
enantioselectivities (17-39%) in the addition to different aromatic 
aldehydes) and (iii) aliphatic aldehydes provide low yields and 
enantioselectivities. 
In addition, other disadvantages of this methodology, which hamper its 
application in industrial processes, are the high loadings of Ti(OiPr)4 and 
the low temperatures required in order to obtain high enantioselectivities. 
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2.1.4. Catalytic enantioselective addition of 
organoaluminium reagents to carbonyl compounds 
The discovery of organoaluminium compounds by Karl Ziegler and Giulio 
Natta in 1953,80 was closely related to the development of the catalytic 
olefin polymerisation procedure for which, ten years later, they would be 
awarded the Nobel Prize. 
Ever since their discovery, the application of organoaluminium reagents in 
asymmetric catalysis has increased during the years due to their great 
stability and low toxicity. 
The first enantioselective alkylation of aldehydes with organoaluminium 
reagents was reported in 1986 by Mukaiyama et al.81 Their methodology 
consists in the allylation of aldehydes using Allyl(iBu)2Al as a nucleophile, 
Sn(OTf)2 as an additive and superstoichiometric amounts of the chiral 
diamine L23 as ligand. The reaction is carried out in dichloromethane at –
78 °C (Scheme 2.31).  
 
Scheme 2.31 – Mukaiyama’s addition of organoaluminium reagents to aldehydes  
In 1997, Chan et al. developed the first enantioselective addition of Et3Al 
to aromatic aldehydes using a catalytic amount of a BINOL ligand and an 
excess of Ti(OiPr)4.
82 The corresponding chiral secondary alcohols are 
obtained in good to excellent yields (59-99%) and enantioselectivities (52-
96%) (Scheme 2.32). 
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Scheme 2.32 – Chan’s catalytic enantioselective addition of Et3Al to aldehydes 
Few years later, in 2005, Woodward et al. developed a new methodology 
for the methylation and ethylation of aldehydes with organoaluminium 
reagents using the chiral phosphoramidite L24 and Ni(acac)2 as catalyst.
83 
The high stability of the complex (R3Al)2·DABCO as a nucleophile, 
compared to R3Al species, allows the use of milder reaction conditions (5 
°C vs –20 °C) and shorter reaction times (1-3 h vs 6 h) (Scheme 2.33). 
Unfortunately, both nucleophiles only give moderate selectivities when the 
reaction is carried out with aliphatic aldehydes.    
 
Scheme 2.33 – Woodward’s addition of organoaluminium reagents to aldehydes 
In an attempt to improve the above mentioned methodology, Pàmies and 
Diéguez’s research group, in collaboration with Prof. Woodward, 
performed a very extensive screening of a new type of chiral sugar 
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phosphate-oxazoline ligands in the addition of both (R3Al)2·DABCO and 
R3Al to different aldehydes.
84 Although only poor yields and 
enantioselectivities were obtained during the initial attempts using ligand 
L25 (Scheme 2.34), ligand L26 has proven more efficient, providing the 
corresponding secondary alcohols in good yields (76-99%) and 
enantioselectivities (64-84%) (Scheme 2.34).85  
 
Scheme 2.34 – Pàmies and Diéguez’s addition of organoaluminium reagents to 
aldehydes 
The first catalytic enantioselective arylation of aldehydes using 
organoaluminium reagents was developed by Gau et al. in 2006.86 The use 
of the BINOLate ligand L27 in catalytic amounts, in the presence of 1.3 eq. 
of Ti(OiPr)4 affords excellent yields (87-96%) and enantioselectivities (91-
99%) in the addition of Ar3Al·(THF) to different aromatic aldehydes 
(Scheme 2.35). Additionally, the methodology can be successfully 
extended to aliphatic aldehydes when ArEt2Al·(THF) is used as a 
nucleophile (Scheme 2.35).87 
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Scheme 2.35 – Gau’s catalytic enantioselective arylation of aldehydes 
In 2013, the first catalytic enantioselective vinylation of aldehydes using 
organoaluminium reagents was reported by Harada et al., using the chiral 
binaphthol ligand L12.
88 The reaction reaches high levels of 
enantioselectivity (68-95%) even though yields are only moderated (33-
78%, Scheme 2.36). The organoaluminium reagents are prepared from 
the corresponding alkyne via a hydroalumination reaction, using Me2AlH (3 
eq.) in the presence of [Ni(dppp)Cl2] (3 mol%).  
 
Scheme 2.36 – Harada’s catalytic enantioselective vinylation of aldeydes 
In 2012, our research group developed a catalytic enantioselective 
addition of organoaluminium reagents to aldehydes catalysed by the Ar-
BINMOL ligand (Sa,R)-L14.
89 The addition of Me3Al to several aldehydes in 
the presence of Ti(OiPr)4 affords a wide range of methyl carbinol units in 
excellent yields (80-99%) and moderate to excellent enantioselectivities 
(62-98%) (Scheme 2.37). The reaction with o-methylbenzaldehyde 
provides low selectivity together with 4% of the reduced product, 
probably due to the increased steric hindrance close to the carbonyl 
group. It is worth mentioning, that the bulky pivaldehyde affords the 
highest enantioselectivity of the series.   
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Scheme 2.37 – Maci  and Yus’ catalytic enantioselective addition of 
trimethylaluminium to aldehydes 
Furthermore, our research group tested the reactivity of different 
organoaluminium reagents using this methodology.89 The reaction 
provides good yields (65-77%) and excellent enantioselectivities (87-92%) 
when Et3Al is used an electrophile (Scheme 2.38). Unfortunately, the 
reaction with (nPr)3Al, although providing excellent enantioselectivities (92-
94%), leads to high amounts of the reduced aldehyde, affording low 
yields (26-35%) of the desired addition product. No product was observed 
from the reaction with iBu3Al as a nucleophile. 
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Scheme 2.38 – Maci  and Yus’ catalytic enantioselective addition of 
organoaluminium reagents to aldehydes 
2.1.5. Hydrozirconation reaction for the use of alkenes 
as nucleophiles. 
As it has been shown in the previous sections of this thesis, the catalytic 
enantioselective 1,2-addition reaction to carbonyl compounds with 
organometallic reagents is a powerful method in synthetic chemistry. 
However, the developed methodologies for this 1,2-addition reaction, that 
normally use non-stabilized carbanions (i.e. organomagnesium, 
organolithium, organotitanium and organoaluminium reagents), suffer 
from a number of limitations that prevent their use in many situations. For 
example, reactions with organometallic reagents typically require the use 
of cryogenic temperatures to restrain their high reactivity and achieve high 
levels of enantioselectivity. A principle of green chemistry states that 
synthetic methods should be conducted at ambient temperature.90 
Therefore, the development of new methods for 1,2-addition reactions to 
carbonyl compounds that are effective at room temperature would be 
highly recognized. 
Additionally, the reactivity of organometallic reagents presents challenges 
in the use of functionalized reagents50, 91 and it is associated with safety 
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issues that can restrict implementation in industrial processes and large 
scale reactions.14 For example, most of the reactions involving premade 
organometallic reagents require the use of inert gas (nitrogen or argon) 
and moisture-free reaction conditions.92  
Using alkenes as nucleophilic partners in enantioselective 1,2-addition 
reactions to carbonyl compounds would be very advantageous and highly 
desirable. Alkenes are among the most readily available organic 
molecules, and are feedstocks for the preparation of many commodity 
chemicals.93 In addition, alkenes are inexpensive and have favourable 
properties when compared to pre-made organometallics; for example, 
they are easy to handle.94, 95  
Alkylmetal species, such as organozirconium reagents,96-98 can be easily 
generated from cheap and readily available alkenes via hydrometalation, 
using the Schwartz reagent (Cp2ZrHCl, Scheme 2.39).
96, 99-101 Many 
functional groups are compatible with the hydrozirconation reaction 
conditions102, 103 and both alkyl- or alkenylzirconocene chlorides prepared 
with this method are stable complexes at ambient temperature.  
 
Scheme 2.39 – Preparation of organozirconium reagents with the Schwartz 
reagent 
Organozirconium compounds are gaining an increasing importance in 
organic synthesis.104, 105 Zirconium occurs in the lithosphere to the extent 
of 0.022%.106 It is therefore roughly as abundant as C. It is also one of 
the several least expensive transition metals along with Ti, Mn, Fe and Cu 
and probably the least expensive second transition series element. 
Although due precautions must always be taken, Zr does not appear to 
have been associated with acute and/or severe toxicity. 
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Organozirconium reagents can undergo C–C bond-forming processes, a 
fruitful area of research pioneered by and extensively developed by Wipf 
and others.96, 103, 107-112 One major area of applicability is the use of 
organozirconium derivatives in transition-metal-catalyzed cross-couplings, 
such as Negishi couplings with palladium and nickel catalysts.113 These 
cross-coupling reactions have proved to be an excellent tool for the 
formation of conjugated dienes, and have been successfully applied to 
synthesis of natural products such as motuporin,114, 115 reveromycin B116 
and xerulin117 (see example in Scheme 2.40). 
 
Scheme 2.40 – Palladium catalysed cross-coupling with an organozirconium 
reagent for the synthesis of motuporin 
The inherently low reactivity of the organozirconocene chloride 
compounds (produced after hydrometalation with Schwartz reagent) to 
electrophilic reagents, such as carbonyl groups, restrains their use as 
synthetic reagents. The electronegativity value for Zr is 1.4; roughly 
comparable to Ti (1.5), Al (1.5) and Zn (1.6). This suggests that the low 
reactivity of RZrCp2Cl is due to the large steric impediment or to specific 
electronic interactions of C–C and C–H bonds of alkyl groups with low-
lying empty d-orbitals.118 While these facts limit the scope of electrophiles 
that organozirconocenes may engage directly, transmetalation enables a 
broad variety of transformations. Thus, the use of a catalyst or a 
stoichiometric mediator for the reaction of organozirconocene chlorides is 
essential to promote a carbon-carbon bond formation (including in the 
racemic form).119 It has been reported that Ag(I)120-123 and ZnBr2
124 are 
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efficient catalysts for the addition of alkyl- and alkenylzirconocene chloride 
to aldehydes. K. Suzuki et al. described, in 1995, the use of AgAsF6 as a 
catalyst for the addition of organozirconocene chlorides to aldehydes in 
excellent yields (Scheme 2.41).122  
 
Scheme 2.41 – Addition of organozirconocene chlorides to aldehydes catalysed 
by AgAsF6    
Alternatively, M. Srebnik reported the use of ZnBr2 as an efficient catalyst 
for this chemical transformation, achieving excellent yields for both 
aromatic and aliphatic aldehydes (Scheme 2.42).124 
 
Scheme 2.42 – Addition of organozirconium reagents to aldehydes catalysed by 
ZnBr2 
It has also been reported that the Me2Zn-mediated addition of 
alkenylzirconocene chloride to aldehydes107, 125, 126 or aldimines125, 127-129 
yields allylic alcohols or amines, respectively. In both methodologies, 
described by P. Wipf et al., the alkenyl zirconocene is prepared by reacting 
an alkyne with the Schwartz reagent, followed by reaction with an 
aldehyde (Scheme 2.43) or with an aldimine (Scheme 2.44) in the 
presence of Me2Zn.
125 In case of the reaction with aldimines, the allylic 
amine or the cyclopropyl amine can be obtained depending on the solvent 
used and the reaction temperature. 
 
CHAPTER 2 
 
123 
 
 
Scheme 2.43 – Asymmetric addition of alkenyl zirconocenes to aldehydes in the 
presence of Me2Zn  
 
Scheme 2.44 – Solvent dependent addition of alkenyl zirconocenes to aldimines 
in the presence of Me2Zn. 
A Rh(I) catalyst for the addition of alkenylzirconocene chlorides to 
aldimine derivatives has also been reported.130 The transmetalation of 
organozirconocenes to aluminum,131 boron, copper,112, 132-135 mercury, 
nickel, palladium, tin, and zinc metals107, 125, 126, 136-139 is also known. 
By way of example, the hydrozirconation of alkenes and alkynes and their 
addition to acyl chlorides in the presence of catalytic amounts of copper 
(I) has been summarised in Scheme 2.45. This methodology, developed 
by Wipf in 1992,135 provides the corresponding ketones in moderate to 
high yields.  
 
Scheme 2.45 – Transmetalations of organozirconocenes to copper (I) by Wipf 
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Although it is not within the scope of this thesis, it should be briefly 
mentioned that, while alkyl and alkenylzirconocene54, 123, 140, 141 derivatives 
are quite inert toward carbonyl compounds, alkyl, aryl and 
alkenylzirconium trialkoxides such as MeZr(OnBu)3 readily add to 
aldehydes and ketones,142, 143 although enolizable substrates are often 
problematic and the rate of reduction via a Meerwein-Ponndorf-Verley 
reaction is quite high, since they react slowly.144 Also, allylzirconocenes, 
such as chloroallylzirconocene, are more reactive than alkyl and 
alkenylzirconocene derivatives and react with aldehydes.145-148  
In general, organozirconium reagents have been rarely used in 
enantioselective reactions, especially those involving catalytic processes.149 
In 1994, Wipf reported107, 127 a high-yielding protocol for the catalytic 
asymmetric addition of alkenylzirconocenes to aldehydes, based on an in 
situ transmetalation of the zirconium reagents to alkylzinc species using 
stoichiometric amounts of Me2Zn.
126, 150, 151 On similar lines, the catalytic 
asymmetric addition of alkenylzirconium reagents Cp2ZrCH=CHR to 
ketones has been carried out in the presence of a bis-(sulphonamide) diol 
ligand (L29) in the presence of 1.2 eq of Ti(O
iPr)4. In this last procedure, 
the alkenylzirconium reagent prior to being transmetallated to Ti needs to 
be treated with 1 eq of Me2Zn and transmetallated to the corresponding 
MeZnCH=CHR.137 The corresponding allylic alcohols are obtained in 
excellent yields and enantioselectivities (Scheme 2.46).  
 
Scheme 2.46 – Catalytic asymmetric vinylation and of ketones in the presence of 
the ligand L29 
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Only recently, other enantioselective catalytic methodologies involving 
organozirconium reagents have been developed. These include: 
- enantioselective copper-catalysed asymmetric conjugate addition 
reactions103, 111, 152, 153 to acyclic154 and cyclic94, 155-158 enones, 
lactones,159 1,4- and 1,6-additions to functionalised steroid 
derivatives (Scheme 2.47),95, 160 remote asymmetric C−H activations 
sequences initiated by alkene isomerization 9 (Scheme 2.48).161  
- enantioselective alkenylation of -bromoketones via nickel-
catalyzed cross-coupling (Scheme 2.49).162 
 
Scheme 2.47 – Copper-catalysed asymmetric conjugate addition to acyclic154 
and cyclic155 enones, lactones159 and 1,6-addition to functionalised steroid 
derivatives160  
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Scheme 2.48 – Remote asymmetric C-H activation161 
 
Scheme 2.49 – enantioselective alkenylation of -bromoketones via nickel-
catalyzed cross-coupling162 
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2.2. Aims and objectives 
Extensive research has been done during the last 20 years for the 
asymmetric formation of carbinol motifs. In particular, the presence of 
chiral methyl carbinol units in a large number of natural products and 
biologically active compounds, has turned them into especially attractive 
synthetic targets for both academia and industry.66, 163-167 
The anticancer drug Cruzotinib, developed by Pfizer,168 and the natural 
products (E)-15,16-dihydrominquartynoic acid164 and 
tarchonanthuslactone165 (Figure 2.3) are some examples, amongst many 
others, of relevant chemicals containing methyl carbinol units. 
 
Figure 2.3 – Chiral methyl carbinols in natural products and biologically active 
compounds 
Amongst all the approaches to access this structural fragment, the 
enantioselective addition of organometallic reagents to carbonyl 
compounds stands out for its simplicity to form a C-C bond and an 
asymmetric centre at the same time.1, 2, 8-14  
As discussed in the introductory section of this chapter, enantioselective 
catalysed versions of this transformation have been extensively studied 
with organozinc and organoaluminium compounds, and fairly studied with 
organomagnesium and organolithium reagents. However, there are still 
some limitations that need to be overcome. For example, in many cases, 
the required super stoichiometric amounts of Ti(OiPr)4 make the process 
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inefficient on an industrial production scale. Furthermore, the need of 
stoichiometric amounts of Lewis acid additives and/or the low 
temperatures are, in most cases, industrially impractical.  
Additionally, the currently available methodologies to perform this 
transformation involve the use of non-stabilised organometallic reagents 
as nucleophiles, which are frequently unstable, too reactive, sometimes 
pyrophoric and, therefore unsafe on industrial scale. 
Being aware of the limitations of the currently available methodologies, 
the particular aims of the work discussed in this chapter can be 
summarised as follows:  
(i) Development of an alternative methodology for the addition of 
organometallic reagents to carbonyl compounds that allows a 
reduction in the titanium content and allows milder reaction 
conditions, compared to currently existing procedures.  
(ii) Expand the use of Ar-BINMOL ligands to other organometallic 
reagents such as organotitanium and organozirconium 
compounds. These nucleophiles, although less reactive, are 
considered safer than the corresponding organomagnesium, 
organolithium and organozinc reagents. 
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2.3. Results and discussion 
2.3.1. Catalytic asymmetric addition of organolithium 
reagents to aldehydes 
Our studies on alternative methodologies for the catalytic enantioselective 
addition of organometallic reagents to carbonyl compounds that allow a 
reduction in the titanium content, started with the addition of 
organolithium reagents to aldehydes. 
Due to the relevance of methyl carbinol motifs, we decided to start our 
research by testing the enantioselective addition of methyllithium to 
different aldehydes.  
Our group had previously reported79 that the addition of MeLi to 
benzaldehyde (1), to provide 1-phenylethanol (2), proceeds in 87% yield 
and 90% ee when Ph-BINMOL ligand (Sa,R)-L14 is used as catalyst, at –40 
°C in toluene and in the presence of 6 eq. of Ti(OiPr)4. 
Assuming that the first step of this chemical transformation is a 
transmetallation of the methyl group from the MeLi to the Ti(OiPr)4, we 
envisioned that a more labile chloride ligand in the titanium source would 
facilitate the process and allow both a reduction of the titanium loading 
and an increase of the reaction temperature. For this reason, we decided 
to explore TiCl(OiPr)3 as an alternative titanium source. 
The optimisation of the reaction conditions was carried out on the addition 
of methyllithium to benzaldehyde, which was chosen as model reaction. 
Results are shown in the Table 2.1 below. 
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Table 2.1 – Optimisation of reaction conditions for the addition of MeLi to 
benzaldehyde 
 
Entry [Ti] source 
(eq.) 
Solvent MeLi 
(eq.) 
Conv.b 
(%) 
eeb 
(%) 
1c TiCl(iPrO)3 (6.0) Toluene 3.2 72 22 (R) 
2c TiCl(iPrO)3 (3.2) Toluene 3.2 98 92 (R) 
3c TiCl(iPrO)3 (2.5) Toluene 3.2 92 92 (R) 
4d TiCl(iPrO)3 (2.5) THF 3.2 0 n.d. 
5 TiCl(iPrO)3 (2.5) Et2O 3.2 99 70 (R) 
6 TiCl(iPrO)3 (2.0) Et2O 3.2 89 30 (R) 
7 TiCl(iPrO)3 (2.0) Et2O 2.0 99 78 (R) 
8 TiBr2(
iPrO)2 (2.5) Et2O 3.2 99 0 
9 TiF4 (2.5) Et2O 3.2 98 0 
10 TiCl(iPrO)3 (2.5) Et2O 2.0 99 86 (R) 
11 TiCl(iPrO)3 (2.6) Et2O 2.0 98 84 (R) 
12 TiCl(iPrO)3 (2.8) Et2O 2.0 99 (90)
e 93 (R) 
13 TiCl(iPrO)3 (2.8) Et2O 1.7 92 78 (R) 
a
 Reaction conditions: 1 (0.1 mmol, 1 eq.), MeLi (1.6 M in Et2O), [Ti], (Ra,S)-L14 
(0.2 eq.), Et2O (C = 0.067 M), 20 C, 10 min. 
b Determined by Chiral GC (see 
Experimental Part for details). c Performed at 40 C, 1 h. d Reaction time 1 h. e 
Isolated yield after flash chromatography. 
 
The addition of MeLi (3.2 eq.) to benzaldehyde (1) in the presence of 
TiCl(OiPr)3 (6.0 eq.) in toluene at –40 °C, using Ph-BINMOL (Ra,S)-L14 (20 
mol%) as ligand, afforded 1-phenylethanol (2) in moderate yield (72%) 
and low enantioselectivity (22% ee, entry 1, Table 2.1). Fortunately, a 
reduction in the amount of TiCl(OiPr)3 down to 3.2 eq., provided the 
desired alcohol 2 in excellent conversion (98%) and enantioselectivity 
(92% ee, entry 2). Further reductions in the titanium content (down to 2.5 
eq.) could be performed without having an effect in the enantioselectivity 
of the reaction (entry 3). 
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The model reaction was also tested using different solvents and 
temperatures. No product was observed when the reaction was carried 
out in THF at higher temperatures (–20 °C, entry 4), and when Et2O was 
used as a solvent at the same temperature, the product 2 was obtained in 
99% conversion and 70% ee (entry 5). When the amount of TiCl(OiPr)3 
was reduced to 2.0 eq. the enantioselectivity decreased drastically (30% 
ee, entry 6). Fortunately, full conversion and 78% ee was achieved by 
adjusting the amount of MeLi to 2.0 eq (entry 7). 
Other titanium sources like TiBr2(O
iPr)2 and TiF4 were also examined, but 
both of them led to the alcohol 2 as a racemic mixture (entries 8 and 9). 
Next, we kept the loading of MeLi at 2.0 eq. and we gradually increased 
the amount of TiCl(OiPr)3 (entries 10–12). The optimal amount of 
TiCl(OiPr)3 proved to be 2.8 eq., providing full conversion and 93% ee 
(entry 12). Other attempts to lower the amount of methyllithium were 
unsuccessful, affording lower conversions and enantioselectivities (entry 
13). 
With the optimised conditions in hand, we proceeded to test the scope of 
the reaction with a wide range of aldehydes, with different substitution 
patterns and electronic properties (Table 2.2). Gratifyingly, full conversion 
was obtained after only 10 min of reaction, achieving high 
enantioselectivities in most of the cases. The stereochemistry of the 
products obtained was determined by comparing the optical rotation 
values with the data previously reported in the literature. 
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Table 2.2 – Asymmetric addition of MeLi to aldehydes catalysed by (Sa,R)-L29 
               
Entry Product Yield (%)
b ee (%)
c 
1 
 
93 92 (R) 
2 
 
94 90 (R) 
3 
 
92 44 (R) 
4 
 
85 89.5 (R) 
5 
 
95 93 (R) 
6 
 
(98)d 84 (R) 
 
7 
 
 
90 
 
87 (R) 
8 
 
89 86 (R) 
9 
 
92 80 (R) 
10 
 
15 (97)e 80 (R) 
11 
 
92 94 (R) 
12 
 
93 91 (R) 
CHAPTER 2 
 
133 
 
13 
 
80 73 (R)  
14 
 
94 63 (R)f 
15 
 
 
(15)d 
 
 
95 (R)       
 
16g 
 
(20)d 89 (R) 
a Reaction conditions: aldehyde (0.1 mmol, 1.0 eq.), MeLi (1.6 M in Et2O, 2.0 eq.), 
(Ra,S)-L14 (0.2 eq.), TiCl(
iPrO)3 (1.0 M in hexane, 2.8 eq.), Et2O, 20 C, 10 min. 
b 
Isolated yield after flash chromatography. c Determined by Chiral GC. Configuration 
based on literature data (see Experimental Part for details). d Conversion 
determined by Chiral GC due to the high volatility of the product. e Conversion 
determined by GC due to the product being inseparable from the ligand by flash 
chromatography. f Determined on the corresponding acetate derivative (see 
Experimental Part for details). g Performed at 0 C. 
 
 
The addition of methyllithium to electron-rich aromatic aldehydes such as 
p-anisaldehyde and p-tolylaldehyde led to high yields and 
enantioselectivities (entries 1 and 2, Table 2.2). Unfortunately, only a 44% 
ee was obtained in the reaction with o-anisaldehyde (entry 3), probably 
due to the increased steric hindrance close to the carbonyl group. The 
reaction with other aromatics like 2-naphthaldehyde and the 
heteroaromatics 2-thiophen-2-carbaldehyde and furfural provided high 
yields (85-98%) and enantioselectivities (84-93%, entries 4–6). p-Bromo 
and p-chlorobenzaldehyde were compatible with the reaction conditions 
and afforded the corresponding secondary alcohols in excellent yields (89-
90%) and enantioselectivities (86-87%, entries 7 and 8). The reaction 
with (E)-cinnamaldehyde provided high yield (92%) but only moderate 
enantiocontrol (80%, entry 9).  
When the reaction was attempted with aromatic aldehydes with electron-
withdrawing substituents (entries 10–12), high yields (93-97%) and 
moderate to high enantioselectivities (80-91%) were obtained. It is worth 
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mentioning that the reaction conditions are compatible with a cyano group 
in the substrate (entry 12). 
The scope of the reaction was also expanded to the more challenging 
aliphatic aldehydes. Promising results were obtained for the addition of 
MeLi to aliphatic aldehydes with an enolizable position (entries 13 and 14). 
For instance, 2-phenylacetaldehyde provided the corresponding carbinol in 
80% yield and 73% ee (entry 13), whilst 1-octanal achieved higher yield 
(94%) but a lower enantiocontrol (63% ee, entry 14). On the other hand, 
the non-enolizable but bulky pivaldehyde led to the formation of the 
corresponding product in excellent enantioselectivity (95%) but really low 
conversion (15%, entry 15). However, the low conversion could be 
improved by performing the reaction at higher temperatures (0 °C), which 
caused a slightly drop in the enantioselectivity (89% ee, entry 16). 
It had been previously demonstrated in our research group that the use of 
the 4-Py-BINMOL furnished higher enantiocontrol than Ph-BINMOL in the 
addition of Grignard reagents to aliphatic aldehydes.60 With this in mind, 
we tested the new titanium source with aliphatic aldehydes, using (Ra,S)-
L15 as catalyst. To our delight, the addition of MeLi in the presence of 
TiCl(OiPr)3, catalysed by the ligand (Ra,S)-L15, provided higher 
enantioselectivities in the addition to aliphatic aldehydes than (Ra,S)-L14 
(Table 2.3).  
Table 2.3 – Asymmetric addition of MeLi to aliphatic aldehydes catalysed by 
(Ra,S)-L15 
 
Entry RCHO Yield (%)b ee (%)c 
1 
 
93 91 (R) 
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2 
 
(28)d 
 
97 (R)      
 
3e 
 
(30)d 83 (R) 
4 
 
84 89 (R)f 
5 
 
(98)d 92 (R)f 
6 
 
(87)d 94 (R)f 
 
 
7 
 
 
 
94 
 
 
90 (R) 
a Reaction conditions: aldehyde (0.1 mmol, 1.0 eq.), MeLi (1.6 M in Et2O, 2.0 eq.), 
(Ra,S)-L15 (0.2 eq.), TiCl(
iPrO)3 (1.0 M in hexane, 2.8 eq.) Et2O, 20 C, 10 min. 
b 
Isolated yield by flash chromatography. c Determined by chiral GC. Configuration 
based on literature data (see Experimental Part for details). d Conversion 
determined by chiral GC due to the high volatility of the product. e Performed at 0 
C. f Determined on the corresponding acetate derivative (see Experimental Part). 
 
 
The addition of methyllithium to 2-phenylacetaldehyde catalysed by 
(Ra,S)-L30 exhibited excellent yield (93%) and enantioselectivity (91% ee, 
Table 2.3, entry 1), providing a significant improvement compared with 
the result obtained with the previous Ph-BINMOL ligand (Ra,S)-L14 (Table 
2.2, entry 13). The reaction with pivaldehyde afforded a low conversion 
(28%) but an excellent enantioselectivity (97% ee, entry 2). 
Unfortunately, increasing the reaction temperature to 0 °C did not 
improve the conversion, and decreased the enantioselectivity to 83% ee 
(entry 3). The addition of MeLi to octanal (entry 4), provided the 
corresponding product 4n in high yield and enantioselectivity (84% yield, 
89% ee). The α- and β-branched aliphatic aldehydes such as 
cyclohexylcarbaldehyde and isopentanal led to the corresponding alcohols 
4p and 4q in high conversions and enantioselectivities (entries 5 and 6). 
Finally, the addition of MeLi to the α,β-unsaturated cinnamaldehyde 
proceeded with excellent yield (94%) and remarkably improved 
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enantiocontrol (90%, entry 7) compared to the use of the ligand (Ra,S)-
L14 (80% ee, entry 9, Table 2.2). 
To finish the study of the scope of the reaction, different organolithium 
reagents were tested (Table 2.4). 
Table 2.4 – Asymmetric addition of organolithium reagents to aldehydes 
 
Entry Product L 
Yieldb 
(%) 
eec (%) 
 
1d 
 
 
L15 
 
87 
 
97 (R) 
 
2 
 
 
L15 
 
78 
 
91 (R)e 
 
3f 
 
 
L14 
 
91 
 
60 (R) 
 
4 
 
 
L14 
 
91  
 
13 (R) 
a Reaction conditions: aldehyde (0.1 mmol, 1.0 eq.), R1Li (2.0 eq.), (Ra,S)-L (0.2 eq.), 
TiCl(iPrO)3 (1.0 M in hexane, 2.8 eq.) Et2O, 20 C, 10 min. 
b Isolated yield by flash 
chromatography. c Determined by chiral GC or HPLC. Configuration based on 
literature data (see Experimental part for details). d Reaction conditions: aldehyde 
(0.1 mmol, 1.0 eq.), TiCl(iPrO)3 (1 M in hexane, 3.2 eq.), 
nBuLi (1.6 M in hexane, 2.5 
eq.), Et2O, 20 C. 
e Determined on the corresponding acetate derivative (see 
Experimental part for details). f Reaction conditions: aldehyde (0.1 mmol, 1.0 eq.), 
TiCl(iPrO)3 (1 M in hexane, 5.0 eq.), 
iBuLi (1.7 M in heptane, 2.5 eq.), Et2O, 20 C. 
 
 
The addition of nBuLi to both the aromatic benzaldehyde and the aliphatic 
octanal, provided good yields and excellent enantioselectivities (entries 1 
and 1, Table 2.4). However, when the reaction was attempted with the 
sterically more demanding iBuLi, high yield (91%) but only moderate 
enantioselectivity (60% ee, entry 3) was obtained. Finally, the reaction of 
PhLi with naphthaldehyde provided a good yield but low enantioselectivity 
(13% ee, entry 4). 
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To summarize, a new catalytic system for the addition of alkylithium 
reagents to aldehydes has been developed using Ar-BINMOL ligands in the 
presence of TiCl(OiPr)3. This methodology allows the preparation of methyl 
carbinol units in good yields and high levels of enantiocontrol. The 
reaction takes place under milder conditions compared to the 
methodologies previously described in the literature, employing lower 
titanium loadings and allowing more practical reaction temperatures and 
shorter reaction times. All those characteristics make the methodology 
more suitable for both academic and industrial applications.   
2.3.2. Catalytic enantioselective addition of 
methyltriisopropoxititanium to aldehydes 
As previously mentioned in the introduction of this chapter, although an 
exact mechanism for the enantioselective addition of organozinc, 
organomagnesium or organolitium reagents to carbonyl compounds in the 
presence of a titanium salt such as Ti(OiPr)4 is not fully known, the 
general belief is that a transmetallation of the corresponding R group from 
the Zn, Mg or Li atom to a Ti center must take place at some stage in the 
catalytic cycle.56  
For this reason, we decided to test our very versatile Ar-BINMOL ligands 
as catalysts for the direct enantioselective addition of organotitanium 
reagents to carbonyl compounds. Our studies focused on the use of the 
commercially available MeTi(OiPr)3. We rationalised that the direct use of 
this nucleophile would allow the avoidance of an excess of a titanium 
source (e.g. Ti(OiPr)4) because no transmetallation would be in this case 
needed. In addition, since the MeTi(OiPr)3 is not a very reactive 
nucleophile, we also speculated that milder conditions and more practical 
temperatures would be probably allowed in the process, compared to the 
previously used more reactive organomagnesium and organolithium 
reagents. 
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Table 2.5 – Optimisation of reaction conditions for the addition of MeTi(OiPr3) to 
benzaldehyde 
 
Entry Solvent T (C) L14 (mol%) Conv. (%)
b ee (%)b 
1 Toluene 40 20 78 94 (R) 
2 Et2O 0 20 >99 97 (R) 
3 Et2O 0 10 99 96 (R) 
4 Et2O 0 5 99 78 (R) 
5 Et2O RT 10 >99 94 (R) 
6 Et2O 0 10
c 11 24 (R) 
a Reaction conditions: 1 (1 eq., 0.07 M), MeTi(OiPr)3 (1 M in THF, 1.5 eq.), (Ra,S)-
L14, 1.5 h. 
b Determined by chiral GC. c (R)-BINOL was used as ligand. 
 
 
The optimisation of the reaction conditions was carried out using 
benzaldehyde (1) as the model substrate. Our studies started with the 
testing of the optimal solvent and temperature conditions previously found 
in our research group for the addition of Grignard reagents to aldehydes 
using L14 as a ligand. Very promising results were obtained using 20 
mol% of L14 and 1.5 eq. of MeTi(O
iPr)3; the reaction afforded 78% 
conversion and 94% ee after 1 h (Table 2.5, entry 1). The use of Et2O as 
a solvent allowed the increase of the reaction temperature to 0 °C, 
reaching full conversion and excellent enantioselectivity (97% ee, entry 2). 
Under these conditions, the catalyst loading could be reduced to 10 mol% 
without observing any significant loss of conversion and enantiocontrol 
(entry 3). Lower catalyst loadings provided full conversion but lower 
enantioselectivity (78% ee, entry 4). 
The reaction could be carried at room temperature in the presence of 10 
mol% of L14 and only a small decrease in enantioselectivity was observed 
(compare entries 3 and 5). As a mode of camparison, we performed the 
reaction using (R)-BINOL as chiral ligand (entry 6) in Et2O at 0 °C, leading 
to a very low conversion (11%) and enantioselectivity (24% ee). 
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With the optimised conditions in hand, we examined the scope of the 
reaction with different aldehydes (Table 2.6). The system proved to be 
efficient, providing good yields (84-96%) and enantioselectivities (56 to 
>99%). 
Table 2.6 – Asymmetric addition of MeTi(OiPr)3 to aromatic aldehydes catalysed 
by (Sa,R)-L14 
 
Entry Product Conv. (%)b Yield (%)c ee (%)b 
 
    1 
 
 
90 
 
n.d. 
 
55 (R) 
2d >99 96 56 (R) 
 
    3 
 
 
82 
 
n.d. 
 
>99 (R) 
4d 99 92 >99 (R) 
 
 5d 
 
 
99 
 
96 
  
93 (R) 
 
6 
 
 
97 
 
90 
 
97 (R) 
 
7 
 
 
99 
 
89 
 
95 (R) 
 
8 
 
 
97 
 
94 
 
96 (R) 
 
9d 
 
 
58 
 
n.d. 
 
86 (R) 
10e 89 84 87 (R) 
 
11 
 
 
67 
 
n.d. 
 
90 (R) 
12e 98 95 94 (R) 
 
13f 
 
 
97 
 
95 
 
95 (R) 
a Reaction conditions: 3 (1 eq., 0.07 M), MeTi(OiPr)3 (1 M in THF, 1.5 eq.), (Ra,S)-
L14 (10 mol%), 1.5 h. 
b Determined by chiral GC or HPLC. c Isolated yield after 
flash chromatography. d Reaction performed with 1.7 eq. of MeTi(OiPr)3.
 e 
Reaction performed with 2.0 eq. of MeTi(OiPr)3. 
f Reaction performed using 0.5 
g of 1. 
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A wide variety of (hetero)aromatic aldehydes, containing both electron 
donating and withdrawing groups, were tested. In some cases, the 
loading of MeTi(OiPr)3 was increased up to 1.7 eq. (Table 2.6, entries 2, 4, 
5 and 9) or 2.0 eq. (entries 10 and 12) in order for the reaction to reach 
full conversion. In those cases, a small increase of the enantioselectivity 
was also observed. 
The reaction with o-methoxybenzaldehyde provided the lowest 
enantioselectivity (56%, entry 2) probably due to the high steric hindrance 
close to the reactive site. Remarkably, the methodology proved to be 
compatible with functionalised substrates, such as 4g and 4l (entries 6 
and 8). To our delight, all the reactions reached full conversion in less 
than 1.5 h and no by-product was observed in any case. Additionally, the 
unreacted starting material and the ligand could be both recovered from 
the reaction crude. The recovered ligand could be recycled and reused 
without any loss of activity. Furthermore, in order to test the robustness of 
the methodology, a larger scale reaction was performed with 
benzaldehyde 1 (47 mmol, 0.5 g, entry 13) and no erosion of conversion 
or enantioselectivity was observed compared to the lower scale reaction 
(compare entry 3, Table 2.5 with entry 13, Table 2.6). 
Next, the reaction was tested with some aliphatic and α,β-unsaturated 
aldehydes (Table 2.7). In some of the reactions, the ligand L15 showed a 
higher efficiency than the ligand L14. 
Table 2.7 – Asymmetric addition of MeTi(OiPr)3 to aliphatic and α,β-unsaturated 
aldehydes 
 
Entry Product L Conv. (%)b Yield (%)c ee (%)b 
 
 1d 
 
 
L14 
 
65 
 
n.d. 
 
80 (R) 
2 L15 90 88 82 (R) 
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    3 
 
 
 
L14 
 
99 
 
n.d. 
 
81 (R) 
4 L15 99 93 85 (R) 
 
5 
 
 
L15 
 
99 
 
95 
 
90e (R) 
 
6 
 
 
L15 
 
99 
  
94e (R) 
 
7  
 
L15 
 
77f  
  
90e (R) 
 
8d 
 
 
L15 
 
20 
 
n.d. 
 
94 (R) 
9g L14 78 n.d. 93 (R) 
a Reaction conditions: 3 (1 eq., 0.07 M), MeTi(OiPr)3 (0.5 M in THF, 1.5 eq.), 
(Ra,S)-L (10 mol%), 1 h. 
b Determined by chiral GC or HPLC. c Isolated yield after 
flash chromatography. d Reaction performed with 1.7 eq. of MeTi(OiPr)3. 
e 
Determined by chiral GC on the acetate derivative. f 7% of (CH3)2CHCH2CH2OH 
was detected. g Reaction performed with 2.0 eq. of MeTi(OiPr)3.  
 
 
The addition of MeTi(OiPr)3 to cinnamaldehyde catalysed by L14 afforded a 
low conversion (65%) and enantioselectivity (80%) even when 1.7 eq. of 
the nucleophile were used (Table 2.7, entry 1). However, the use of the 
ligand L15 provided a higher conversion (90%) and enantioselectivity 
(82% ee, entry 2). A similar effect was observed with the addition to 
phenylacetaldehyde, increasing the selectivity from 81% to 85% when L15 
was used (compare entries 3 and 4). The addition to the linear octanal 
and the α-branched cyclohexanal afforded full conversion and high 
enantioselectivities (90% and 94% ee, respectively, entries 5 and 6). The 
reaction with the β-branched isovaleraldehyde led to a high 
enantioselectivity (90% ee) but moderate conversion (77%, entry 7). 
Finally, the bulkier pivaldehyde provided an excellent enantiocontrol (94% 
ee) but very low conversion (20%, entry 8). The result could be improved 
by switching to the ligand L14 and using 2 eq. MeTi(O
iPr)3, which 
increased the conversion to 78% (entry 9). 
In conclusion, the use of MeTi(OiPr)3 allowed a decrease in the catalyst 
loading to 10 mol% and an increase of the reaction temperature to 0 °C, 
compared to the more reactive organolithium and organomagnesium 
reagents, which require higher catalysts loadings (20 mol%) and usually 
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lower and more impractical temperatures (down to –40 °C). This one pot 
methodology, allows the preparation of the very versatile methyl carbinol 
units using readily available reagents. The shorter reaction times and the 
higher temperatures make this process more attractive for both academia 
and industry.   
2.3.3. Catalytic enantioselective 1,2-addition of alkenes 
to aldehydes  
In the search of new synthetic strategies for the catalytic enantioselective 
addition of easy-to-handle and readily available nucleophiles to carbonyl 
compounds, we decided to evaluate the use of alkenes as alkylmetal 
equivalents in the asymmetric 1,2-addition to aldehydes. This reaction 
would be synthetically relevant as it would accomplish a transformation 
that is not currently possible.  
Our investigations started2 by evaluating the use of the very versatile Ar-
BINMOLs38-40, 169 as ligands in the addition of 1-hexene to benzaldehyde 
(Table 2.8). We envisioned that the hydrozirconation of 1-hexene with 
Schwartz reagent would generate the corresponding organozirconium 
reagent, which could act as the nucleophile in the addition to the carbonyl.  
Following known procedures,96, 99-101 2 eq. of 1-hexene were treated with 
2 eq. of Cp2ZrHCl; a change from a white suspension to a yellow solution 
indicated the successful formation of the corresponding organozirconium 
compound, which was then added to a solution of benzaldehyde (1 eq., 
0.125 M) and Ph-BINMOL (20 mol%) in THF or DCM at RT. As expected, 
very low conversion of the desired alcohol 6 was observed in both cases 
(9 and 13%, respectively, Table 2.8, entries 1 and 2). Under similar 
conditions (0.125 M in benzaldehyde), the reaction was attempted in the 
presence of 2.5 – 2.8 eq. of different additives (AgOTs, TiCl(OiPr)3, CuI 
and Et2Zn) in both THF and DCM at RT. Unfortunately, no conversion was 
                                                             
2 The optimisation of the reaction conditions was carried out by Dr Marcos Veguillas at 
Manchester Metropolitan University during the spring of 2016. 
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observed in any case; only the presence of 2 eq. of Et2Zn provided 19% 
conversion of racemic product 6 (entry 3). We observed that when the 
reaction was carried out under more concentrated conditions (0.5 M in 
benzaldehyde) and using DCM as solvent, the conversion towards the 
desired product 6 could be increased up to 44%, although the 
enantioselectivity of the process remained zero (entry 4).  
Next, we decided to evaluate the use of different zinc sources as additives 
for the reaction. After an extensive screening, we observed that the use of 
ZnBr2 (0.5 eq.) in combination with Ti(O
iPr)4 (1.5 eq.) provided the 
desired alcohol 6 in 83% isolated yield and a promising 80% ee, using 
only 1.4 eq. of the alkene and 1.2 eq. of the Schwartz reagent, in DCM 
(0.5 M in benzaldehyde) at RT (entry 5). It is important to mention that 
the reaction proved to be very sensitive to the concentration and no 
conversion was observed under more diluted conditions (0.11 M of 1 in 
DCM, entry 6).  
Working at the optimal 0.5 M concentration of substrate in DCM, we 
trialled a different titanium source (TiCl(OiPr)3 instead of Ti(O
iPr)4), 
however, an increased reduction of the starting material to 
phenylmethanol was observed, whilst the desired product 6 was obtained 
in a racemic form (entry 7). It is worth mentioning that the use of 
TiCl(OiPr)3 in combination with Et2Zn or AgOTs did not provide any 
conversion either in DCM or THF, at 0.125 M or at 0.5 M. 
Changing the titanium loading (entries 8 and 9) or the amount of ZnBr2 
used in the reaction (entries 10 and 11), also afforded increased amounts 
of the undesired reduced product and lower enantioselectivities. To our 
surprise, when the reaction was carried out at lower temperature (0 °C, 
overnight) lower enantioselectivity was observed (35% ee, entry 12). 
Higher temperatures (35 °C), provided slightly higher enantioselectivity to 
the value obtained at RT. (82% ee, compare entries 13 and 5), but lower 
conversion (51%). 
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By way of comparison, the reaction was assayed using (R)-BINOL (20 
mol%) as ligand; 9% conversion to the desired product 6 was obtained in 
56% ee (entry 14). Different solvent systems – tert-butylmethyl ether, 
toluene and diethyl ether (entries 15 to 17) – were assayed for the 
reaction, in combination with DCM, which is the optimal solvent for the 
hydrozirconation step; unfortunately, all of them provided lower 
conversions and enantioselectivities than the exclusive use of DCM.  
Lowering the amounts of the Schwartz reagent and the alkene provided 
higher enantioselectivity (90%) but lower conversion towards the desired 
6, due to a substantial increase of reduction byproduct (entry 18). 
Fortunately, improved results were obtained with increased amounts of 
Schwartz reagent and the alkene, and, after fine adjustments, 99% 
conversion and 91% ee could be reached in 5 h when 2 eq. of Schwartz 
reagent were used in combination with 2.2 eq. of alkene in DCM at slightly 
higher temperature (35 °C, entry 19).  
Table 2.8 – Optimisation of reaction conditions for the addition of 1-hexene to 
benzaldehydea  
 
Entry Cp2ZrHCl 
(eq.) 
1-
hexene 
(eq.) 
T (°C) Ti(OiPr)4 
(eq.) 
ZnBr2 (eq.) 1/reduced/6
b eec 
  1d,e 2 2 RT - - 91/0/9 0 
2e 2 2 RT - - 87/0/13 0 
3e 2 2 RT - 2.0f 81/0/19 0 
     4 2 2 RT - 2.0f 56/0/44 0 
5 1.2 1.4 RT 1.5 0.5 n.d. 
(83)g 
80 (R) 
 6h 1.2 1.4 RT 1.5 0.5 99/0/1 0 
7 1.2 1.4 RT 1.5i 0.5 0/78/22 0 
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8 1.2 1.4 RT 1.0 0.5 0/57/43 35 (R) 
9 1.2 1.4 RT 2.0 0.5 5/89/5 62 (R) 
10 1.2 1.4 RT 1.5 0.2 9/73/18 80 (R) 
11 1.2 1.4 RT 1.5 0.7 5/74/20 66 (R) 
12 1.2 1.4 0 1.5 0.5 25/67/6 35 (R) 
13 1.2 1.4 35 1.5 0.5 13/36/51 82 (R) 
14j 1.2 1.4 RT 1.5 0.5 8/83/9 56 (R) 
15k 1.2 1.4 RT 1.5 0.5 9.6/74/15.4 79 (R) 
16l 1.2 1.4 RT 1.5 0.5 6.4/93/1.2 n.d. 
 17m 1.2 1.4 RT 1.5 0.5 4.5/89/6.5 59 (R) 
18 1.0 1.2 RT 1.5 0.5 30/59/11 90 (R) 
19 2.0 2.2 35 1.5 0.5 0/0/99 
(87)g 
91 (R) 
a Reaction conditions: 1 (0.15 mmol, 1.0 eq.), (Ra,S)-L14 (0.2 eq.), Ti(O
iPr)4 (1.5 eq.), DCM (0.5 
M), room temperature, overnight. b Determined by CG-MS; reduced = phenyl methanol. c 
Determined by Chiral GC (see Experimental Part for further details).  d Reaction carried out in 
THF. e 0.125 M in benzaldehyde. f Reaction carried out with Et2Zn instead of ZnBr2. 
g Isolated 
yield after flash chromatography. h Concentration of 1 was 0.11 M in DCM. i Reaction carried 
out with TiCl(OiPr)3 instead of Ti(O
iPr)4.
 j (R)-BINOL (20 mol%) used as a ligand. k TBDME/DCM 
were used as a solvent l Toluene/DCM were used as a solvent. m Et2O/DCM were used as a 
solvent. 
 
 
With the optimised conditions in hand, we tested the scope of the reaction 
with different aromatic aldehydes (Table 2.9). Thus, the reaction of 1-
hexene with p-tolualdehyde afforded product 8a with good yield (74%) 
and excellent enantioselectivity (94%, Table 2.9, entry 1). In the case of 
m- and o-tolualdehyde (entries 2 and 3), where the methyl substituent in 
the aromatic ring is closer to the reactive site, higher percentages of 
reduced and dehydration product 8’ (Figure 2.4) were obtained, as well as 
lower enantioselectivity (85% and 75% respectively), probably due to 
increased steric hindrance close to the carbonyl group. The reaction with 
p-bromo and p-chlorobenzaldehyde afforded moderated yields (56% and 
59%) and excellent enantioselectivities (91% and 90%, entries 4 and 5, 
respectively). The use of p-acetylbenzaldehyde as starting material (entry 
6), provided the corresponding alcohol 8f in excellent enantioselectivity 
(91%) but low yield (32%). This is due to the reduction of the acetyl 
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group by -hydride transference from the organometallic reagent, by-
product that could be detected by GC-MS (8f’’, Figure 2.4). Gratifyingly, 
the methodology proved to be compatible with other functional groups like 
p-CN (entry 7) and p-CF3 (entry 8), leading to good yields (55-58%) and 
high enantioselectivities (87% ee). 
Table 2.9 – Enantioselective catalysed addition of 1-hexene to aromatic 
aldehydes - Scope of the reactiona  
 
Entry Product 7/reduced/8b Yield (%)c ee (%)d 
1 
 
0/6/94 74 91 (R) 
2 
 
0/15/77e 54 85 (R) 
3 
 
0/28/54f 49 75 (R) 
4 
 
3/10/87 56 91 (R) 
5g 
 
2/6/92 59 90 (R) 
6 
 
1/4/76h 32 91 (R) 
7g 
 
0/19/81 58 87 (R) 
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8 
 
3/28/69 55 87i (R) 
a Reaction conditions: 7 (0.15 mmol, 1.0 eq.), (Ra,S)-L14 (0.2 eq.), Ti(O
iPr)4 (1.5 eq.), 1-
hexene (2.2 eq.), Cp2ZrHCl (2.0 eq.), ZnBr2 (0.5 eq.), DCM (0.375 M), 35 °C, overnight. 
b Determined by GC-MS. c Isolated yield after flash chromatography. d Determined by 
Chiral GC. Configuration based on literature data (see Experimental Part for details). e 
8% of dehydration product 8’ was observed by GC-MS. f 18% of dehydration product 
was observed by GC-MS. g The reaction was carried out in DCM (0.3 M). h 19% of 8f’ 
was observed by GC-MS. i Determined on the corresponding acetate derivative (see 
Experimental part for further details).  
 
 
 
Figure 2.4 – By-products of the reaction detected by GC-MS 
Next, we tested the scope of the reaction with different alkenes (Table 
2.10). Thus, the reaction of 4-phenyl-1-butene with benzaldehyde (entry 
1), provided excellent yield (93%) and good enantioselectivity (77% ee). 
To our delight, the methodology is also compatible with functionalised 
alkenes. The reaction of benzaldehyde with 4-[(tert-
butyldimethylsilyl)oxy]-1-butene led to the desired alcohol 10b in 
moderate yield (42%) but good enantioselectivity (88% ee, entry 2). 
Similar results were obtained when 4-chlorobut-1-ene was used as 
nucleophile (entry 3), providing 40% yield and 86% ee.  
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Table 2.10 – Enantioselective catalysed addition of alkenes to benzaldehyde - 
Scope of the reactiona 
 
Entry Product 1/reduced/10b Yield (%)c ee (%)d 
1e 
 
0/0/>99 93 77 (R) 
2 
 
n.d. 42 88 (R) 
3 
 
0/10/75f 40 86g (R) 
a Reaction conditions: 1 (0.15 mmol, 1.0 eq.), (Ra,S)-L14 (0.2 eq.), Ti(O
iPr)4 (1.5 eq.), 9 
(2.2 eq.), Cp2ZrHCl (2.0 eq.), ZnBr2 (0.5 eq.), DCM (0.375 M), 35 °C, overnight. 
b 
Determined by GC-MS. c Isolated yield after flash chromatography. d Determined by 
Chiral GC. Configuration based on literature data (see Experimental Part for details).  e 
Reaction carried out with 9 (3.0 eq.) and Cp2ZrHCl (2.8 eq.). 
f 15% of dehydration 
product was observed by GC-MS. g Determined on the corresponding cyclised 
derivative 10c’ (see Experimental part for details).  
 
 
As an application of this methodology, product 10c was transformed into 
its corresponding tetrahydropyran adduct 10c’. Tetrahydropyran rings are 
very important structural moieties, which are present in a large variety of 
natural products such as polyether antibiotics and marine macrocycles.170-
174 Additionally, they are also employed in the perfume industry or as 
flavouring ingredients in the food industry.175  
Thus, following a common and straightforward procedure,176 alcohol 10c 
was dissolved in dry THF and treated with 2 eq. of KOtBu at RT. 
Tetrahydropyran 10c’ was obtained in 84% yield after purification by 
column chromatography (Scheme 2.50). It is worth pointing out that no 
racemization occurs during the cyclisation,177 both 10c and 10c’ were 
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obtained in 86% ee. This strategy constitutes a novel and straight forward 
method for the synthesis of chiral tetrahydropyran derivatives via an 
enantioselective 1,2-addition of an alkene to a carbonyl followed by an 
intramolecular SN2 reaction. 
 
Scheme 2.50 – Formation of the tetrahydropyran ring from product 10c  
In conclusion, we have developed a new and efficient procedure for the 
catalytic asymmetric addition reaction of alkylzirconium species to 
aromatic aldehydes, based on the use of a readily available non-racemic 
diol ligand and Ti(OiPr)4. The alkylzirconium nucleophiles are generated in 
situ by hydrozirconation of alkenes with Schwartz reagent; thus avoiding 
the use of premade organometallic reagents. The reaction proceeds under 
mild conditions and it allows the synthesis of the corresponding chiral 
secondary alcohols in moderated to good yields (32-93%) and good to 
excellent enantioselectivities (75-91% ee). It is worth mentioning that the 
reaction is compatible with the presence of functional groups in both the 
aldehyde and the alkene. Furthermore, the methodology allows the 
enantioselective synthesis of chiral tetrahydropyrans by a subsequent SN2 
reaction on the addition product obtained. These tetrahydropyrans are 
important motifs from a pharmaceutical and an agricultural point of view. 
2.3.4. Attempted enantioselective synthesis of 
fluoxetine  
Being aware of the potential of all the catalytic asymmetric methodologies 
developed in our group during the last years,59, 60, 62, 79, 89, 178, 179 we 
envisioned their application to the enantioselective synthesis of the 
antidepressant fluoxetine, whose racemic synthesis has been studied in 
the first chapter of this thesis.  
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As stated by the 9th principle of Green Chemistry,90 “Catalytic reagents 
are superior to stoichiometric reagents”  therefore, a synthetic pathway 
for the preparation of fluoxetine, that involves catalytic methods, would 
constitute a greener and highly desirable strategy (see Chapter 1, section 
1.3.2).  
As previously mentioned in Chapter 1, section 1.3.1; even though Prozac 
is sold as a racemate, the different activities and metabolic rates between 
both enantiomers have generated a growing interest in the synthesis of 
both isomers in an optically pure way. Ideally, once the catalytic 
asymmetric step has been developed, it could be attempted using ball 
milling or microwave assisted heating in order to make the process even 
more sustainable.  
Thus, three different strategies for the asymmetric synthesis of fluoxetine 
were proposed and evaluated (Schemes 2.51–2.53); all of them based on 
the enantioselective addition of a Grignard reagent to the cheap and 
commercially available benzaldehyde.   
Route A consists on the catalytic asymmetric addition of allylmagnesium 
bromide to benzaldehyde, which would provide enantiopure 11. Next, an 
ozonolysis reaction would afford the aldol 12, that could be transformed 
to the hydroxylamine 13 via a reductive amination process. Last, the O-
arylation methodology developed in the first chapter of this thesis would 
lead to enantiopure fluoxetine (14) (Scheme 2.51).  
 
Scheme 2.51 – Proposed asymmetric synthesis of fluoxetine – Route A, 4 steps 
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Route B starts with the asymmetric addition of 3-
dimethylaminopropylmagnesium chloride to benzaldehyde, which would 
provide enantiopure hydroxyamine 15. Next, the O-arylation and N-
demethylation steps previously studied would afford fluoxetine (14) 
(Scheme 2.52). 
 
Scheme 2.52 – Proposed asymmetric synthesis of fluoxetine – Route B, 3 steps 
Finally, route C consists of the asymmetric addition of (1,3-dioxolan-2-
ylmethyl)magnesium bromide to benzaldehyde, which would provide the 
acetal 17. Next, a simple hydrolysis would allow the synthesis of 12, 
common intermediate with route A (Scheme 2.53). 
 
Scheme 2.53 – Proposed asymmetric synthesis of fluoxetine – Route C, 4 steps 
Route A was firstly attempted, due to the commercial availability of 
allylmagnesium bromide. The results obtained are summarised on the 
Table 2.11 below. 
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Table 2.11 – Attempted catalytic enantioselective addition of allylmagnesium 
bromide to benzaldehyde 
 
Entry (Ra,S)-L Solvent Temperature (°C) Conv. (%)
b ee (%)c 
1 L14 Toluene 40 58 0 
2 L17 Toluene 40 >99 0 
3 L15 Toluene 40 >99 0 
4 L17 Et2O 20 50 0 
5d L17 Et2O 20 25 0 
a Reaction conditions: 1 (0.3 mmol, 1.0 eq.), allylmagnesium bromide (1 M in Et2O, 3.8 
eq.) (Ra,S)-L (0.2 eq.), Ti(O
iPr)4 (1.5 eq.), toluene or Et2O (2.5 mL), 20 or 40 °C, 4 h. 
b 
Determined by GC-MS. c Determined by Chiral GC on the corresponding acetate 
derivative (see Experimental Part for details). d The reaction was carried out with 
Ti(OiPr)4 (10 eq.) and allylmagnesium bromide (2.5 eq.). 
 
 
We started our investigations by using the optimised conditions for the 
addition of Grignard reagents to aldehydes catalysed by Ar-BINMOLs 
ligands developed by our group in 2011.59 Unfortunately, the reaction of 
benzaldehyde with allylmagnesium bromide (3.8 eq.) in the presence of 
Ti(OiPr)4 (15 eq.) and catalysed by (Ra,S)-L14 afforded racemic alcohol 11 
in 58% conversion (Table 2.11, entry 1). Under the same reaction 
conditions, the Ar-BINMOL ligands L15 and L17 provided full conversion, 
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but no enantioselectivity (entries 2 and 3, respectively). When the reaction 
was carried out in Et2O at –20 °C (optimal temperature and solvent for the 
addition of Grignard reagents to aliphatic aldehydes, developed in our 
group in 2013),60 50% conversion to the racemic alcohol 11 (entry 4) was 
obtained. Variations in the equivalents of Ti(OiPr)4 and/or allylmagnesium 
bromide did not result in any improvement (see, for example, entry 5). 
Our investigations on the proposed Route B started with the attempt to 
prepare 3-dimethylaminopropylmagnesium chloride from the commercially 
available 2-chloro-N,N-dimethylethylamine hydrochloride salt 20 (Table 
2.12). To test if the Grignard reagent 21 was successfully formed, the 
solution was reacted with benzaldehyde at 0 °C, allowing the resulting 
mixture to reach room temperature overnight. The reaction was analysed 
by GC-MS to determine the conversion of racemic product 15.   
Table 2.12 – Attempted formation of the Grignard reagent 21 and reaction with 
benzaldehyde 
 
Entry Starting 
material 
Mg (eq.) Activator Base (eq.) Solvent Conversion to 
()-15 (%)b  
1 20 3.0 I2 - Et2O 0 
2 20’ 1.0 I2 - Et2O 0 
3 20’ 3.0 I2 - Et2O 0 
4 20’ 1.0 I2 - THF 0 
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5 20’ 1.0 I2 - 
tBuOMe 0 
6 20 1.5 - BuLi (1 eq.) THF 0 
7 20 1.5 - BuLi (1 eq.) Et2O 0 
8 20 1.5 - NaH (1 eq.) Et2O 0 
a Reaction conditions: 20 or 20’ (12.5 mmol, 1.0 eq.), Mg powder (1.0, 1.5 or 3.0 eq.), base 
(1.0 eq.), solvent (1 M) b Determined by GC-MS after overnight reaction with benzaldehyde 
(see Experimental Part for details). 
 
 
Our investigations started with the reaction of the hydrochloride salt 20 
with 3 eq. of magnesium powder in diethyl ether using catalytic amounts 
of I2 to activate the surface of the magnesium powder (Table 2.12, entry 
1), the mixture was heated to reflux overnight. The resulting solution was 
cooled down to room temperature and added to benzaldehyde but no 
product 15 was detected by GC-MS (entry 1). We assumed that the 
hydrochloride salt was not reactive enough to form the Grignard reagent 
or the solubility was too low in Et2O, for these reasons, we attempted to 
make the Grignard reagent 21 from the free amine 20’. 
The free amine 20’ is, however, too volatile to be isolated using common 
work-up techniques, therefore, we opted for dissolving the hydrochloride 
salt 20 in aqueous 2 M NaOH. After stirring at RT for 30 min, an organic 
layer (free amine 20’) was formed on top of the solution. The free amine 
was taken with a syringe, and subsequently added to a suspension of Mg 
turnings (preactivated with I2) in different solvents. Using this 
experimental procedure, we attempted the formation of the Grignard 
reagent 21 in diethyl ether – using 1 or 3 eq. of magnesium powder 
(entries 2 and 3) – in THF (entry 4) and in tBuOMe (entry 5) as solvents. 
Unfortunately, no product 15 was observed by GC-MS in any case. 
Next, we envisioned that the free amine could be generated in situ by the 
reaction with a strong base like nBuLi or NaH, and that the Grignard 
reagent 21 could be subsequently formed by the reaction with the Mg 
turnings under reflux conditions. Thus, to a suspension of 20 in dry THF 
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and Mg (1.5 eq.), nBuLi (1 eq.) was added was added dropwise at 0 °C 
and the reaction was heated to reflux overnight (entry 6). After the 
addition of benzaldehyde, no conversion to 15 was observed. The same 
strategy was attempted using Et2O as a solvent and 
nBuLi (1 eq., entry 7) 
or NaH 60% dispersion in mineral oil (1 eq., entry 8) as base; 
unfortunately, no product was formed in either case. 
Last, we attempted the synthesis of fluoxetine through Route C (Scheme 
2.53), which begins with the asymmetric addition of (1,3-dioxolan-2-
ylmethyl)magnesium bromide (commercially available as a 0.5 M solution 
in THF) to benzaldehyde. Our attempts at this reaction are summarized in 
the table below. 
Table 2.13 – Attempted enantioselective addition of (1,3-dioxolan-2-
ylmethyl)magnesium bromide to benzaldehyde catalysed by Ph-BINMOL L14
a 
 
Entry Solvent Temperature (°C) Time (h) Conversion (%)b ee (%)c 
1d THF Reflux 18 36e 0 
2f Toluene –40 3 0 - 
3f Toluene 0 2 0 - 
4f Toluene RT 18 n.d.e - 
5f Et2O –20 4 0 - 
6f Et2O RT 18 n.d.
e - 
7  THF –40 4 0 - 
8 THF RT 18 n.d.e - 
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9 THF Reflux 18 n.d.g - 
10 Toluene –40 4 0 - 
11 Toluene RT 18 n.d.e - 
12 Et2O –20 4 0 - 
13 Et2O RT 18 n.d.
e - 
a Reaction conditions: 1 (0.1 mmol, 1.0 eq.), Ti(OiPr)4 (15 eq.), (Ra,S)-L14 (0.20 
eq.), 22 (0.5 M in THF, 3.8 eq.), dry THF (0.06 M). b Determined by GC-MS. c 
Determined by chiral GC. d Reaction performed in the absence of ligand and 
Ti(OiPr)4. 
e The formation of reduced product (phenylmethanol) was 
observed by GC-MS. f The THF present in the Grignard reagent was removed 
under vacuum (see Experimental Part for details).  
 
The reaction of 22 with benzaldehyde in THF, in the absence of chiral 
ligand and Ti(OiPr)4, provided 36% of conversion to the corresponding 
racemic product 17 together with 64% of conversion to the reduced 
product phenylmethanol (entry 1).  
Our investigations started by exploring the use of the optimal conditions 
for the addition of Grignard reagents to aldehydes developed by our 
group59 (entry 2). Our previous studies have shown that THF is not 
compatible with our methodology,59 for this reason, the THF of the 
Grignard solution was removed under vacuum before use. Thus, a solution 
of (Ra,S)-L14 and Ti(O
iPr)4 in toluene was transferred into a Schlenk flask 
containing 22 (the THF of which had been previously removed under 
vacuum), followed by the addition of benzaldehyde. The reaction was 
attempted at –40°C, 0 °C and RT (entries 2-4). Analysis by GC-MS 
confirmed that no reaction took place at –40°C or 0 °C (Table 2.13, 
entries 2 and 3), while room temperature provided full conversion to the 
reduced product phenylmethanol (entry 4). The same outcome was 
observed when the reaction was carried out in Et2O as solvent (entries 5 
and 6); no conversion was obtained at –20°C and full conversion to the 
reduced product was achieved when working at RT. 
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The same reaction conditions were tested using dry THF as solvent, 
without removing the solvent of the Grignard reagent. Unfortunately, no 
reaction took place at –40 °C (entry 7) and room temperature and reflux 
conditions provided exclusively reduced product phenylmethanol (entry 8 
and 9). Next, we attempted the reaction using in toluene (entries 10 and 
11) and diethyl ether (entry 12 and 13) as solvent, but without removing 
the THF from the Grignard reagent. In all cases, no reaction was observed 
at low temperature while RT led to full conversion to the reduced product. 
In conclusion, our preliminary research on the Ar-BINMOL catalysed 
enantioselective synthesis of fluoxetine by addition of a Grignard reagent 
to benzaldehyde have been unsuccessful.  
Different reaction conditions and titanium sources remain to be studied. In 
addition, other synthetic routes could be also explored. For example, the 
proposed route D (Scheme 2.54) constitutes a promising approach, based 
on the high enantioselectivities achieved through the addition of 
organozirconium reagents to aldehydes described in the previous section.  
 
Scheme 2.54 – Proposed asymmetric synthesis fluoxetine – Route D, 3 steps 
This strategy, route D, begins with the formation of the alkylzirconium 
reagent obtained from the reaction between 18 and Schwartz reagent. 
The alkene 18 could be easily prepared by the acylation of N-
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ethylidenemethylamine with Boc anhydride, as previously described by 
Breederveld.180, 181 Next, the addition of the corresponding alkylzirconium 
reagent to benzaldehyde in the presence of a chiral ligand would provide 
enantiomerically pure 19. A subsequent deprotection of the Boc group 
and an O-arylation reaction would finally provide our target fluoxetine 
(Scheme 2.54). 
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2.4. Experimental Part 
2.4.1. General instrumentation 
TLC: Thin layer chromatography (TLC) was run on silica gel 60 aluminium 
sheets, 0.25 mm thick (F254 Merck KGaA®). The components were 
visualized by UV light (254 nm), phosphomolybdic acid or KMnO4 staining 
solutions.  
IR: IR spectra were recorded on Nicolet® 380 FT/IR – Fourier Transform 
Infrared Spectrometer. Only the most significant frequencies have been 
considered for the characterisation, and have been reported in cm-1.   
NMR: 1H NMR, 13C NMR and 19F NMR were recorded on a JEOL® ECS-400 
(400, 100.6 and 376.5 MHz, respectively) using CDCl3 or CD3OD as 
solvent. Chemical shift values are reported in ppm with TMS as internal 
standard (CDCl3: δ 7.26 for 
1H-NMR, δ 77.0 for 13C-NMR). Data are 
reported as follows: chemical shifts, multiplicity (s= singlet, d= doublet, 
t= triplet, q= quartet, quint = quintet, m= multiplet, br= broad), coupling 
constants (Hz), and integration. 
Flash chromatography: Column chromatography was carried out using 
Geduran® Silica gel 60, 40-63 microns RE. The eluent used is mentioned 
in each particular case. 
Melting points: Melting points were measured in a Stuart® SMP10 
melting point apparatus and are not corrected. 
GC: Chromatograms (for both conversion and enantioselectivity 
determination) have been recorded using an Agilent Technologies® 
7890A GC System and a Hewlett Packard® 5890 Series II GC System, 
with a CycloSil-β (Agilent Technologies, 30 m x 0.25 mm) and a CP-
Chirasil-DEX CB (Varian, 25 m x 0.25 mm) column, respectively; injector 
and detector temperatures: 250 °C. 
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HPLC: Analysis (for enantioselectivity determination) was carried out on a 
Agilent 1100 Series HPLC equipped with a G1315B diode array detector 
and a Quat. Pump G1311A, using the columns Lux 5µ Cellulose-1 and Lux 
5µ Cellulose-3 (Phenomenex®, 250 mm x 4.60 mm). 
Optical rotations: Were measured on a Bellingham + Stanley® ADP 
440+ Polarimeter with a 0.5 cm cell (c given in g/100 mL).  
GCMS: Low resolution mass spectra were recorded on a GC-MS 
spectrometer (Hewlett Packard® HP 5890 Series II GC System) equipped 
with a DB-5 column (J&W Scientific®, 30 m × 0.32 mm), connected to a 
Hewlett Packard® HP 5972 Series Mass Selective Detector. Helium was 
used as carrier gas at 10 psi, and the samples were ionized by an 
electronic impact (EI) source at 70 eV.  
HRMS: High resolution mass spectra were obtained on a Agilent 
Technologies® 6540 Ultra-High-Definition (UHD) Accurate-Mass equipped 
with a time of flight (Q-TOF) analyser and the samples were ionized by 
ESI techniques and introduced through a high pressure liquid 
chromatography (HPLC) model Agilent Technologies® 1260 Infinity 
Quaternary LC system. Samples were eluted with mixture of MeOH and 
0.1% formic acid, with a flow of 0.2 ml/min.  
2.4.2. General methods and considerations 
All glassware employed during inert atmosphere experiments was flame-
dried under vacuum. Dry argon was used as inert gas for reactions that 
required inert atmosphere. All liquid aldehydes were freshly distilled before 
use. Organolithium reagents were purchased from Sigma-Aldrich and used 
without further purification. Anhydrous THF, DCM, toluene and Et2O were 
obtained from a Pure Solv™ Solvent Purification Systems. 
The rest of the commercially available reagents were purchased from 
Aldrich, Acros, Alfa Aesar, Manchester Organics, Fisher and Maybridge and 
used without further purification, unless stated otherwise. 
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Ligands (Ra,S)-L14, (Ra,S)-L15 and (Ra,S)-L17 were prepared according to 
literature procedures60 from (R)-BINOL, purchased from Manchester 
Organics.  
2.4.3. Experimental procedure and data of compounds 
2.4.3.1. Synthesis of Ar-BINMOL ligands  
2.4.3.1.1. Synthesis of monobenzylated (R)‐BINOL derivatives (R)‐P14, P15 
and P17 
The intermediates (R)‐P14, P15 and P17 were prepared starting from 
commercially available (R)‐BINOL according to two different procedures: 
 
Scheme 2.55 – Synthesis of Ar-BINMOL ligands, first step 
Procedure A:182 Synthesis of (R)‐P14 and (R)‐P17. 
(R)‐BINOL (2.0 g, 7.0 mmol) was dissolved in 50 mL of acetone in a round 
bottom flask, then K2CO3 (1.5 g, 10.5 mmol, 1.5 eq.) and the 
corresponding benzyl bromide derivative (ArCH2Br, 7.0 mmol, 1.0 eq) 
were added and the mixture was heated at 60 °C during 6 h. The reaction 
crude was concentrated under vacuum and was extracted with EtOAc (3 × 
15 mL). The combined organic layers were dried over magnesium sulfate 
and concentrated under vacuum. Synthetic intermediates P were used in 
the next step without further purification, Data of the products were in 
accordance with the previously reported in literature.40, 59  
Procedure B: Synthesis of (R)‐P15. 
(R)‐BINOL (2.0 g, 7.0 mmol) was dissolved in 40 mL of acetone in a round 
bottom flask and a solution of K2CO3 (2.9 g, 21.0 mmol, 3.0 eq.) in 4 mL 
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of water was added. Next, 4-(bromomethyl)pyridine (7.0 mmol, 1.0 eq.) 
was added and the mixture was heated at 65 °C during 12 h. The reaction 
crude was filtered under vacuum over Celite®, washing the cake with 
EtOAc (3 × 50 mL) and solvent was evaporated under vacuum. The 
hydroxyether (R)‐P15 was purified by flash silica gel chromatography. Data 
of the product in accordance with the previously reported in literature.60 
(R)‐2'‐(pyridin‐4‐ylmethoxy)‐(1,1'‐binaphthal
en)‐2‐ol ((R)‐P15):
60 Obtained as a white solid 
after column chromatography (Hex/EtOAc 100:0 to 
0:100) and recrystallisation in Hex/EtOAc. Yield: 
66%.  Mp = 182–184 °C. IR (ATR) 3064, 1610, 1504, 1325, 1264, 1044, 
798. 1H NMR (400 MHz, CDCl3) δ 8.26 (d, J = 4.5 Hz, 2H), 7.97 (d, J = 
9.0 Hz, 1H), 7.91 (d, J = 8.9 Hz, 1H), 7.87 (d, J = 7.8 Hz, 2H), 7.42–7.34 
(m, 3H), 7.34–7.26 (m, 3H), 7.21 (ddd, J = 8.1, 6.8, 1.3 Hz, 1H), 7.06 (d, 
J = 8.4 Hz, 1H), 6.85 (d, J = 5.2 Hz, 2H), 5.08 (d, J = 13.9 Hz, 1H), 5.03 
(d, J = 13.8 Hz, 1H), 3.18 (br s, 1H). 13C NMR (100.6 MHz, CDCl3) δ 
154.3, 151.6, 148.9, 146.9, 134.0, 133.8, 130.9, 129.9, 129.1, 128.2, 
127.5, 126.5, 125.2, 124.7, 123.3, 121.2, 117.7, 115.4, 114.8, 69.4.  
2.4.3.1.2. Synthesis of Ar‐BINMOLs derivatives (Ra,S)-L14, L15 and L17 
Two different procedures were used to synthesize the ligands L14, L15 and 
L17 through a [1,2]‐Wittig rearrangement from the corresponding 
hydroxyethers (R)‐P14, P15 and P17. 
Procedure A: Synthesis of (Ra,S)‐L14 and (Ra,S)‐L17 
n-BuLi (2.5 M in hexane, 2.5 eq) was slowly added to a solution of the 
corresponding precursor (R)‐P14 or (R)‐P17 (4.0 mmol) in dry THF (30 mL) 
at –78 °C. The mixture was stirred for 2 h at –78 °C and then quenched 
with water at 0 °C. The resulting mixture was extracted with EtOAc (3 × 
10 mL), and the combined organic layers were washed with brine, dried 
over magnesium sulfate and concentrated under vacuum. The crude 
product was purified by chromatography on flash silica gel to give the 
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desired products. Data of the products was in accordance with the 
previously reported in the literature. 
Procedure B: Synthesis of (Ra,S)‐L15 
n-BuLi (2.5 M in hexane, 5.0 eq) was slowly added to a solution of (R)‐P15 
(4.0 mmol) in dry THF (40 mL) at room temperature. The mixture was 
stirred for 12 h at 70 °C and then the reaction was quenched with water 
at 0 °C. The resulting mixture was extracted with EtOAc (3 × 15 mL) and 
the combined organic layers were dried over magnesium sulfate and 
concentrated under vacuum. The crude product was purified by 
chromatography on flash silica gel to give the desired product (Ra,S)‐L15. 
 
Scheme 2.56 – Synthesis of Ar-BINMOL ligands, second step 
 (Ra)-2'-[(S)-hydroxy(phenyl)methyl]-(1,1'-
binaphthalen)-2-ol ((Ra,S)-L14):
40 Obtained as a 
white solid after column chromatography (Hex/EtOAc 
100:0 to 85:15). Yield: 85%. Mp = 72–75 °C. IR 
(ATR) 3276, 3058, 2926, 2850, 1620, 1595, 1341, 
1268, 1027, 1012. 1H NMR (400 MHz, CDCl3) δ 7.90 (ddd, J = 21.8, 13.0, 
8.5 Hz, 4H), 7.60 (d, J = 8.7 Hz, 1H), 7.47 (ddd, J = 8.0, 6.8, 1.1 Hz, 1H), 
7.33 (d, J = 8.8 Hz, 1H), 7.29 (d, J = 7.9 Hz, 1H), 7.27–7.24 (m, 1H), 
7.20–7.08 (m, 5H), 7.06–6.98 (m, 2H), 6.83 (d, J = 8.4 Hz, 1H), 5.69 (s, 
1H), 5.61 (br s, 1H), 2.64 (br s, 1H). 13C NMR (100.6 MHz, CDCl3) δ 
151.2, 142.5, 141.4, 134.0, 133.4, 132.9, 130.2, 129.9, 129.7, 129.1, 
128.1, 127.1, 126.8, 126.7, 126.5, 126.0, 125.1, 125.0, 123.6, 117.9, 
117.2, 73.4. 
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(Ra)‐2'‐[(S)‐hydroxy(pyridin‐4‐yl)methyl]‐(1,1'‐
binaphthalen)‐2‐ol ((Ra,S)‐L15):
60 Obtained as a 
yellow solid after column chromatography 
(Hex/EtOAc 100:0 to 20:80). Yield: 33% (two 
steps). Mp: 100–103 °C. IR (ATR) 3297, 3055, 1606, 1506, 1342, 813, 
747. 1H NMR (400 MHz, CDCl3) δ 8.15 (d, J = 6.2 Hz, 2H), 7.95–7.73 (m, 
4H), 7.42 (ddd, J = 8.1, 6.5, 1.6 Hz, 1H), 7.36–7.26 (m, 3H), 7.25–7.13 
(m, 3H), 6.97 (d, J = 5.8 Hz, 2H), 6.90 (d, J = 8.3 Hz, 1H), 5.64 (s, 1H), 
3.56 (br s, 2H). 13C NMR (100.6 MHz, CDCl3) δ 152.8, 152.0, 148.3, 
139.8, 134.2, 133.4, 132.9, 131.8, 130.2, 129.4, 128.9, 128.2, 128.1, 
126.8, 126.8, 126.5, 125.0, 124.8, 123.6, 121.5, 118.3, 117.3, 72.1.  
 
(Ra)‐2'‐[(S)‐hydroxy(naphthalen‐1‐yl)methyl]‐(
1,1'‐binaphthalen)‐2‐ol ((Ra,S)‐L17):
60 Obtained 
as a yellow solid after column chromatography 
(Hex/EtOAc 100:0 to 80:20). Yield: 72%. Mp = 
105–108 °C. IR (ATR) 3227, 3051, 1621, 1508, 1268, 783, 748. 1H NMR 
(400 MHz, CDCl3) δ 7.87 (t, J = 6.8 Hz, 2H), 7.81 (t, J = 6.9 Hz, 2H), 7.75 
(d, J = 8.7 Hz, 1H), 7.69 (d, J = 8.2 Hz, 2H), 7.48–7.41 (m, 2H), 7.37 
(ddd, J = 8.1, 6.9, 1.1 Hz, 1H), 7.34–7.27 (m, 3H), 7.27–7.21 (m, 4H), 
7.13 (d, J = 8.3 Hz, 1H), 6.91 (ddd, J = 8.3, 6.9, 1.1 Hz, 1H), 6.40 (s, 
1H), 3.45 (br s, 1H), 1.60 (br s, 1H). 13C NMR (100.6 MHz, CDCl3) δ 
151.9, 140.1, 137.5, 133.8, 133.6, 133.4, 133.2, 131.4, 130.4, 129.8, 
129.4, 128.4, 128.3, 128.1, 127.9, 126.8, 126.7, 126.5, 126.4, 125.6, 
125.4, 125.3, 125.2, 124.9, 123.8, 123.7, 123.4, 118.6, 118.1, 71.6. 
2.4.3.2. Catalytic asymmetric addition of organolithium reagents 
to aldehydes 
General procedure for the addition of organolithium reagents to 
aldehydes: To a stirred solution of (Ra,S)-L14 or L15 (0.20 eq.) in Et2O 
(1.60 mL, 0.06 M), TiCl(OiPr)3 (0.28 mL, 2.80 eq., 1 M in hexane) was 
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added at room temperature. The solution was stirred for 5 min and then 
cooled to –20 °C. Next, the organolithium reagent was added (2.00 eq., 
unless stated differently in the corresponding table) followed by 
immediate addition of the aldehyde (0.1 mmol). The reaction mixture was 
stirred for 10 min and the reaction was then quenched by the addition of 
water. The layers were separated, and the aqueous layer was extracted 
three times with Et2O. The combined organic layers were dried with 
anhydrous MgSO4, filtered and concentrated. The crude reaction product 
was purified by flash silica gel chromatography. 
  (R)-1-Phenylethanol (2):183 Obtained as a colorless oil 
after column chromatography (Hex/EtOAc 5:1). Yield: 
90%. ee: 93%. [α]D
24 = 40 (c 1.0, CHCl3) [Lit.
183 [α]D
26 
= 97 (c 0.28, CHCl3) for 95% ee]. 
1H NMR (400 MHz, CDCl3) δ 7.39–
7.21 (m, 5H), 4.86 (q, J = 6.5 Hz, 1H), 2.10 (br s, 1H), 1.47 (d, J = 6.5 
Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 145.8, 128.4, 127.4, 125.3, 70.3, 
25.1. ee determination by chiral GC analysis, Cyclosil β column, T = 125 
°C, P = 15.9 psi, retention times: tr(R) = 11.3 min (major enantiomer), 
tr(S) = 12.2 min. 
 (R)-1-(4-Methoxyphenyl)ethanol (4a):60 
Obtained as a colorless oil after column 
chromatography (Hex/EtOAc 7:1). Yield: 93%. ee: 
92%. [α]D
24 = 26 (c 1.5, CHCl3) [Lit.
184 [α]D
20 = 
16.5 (c 1.1, CHCl3) for 95.5% ee]. 
1H NMR (400 MHz, CDCl3) δ 7.30 (d, 
J = 8.7 Hz, 2H), 6.88 (d, J = 8.7 Hz, 2H), 4.85 (q, J = 6.4 Hz, 1H), 3.80 
(s, 3H), 1.85 (br s, 1H), 1.47 (d, J = 6.4 Hz, 3H). 13C NMR (100.6 MHz, 
CDCl3) δ 159.0, 138.0, 126.6, 113.8, 70.0, 55.3, 25.0. ee determination by 
chiral GC analysis, Cyclosil β column, T = 125 °C, P = 15.9 psi, retention 
times: tr(R) = 19.8 min (major enantiomer), tr(S) = 20.5 min. 
 (R)-1-(4-Methylphenyl)ethanol (4b):185 Obtained 
as a colourless oil after column chromatography (eluent 
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Hex/EtOAc 9:1). Yield: 94%. ee: 90%. [α]D
25 = 35 (c 4.0, CHCl3) 
[Lit.186 [α]D
26 = 56 (c 1.0, CHCl3) for 96% ee]. 
1H NMR (400 MHz, 
CDCl3) δ 7.26 (d, J = 8.2 Hz, 2H), 7.15 (d, J = 7.6 Hz, 2H), 4.86 (q, J = 
6.4 Hz, 1H), 2.34 (s, 3H), 2.03 (br s, 1H), 1.48 (d, J = 6.5 Hz, 3H). 13C 
NMR (100.6 MHz, CDCl3) δ 142.8, 137.1, 129.1, 125.3, 70.2, 25.0, 21.1. 
ee determination by chiral GC analysis, Cyclosil β column, T = 125 °C, P = 
15.9 psi, retention times: tr(R) = 13.1 min (major enantiomer), tr(S) = 
14.3 min. 
 (R)-1-(2-Methoxyphenyl)ethanol (4c):183 Obtained as 
a colorless oil after column chromatography (Hex/EtOAc 
6:1). Yield: 92%. ee: 44%. [α]D
24 = 1.7 (c 1, CHCl3) 
[Lit.183 [α]D
26 = 24 (c 0.98, CHCl3) for 99% ee]. 
1H NMR (CDCl3, 400 
MHz) δ 7.35–7.25 (m, 2H), 6.98–6.88 (m, 2H), 5.12–5.06 (m, 1H), 3.87 
(s, 3H), 2.68 (d, J = 5.1 Hz, 1H), 1.51 (d, J = 6.3 Hz, 3H). 13C NMR 
(CDCl3, 100.6 MHz) δ 156.4, 133.3, 128.2, 126.0, 120.7, 110.3, 66.4, 
55.2, 22.8. ee determination by chiral GC analysis, Cyclosil β column, T = 
150 °C, P = 15.9 psi, retention times: tr(R) = 10.6 min, tr(S) = 12.3 min 
(major enantiomer). 
 (R)-1-(Naphthalen-2-yl)ethanol (4d):183 Obtained 
as a white solid after column chromatography (eluent 
Hex/EtOAc 8:1). Yield: 85%. ee: 90%. [α]D
24 = 27 
(c 3.7, CHCl3) [Lit.
183 [α]D
28 = 30 (c 0.97, CHCl3) for 
87% ee]. 1H NMR (400 MHz, CDCl3) δ 7.84–7.70 (m, 4H), 7.50–7.39 (m, 
3H), 4.98 (q, J = 6.4 Hz, 1H), 2.39 (br s, 1H), 1.52 (d, J = 6.5 Hz, 3H). 
13C NMR (100.6 MHz, CDCl3) δ 143.1, 133.2, 132.8, 128.2, 127.9, 127.6, 
126.0, 125.7, 123.8, 123.7, 70.4, 25.0. ee determination by chiral GC 
analysis, Cyclosil β column, T = 150 °C, P = 15.9 psi, retention times: 
tr(R) = 55.7 min (major enantiomer), tr(S) = 58.5 min. 
(R)-1-(Thiophen-2-yl)ethanol (4e):183 Obtained as a 
volatile yellow oil after column chromatography 
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(Hex/EtOAc 6:1). Yield: 86%. ee: 93%. [α]D
24 = 6 (c 3.2, CHCl3) [Lit.
183 
[α]D
25 = 20 (c 1.04, CHCl3) for 96% ee]. 
1H NMR (400 MHz, CDCl3) δ 
7.24 (dd, J = 4.8, 1.4 Hz, 1H), 7.00–6.94 (m, 2H), 5.13 (q, J = 6.4 Hz, 
1H), 2.09 (br s, 1H), 1.60 (d, J = 6.4 Hz, 3H). 13C NMR (100.6 MHz, 
CDCl3) δ 149.8, 126.6, 124.4, 123.2, 66.2, 25.2. ee determination by chiral 
GC analysis, Cyclosil β column, T = 125 °C, P = 15.9 psi, retention times: 
tr(R) = 12.1 min (major enantiomer), tr(S) = 13.2 min. 
 (R)-1-(Furan-2-yl)ethanol (4f):183 This product was 
volatile and could not be isolated. Conversion: 98%. 
ee: 84%. 1H NMR (400 MHz, CDCl3) δ 7.38 (dd, J = 1.8, 
0.7 Hz, 1H), 6.33 (dd, J = 3.2, 1.8 Hz, 1H), 6.23 (d, J = 3.2 Hz, 1H), 4.89 
(q, J = 6.6 Hz, 1H), 1.55 (d, J = 6.6 Hz, 3H). 13C NMR (100.6 MHz, 
CDCl3) δ 157.5, 141.9, 110.1, 105.1, 63.6, 21.2. ee determination by chiral 
GC analysis, Cyclosil β column, T = 100 °C, P = 15.9 psi, retention times: 
tr(R) = 10.6 min (major enantiomer), tr(S) = 11.2 min. 
 (R)-1-(4-Bromophenyl)ethanol (4g):183 Obtained as 
a white solid after column chromatography (Hex/EtOAc 
6:1). Yield: 90%. ee: 87%. [α]D
25 = 36 (c 3.3, CHCl3) 
[Lit.183 [α]D
20 = 34.6 (c 1.7, CHCl3) for 94% ee]. 
1H 
NMR (CDCl3, 400 MHz): δ 7.42–7.40 (m, 2H), 7.15–7.12 (m, 2H), 4.73 (q, 
J = 6.3 Hz, 1H), 3.10 (br s, 1H), 1.37 (d, J = 6.3 Hz, 3H). 13C NMR 
(CDCl3, 100.6 MHz): δ 144.6, 131.3, 127.0, 120.9, 69.4, 25.0. ee 
determination by chiral GC analysis, Cyclosil β 125 °C, P = 15.9 psi, 
retention times: tr(R) = 68.2 min (major enantiomer), tr(S) = 76.3 min. 
 (R)-1-(4-Chlorophenyl)ethanol (4h):183 Obtained as 
a yellow oil after column chromatography (Hex/EtOAc 
5:1). Yield: 89%. ee: 86%. [α]D
25 = 23 (c 4.3, 
CHCl3) [Lit.
183 [α]D
26 = 39 (c 1.1, CHCl3) for 97% ee]. 
1H NMR (400MHz, CDCl3) δ 7.31 (d, J = 9.0 Hz, 2H), 7.28 (d, J = 8.9 Hz, 
2H), 4.86 (q, J = 6.5 Hz, 1H), 2.40 (br s, 1H), 1.46 (d, J = 6.5 Hz, 3H). 
13C NMR (100.6 MHz, CDCl3) δ 144.2, 133.0, 128.5, 126.8, 69.7, 25.2. ee 
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determination by chiral GC analysis, Cyclosil β column, T = 115 °C, P = 
15.9 psi, retention times: tr(R) = 65.1 min (major enantiomer), tr(S) = 
72.5 min. 
 (R,E)-4-Phenylbut-3-en-2-ol (4i):60 Obtained as a 
white solid after column chromatography (Hex/EtOAc 
5:1). Yield: 94%. ee: 90%. [α]D
24 = 18 (c 1.0, 
CHCl3) [Lit.
187 [α]D
20 = 23 (c 1.0, CH2Cl2) for 99% ee]. 
1H NMR (400 MHz, CDCl3) δ 7.37 (dd, J = 5.3, 3.2 Hz, 2H), 7.34–7.27 
(m, 2H), 7.27–7.20 (m, 1H), 6.55 (d, J = 15.9 Hz, 1H), 6.25 (dd, J = 15.9, 
6.4 Hz, 1H), 4.47 (p, J = 6.3 Hz, 1H), 1.99 (br s, 1H), 1.36 (d, J = 6.4 Hz, 
3H). 13C NMR (100.6 MHz, CDCl3) δ 136.6, 133.5, 129.3, 128.5, 127.6, 
126.4, 68.8, 23.3. ee determination by chiral HPLC analysis, Lux 5u 
Cellulose 3 column, Hex/i-PrOH 97:2 flow = 1 mL/min, retention times: tr(S) = 
15.8 min, tr(R) = 16.9 min (major enantiomer). 
 (R)-1-(4-Nitrophenyl)ethanol (4j):188 Obtained 
as a colourless oil after column chromatography 
(Hex/EtOAc 9:1 to 7:3). Only 5 mg of 4j were isolated 
pure, the rest of the product was obtained together 
with the ligand as they have the same retention time. Yield: 97%. ee: 
80%. [α]D
25 = 12 (c 1.67, CHCl3) [Lit.
189 [α]D
23 = 32.3 (c 1.03, CHCl3) 
for 99% ee]. 1H NMR (CDCl3, 400 MHz) δ 8.12 (d, J = 8.6 Hz, 2H), 7.52 
(d, J = 8.6 Hz, 2H), 5.00 (q, J = 6.9 Hz, 1H), 3.85 (br s, 1H), 1.49 (d, J = 
6.9 Hz, 3H). 13C NMR (CDCl3, 100.6 MHz) δ 153.3, 146.6, 125.9, 123.4, 
69.0, 25.0. ee determination by chiral GC analysis, Cyclosil β column, T = 
170 °C, P = 15.9 psi, retention times: tr(R) = 30.2 min (major 
enantiomer), tr(S) = 31.3 min. 
 (R)-1-[4-(Trifluoromethyl)phenyl]ethanol 
(4k):76 Obtained as a yellow oil after column 
chromatography (Hex/EtOAc 9:1). Yield: 92%. ee: 
94%. [α]D
25 = 18 (c 6.7, CHCl3) [Lit.
190 [α]D
20 = 
35.3 (c 1.56, CHCl3) for 99% ee]. 
1H NMR (400 MHz, CDCl3) δ 7.60 (d, J 
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= 8.2 Hz, 2H), 7.47 (d, J = 8.6 Hz, 2H), 4.95 (q, J = 6.5 Hz, 1H), 2.16 (br 
s, 1H), 1.49 (d, J = 6.5 Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 149.7, 
129.8, 129.4, 125.6, 125.4, 125.4, 122.3, 69.8, 25.3. ee determination by 
chiral GC analysis, Cyclosil β column, T = 125 °C, P = 15.9 psi, retention 
times: tr(R) = 16.9 min (major enantiomer), tr(S) = 18.1 min. 
 (R)-4-(1-Hydroxyethyl)benzonitrile (4l):191 
Obtained as a yellow oil after column chromatography 
(Hex/EtOAc 8:2). Yield: 93%. ee: 91%. [α]D
25 = 
27.69 (c 4.3, CHCl3) [Lit.
189 [α]D
25 = 43.1 (c 1.02, 
CHCl3) for 96% ee]. 
1H NMR (400 MHz, CDCl3) δ 7.63 (d, J = 8.3 Hz, 
2H), 7.49 (d, J = 8.1 Hz, 2H), 4.96 (q, J = 6.5 Hz, 1H), 2.22 (br s, 1H), 
1.49 (d, J = 6.5 Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 151.1, 132.3, 
126.0, 118.8, 111.0, 69.6, 25.4. ee determination by chiral GC analysis, 
Cyclosil β column, T = 200 °C, P = 15.9 psi, retention times: tr(R) = 38.7 
min (major enantiomer), tr(S) = 39.4 min. 
 (R)-1-Phenylpropan-2-ol (4m):192 Obtained as a 
colourless oil after column chromatography 
(Hex/EtOAc 9:1). Yield: 80%. ee: 73%. [α]D
25 = 
23 (c 4.3, CHCl3) [Lit.
193 [α]D
28 = 35.4 (c 0.75, CHCl3) for 99% ee]. 
1H 
NMR (400 MHz, CDCl3) δ 7.35–7.26 (m, 2H), 7.26–7.16 (m, 3H), 4.08–
3.90 (m, 1H), 2.75 (dd, J = 28.1, 6.4 Hz, 1H), 2.70 (dd, J = 28.1, 6.4 Hz, 
1H), 1.66 (br s, 1H), 1.23 (d, J = 6.2 Hz, 3H). 13C NMR (100.6 MHz, 
CDCl3) δ 138.5, 129.4, 128.5, 126.4, 68.8, 45.8, 22.7. ee determination by 
chiral GC analysis, Cyclosil β column, T = 140 °C, P = 15.9 psi, retention 
times: tr(S) = 40.4 min, tr(R) = 41.7 min (major enantiomer). 
 (R)-2-Nonanol (4n):194 Obtained as a colourless oil. 
Conversion: 84%. ee: 89.5%. IR (ATR) 3340, 2924, 
2855, 1464, 1375, 1114. 1H NMR (400 MHz, CDCl3) δ 
3.82–3.75 (m, 1H), 1.62 (br s, 1H), 1.54–1.20 (m, 12H), 1.19 (d, J = 6.4 
Hz, 3H), 0.88 (t, J = 7.2 Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 68.2, 
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39.3, 31.8, 29.7, 29.3, 25.8, 23.5, 22.6, 14.1. ee was determined by chiral 
GC analysis on derivative 23. 
 (R)-3,3-Dimethylbutan-2-ol (4o):195 This product was 
volatile and could not be isolated. Conversion: 28%. ee: 
97%. 1H NMR (400 MHz, CDCl3) δ 3.47 (q, J = 6.4 Hz, 1H), 
1.76 (br s, 1H), 1.12 (d, J = 6.4 Hz, 3H), 0.89 (s, 9H). 13C NMR (100.6 
MHz, CDCl3) δ 75.6, 34.8, 25.4, 17.8. ee determination by chiral GC 
analysis, CP Chirasil-DEX CB column, T = 35 °C, P = 6 psi, retention times: 
tr(R) = 95.9 min (major enantiomer), tr(S) = 96.7 min. 
 (R)-1-Cyclohexylethan-1-ol (4p):196 This product was 
volatile and could not be isolated. Conversion: 98%. ee: 
93%. 1H NMR (400 MHz, CDCl3) δ 3.54 (quint, J = 6.2 Hz, 
1H), 1.92–1.59 (m, 6H), 1.34–1.09 (m, 7H), 1.09–0.87 (m, 
2H). 13C NMR (100.6 MHz, CDCl3) δ 72.2, 45.1, 28.6, 28.3, 26.5, 26.2, 
26.1, 20.3. ee was determined by chiral GC analysis on derivative 24. 
 (R)-4-Methylpentan-2-ol (4q):83, 197 This product 
was volatile and could not be isolated. Conversion: 
87%. ee: 94%. 1H NMR (400 MHz, CDCl3) δ 3.98–3.75 
(m, 1H), 1.85–1.60 (m, 2H), 1.57 (br s, 1H), 1.50–1.35 (m, 1H), 1.20 (d, 
J = 3.2 Hz, 3H), 0.92 (d, J = 6.6 Hz, 6H). 13C NMR (100.6 MHz, CDCl3) δ 
66.1, 48.6, 24.8, 23.9, 23.1, 22.3. ee was determined by chiral GC 
analysis on derivative 25. 
 (R)-1-Phenylpentan-1-ol (5):198 Obtained as a 
white solid after column chromatography (Hex/EtOAc 
8:1). Yield: 83%. ee: 96%. [α]D
24 = 12 (c 3.3, 
CHCl3) [Lit.
198 [α]D
31 = 39 (c 0.53, CHCl3) for 95% ee]. 
1H NMR (400 
MHz, CDCl3) δ 7.43–7.21 (m, 5H), 4.64 (t, J = 6.6 Hz, 1H), 1.99 (br s, 
1H), 1.87–1.61 (m, 2H), 1.48–1.16 (m, 4H), 0.88 (t, J = 7.0 Hz, 3H). 13C 
NMR (100.6 MHz, CDCl3) δ 144.9, 128.4, 127.4, 125.9, 74.6, 38.8, 28.0, 
22.6, 14.0. ee determination by chiral GC analysis, Cyclosil β column, T = 
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125 °C, P = 15.9 psi, retention times: tr(S) = 13.5 min, tr(R) = 13.8 min 
(major enantiomer). 
 (R)-5-Dodecanol (6):199 Obtained as a colourless 
oil. Conversion: 78%. ee: 91%. IR (ATR) 3370, 
2925, 2855, 1466, 1278. 1H NMR (400 MHz, CDCl3) δ 
3.68–3.54 (m, 1H), 1.63 (br s, 1H), 1.65–1.20 (m, 18H), 0.96–0.84 (m, 
6H). 13C NMR (100.6 MHz, CDCl3) δ 72.0, 37.5, 37.1, 31.8, 29.7, 29.3, 
27.8, 25.6, 22.7, 22.6, 14.1, 14.0. ee was determined by chiral GC 
analysis on derivative 26.  
 (R)-3-Methyl-1-phenylbutan-1-ol (7):200 Obtained as 
a white solid after column chromatography (Hex/EtOAc 
10:1). Yield: 91%. ee: 60%. [α]D
24 = 17 (c 2.3, CHCl3) 
[Lit.200 [α]D
25 = 45 (c 1, CH2Cl2) for 94% ee]. 
1H NMR (400 MHz, CDCl3) 
δ 7.34–7.26 (m, 5H), 4.79–4.70 (m, 1H), 1.85 (br s, 1H), 1.78–1.63 (m, 
2H), 1.57–1.44 (m, 1H), 0.96 (d, J = 1.4 Hz, 3H), 0.94 (d, J = 1.5 Hz, 
3H). 13C NMR (100.6 MHz, CDCl3) δ 145.2, 128.5, 127.5, 125.8, 72.8, 
48.3, 24.8, 23.1, 22.2. ee determination by chiral GC analysis, CP Chirasil-
DEX CB column, T = 125 °C, P = 6 psi, retention times: tr(S) = 40.7 min, 
tr(R) = 41.9 min (major enantiomer). 
 (R)-Naphthalen-2-yl(phenyl)methanol (8):201 
Obtained as a white solid after column 
chromatography (Hex/EtOAc 95:5). Yield: 91%. ee: 
13%. [α]D
25 = 1.40 (c 14.3, CHCl3) [Lit.
202 [α]D
20 = 
5.99 (c 1.5, CHCl3) for 92% ee]. 
1H NMR (400 MHz, CDCl3) δ 7.83–7.61 
(m, 4H), 7.47–7.36 (m, 2H), 7.36–7.15 (m, 6H), 5.81 (s, 1H), 2.87 (br s, 
1H). 13C NMR (100.6 MHz, CDCl3) δ 143.5, 141.0, 133.1, 132.8, 128.4, 
128.2, 128.0, 127.6, 127.5, 126.6, 126.1, 125.9, 125.0, 124.7, 76.2. ee 
determination by chiral HPLC analysis, Lux 5u Cellulose-1 column, 
Hex/iPrOH 95:5 flow = 1 mL/min, retention times: tr(S) = 27.0 min, tr(R) 
= 33.7 min (major enantiomer). 
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General procedure for the synthesis of acetates derivatives 23-
26: In a flame dried Schlenk tube, the corresponding aliphatic alcohol 
[4n, 4p, 4q, or 6] (0.10 mmol) was dissolved in anhydrous DCM (1 mL, 
0.1 M) at 0 °C and Et3N (28 µL, 0.20 mmol, 2.0 eq.), DMAP (1.3 mg, 0.01 
mmol, 0.1 eq.) and acetic anhydride (22 µL, 0.20 mmol, 2.0 eq.) were 
added sequentially. The reaction mixture was stirred at RT for 12 h. The 
reaction was quenched with water (1 mL), extracted with Et2O (3 × 5 mL) 
and the combined organic layers were dried over MgSO4 and concentrated 
under vacuum. The crude product was purified by chromatographic 
column to provide the desired products 23-26. 
 (R)-Nonan-2-yl acetate (23):203 Obtained as a 
colourless oil after purification by column chromatography 
(eluent Hex/EtOAc 97:3) as colorless oil. Yield: 84%. ee: 
91%. [α]D
25 = 3.75 (c 5.3, CHCl3). IR (ATR) 2926, 2856, 
1736, 1371, 1239. 1H NMR (400 MHz, CDCl3) δ 4.94–4.82 (m, 1H), 2.03 
(s, 3H), 1.64–1.40 (m, 2H), 1.38–1.14 (m, 10H), 1.20 (d, J = 6.4 Hz, 3H), 
0.88 (t, J = 7.2 Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 170.8, 71.1, 
35.9, 31.8, 29.4, 29.2, 25.4, 22.6, 21.4, 19.9, 14.1. ee determination by 
chiral GC analysis, Cyclosil β column, T = 125 °C, P = 15.9 psi, retention 
time: tr(S) = 9.3 min, tr(R) = 10.0 min (major enantiomer). 
 (R)-1-Cyclohexylethyl acetate (24):204 This product 
was volatile and could not be isolated. ee: 93%. 1H 
NMR (400 MHz, CDCl3) δ 4.72 (quint, J = 6.4 Hz, 1H), 
2.04 (s, 3H), 1.80–1.61 (m, 5H), 1.43 (m, 1H), 1.27–
1.09 (m, 3H), 1.16 (d, J = 6.4 Hz, 3H), 1.07–0.90 (m, 2H). 13C NMR 
(100.6 MHz, CDCl3) δ 171.0, 74.7, 42.5, 28.4, 26.3, 26.0, 25.9, 20.92, 
17.0. ee determination by chiral GC analysis, CP-Chirasil-DEX CB column, 
T = 100 °C, P = 6 psi, retention time: tr(S) = 27.3 min, tr(R) = 35.6 min (major 
enantiomer). 
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 (R)-4-Methylpentan-2-yl acetate (25):205 The 
product was volatile and could not be isolated. ee 
determination by chiral GC analysis, CP-Chirasil-DEX CB 
column, T = 100 °C, P = 6 psi, retention time: tr(S) = 
4.9 min, tr(R) = 5.3 min (major enantiomer). 
 (R)-Dodecan-5-yl acetate (26): Obtained as a 
yellow oil after purification by column chromatography 
(Hex/EtOAc 97:3). Yield: 78%. ee: 91%. [α]D
25 = 
2.4 (c 8.3, CHCl3). IR (ATR) 2955, 2926, 2858, 1737, 
1236, 1019. 1H NMR (400 MHz, CDCl3) δ 4.86 (quint, 
J = 6.4 Hz, 1H), 2.04 (s, 3H), 1.57–1.44 (m, 4H), 1.38–1.18 (m, 14H), 
0.94–0.82 (m, 6H). 13C NMR (100.6 MHz, CDCl3) δ 171.0, 74.4, 34.1, 
33.8, 31.8, 29.5, 29.2, 27.5, 25.3, 22.6, 22.6, 21.3, 14.1, 14.0. HRMS 
(+ESI): m/z calculated for C14H28O2Na [M+Na]
+: 251.1987. Found: 
251.1975. ee determination by chiral GC analysis, CP Chirasil-DEX CB 
column, T = 115 °C, P = 6 psi, retention time: tr(S) = 51.4 min, tr(R) = 
52.2 min (major enantiomer). 
2.4.3.3. Catalytic enantioselective addition of 
methyltriisopropoxititanium to aldehydes 
General procedure for the addition of 
methyltriisopropoxititanium to aldehydes: To a stirred solution of 
(Ra,S)-L14 or L15 (0.2 eq.) in Et2O (3.0 mL, 0.07 M) at 0 °C, MeTi(O
iPr)3 
(0.3 mL, 1.5 eq. 0.5 M in THF, unless stated differently in the 
corresponding table) was added. The solution was stirred for 1 min and 
then the aldehyde (0.10 mmol) was added. The reaction was stirred for 10 
min and then quenched with water. The layers were separated and the 
aqueous layer was extracted three times with Et2O. The combined organic 
layers were dried over anhydrous MgSO4 and the solvent was removed 
under reduced pressure. The reaction crude was purified by flash silica gel 
chromatography. 
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 (R)-1-Phenylethanol (2):183 Obtained as a colorless oil 
after column chromatography (Hex/EtOAc 6:1). Yield: 
96%. ee: 96%. [α]D
24 = 47 (c 0.7, CHCl3) [Lit.
183 [α]D
26 
= 97 (c 0.3, CHCl3) for 95% ee]. ee determination by 
chiral GC analysis, Cyclosil β column, T = 100 °C, P = 15.9 psi, retention 
times: tr(R) = 30.9 min (major enantiomer), tr(S) = 34.8 min. 
(R)-1-(2-Methoxyphenyl)ethanol (4c):183 Obtained as 
a colorless oil after column chromatography (Hex/EtOAc 
7:1). Yield: 95%. ee: 56%. [α]D
24 = 33 (c 0.3, CHCl3) 
[Lit.183 [α]D
26 = 24 (c 1.0, CHCl3) for 99% ee]. ee determination by chiral 
GC analysis, Cyclosil β column, T = 150 °C, P = 15.9 psi, retention times: 
tr(R) = 9.1 min, tr(S) = 10.4 min (major enantiomer). 
 (R)-1-(3-Methoxyphenyl)ethanol (4r):206 
Obtained as a colorless oil after column 
chromatography (Hex/EtOAc 7:1). Yield: 92%. ee: 
99.5%. [α]D
24 = 28 (c 1.0, CHCl3) [Lit.
206 [α]D
20 = 
51.2 (c 1.0, CHCl3) for 96% ee]. 
1H NMR (400 MHz, CDCl3) δ 7.25 (t, J 
= 8.0 Hz, 1H), 6.94 (m, 2H), 6.98–6.75 (m, 1H), 4.86 (q, J = 6.4 Hz, 1H), 
3.81 (s, 3H), 1.99 (s, 1H), 1.48 (d, J = 6.4 Hz, 3H). 13C NMR (100.6 MHz, 
CDCl3) δ 159.8, 147.6, 129.6, 117.7, 112.9, 110.9, 70.3, 55.2, 25.2. ee 
determination by chiral GC analysis, CP-Chirasil-DEX CB column, T = 125 
°C, P = 6 psi, retention times: tr(R) = 45.1 min (major enantiomer), tr(S) 
= 49.4 min. 
 (R)-1-(4-Methylphenyl)ethanol (4b):185 Obtained 
as a colourless oil after column chromatography (eluent 
Hex/EtOAc 9:1). Yield: 96%. ee: 93%. [α]D
25 = 39.4 
(c 0.7, CHCl3) [Lit.
186 [α]D
26 = 56 (c 1.0, CHCl3) for 
96% ee]. ee determination by chiral GC analysis, CP Chirasil-DEX CB 
column, T = 130 °C, P = 6 psi, retention times: tr(R) = 14.7 min (major 
enantiomer), tr(S) = 16.4 min. 
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 (R)-1-(4-Bromophenyl)ethanol (4g):183 Obtained 
as a white solid after column chromatography 
(Hex/EtOAc 6:1). Yield: 90%. ee: 97%. [α]D
25 = 28 (c 
0.4, CHCl3) [Lit.
183 [α]D
20 = 34.6 (c 1.7, CHCl3) for 94% 
ee]. ee determination by chiral GC analysis, CP-Chirasil-DEX CB column, 
140 °C, P = 6 psi, retention times: tr(R) = 34.3 min (major enantiomer), 
tr(S) = 39.3 min. 
 (R)-1-[4-(Trifluoromethyl)phenyl]ethanol 
(4k):76 Obtained as a yellow oil after column 
chromatography (Hex/EtOAc 9:1). Yield: 89%. ee: 
95%. [α]D
25 = 28.9 (c 0.9, CHCl3) [Lit.
190 [α]D
20 = 35.3 (c 1.6, CHCl3) 
for 99% ee]. ee determination by chiral GC analysis, CP Chirasil-DEX CB 
column, T = 140 °C, P = 6 psi, retention times: tr(R) = 10.9 min (major 
enantiomer), tr(S) = 12.5 min. 
 (R)-4-(1-Hydroxyethyl)benzonitrile (4l):191 
Obtained as a yellow oil after column chromatography 
(Hex/EtOAc 8:2). Yield: 94%. ee: 96%. [α]D
25 = 
35.3 (c 0.9, CHCl3) [Lit.
189 [α]D
25 = 43.1 (c 1.02, 
CHCl3) for 96% ee]. ee determination by chiral GC analysis, CP Chirasil-
DEX CB column, T = 170 °C, P = 6 psi, retention times: tr(R) = 18.8 min 
(major enantiomer), tr(S) = 21.0 min. 
 (R)-1-(Naphthalen-2-yl)ethanol (4d):183 Obtained 
as a white solid after column chromatography (eluent 
Hex/EtOAc 8:1). Yield: 92%. ee: 84%. [α]D
24 = 31 
(c 0.4, CHCl3) [Lit.
183 [α]D
28 = 30 (c 0.97, CHCl3) for 
87% ee]. ee determination by chiral HPLC analysis, Lux 5u Cellulose 3 
column, Hex/i-PrOH 97:3 flow = 1 mL/min, retention times: tr(S) = 29.7 
min, tr(R) = 38.7 min (major enantiomer). 
 (R)-1-(Thiophen-2-yl)ethanol (4e):183 Obtained as 
a volatile colorless oil after column chromatography 
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(Hex/EtOAc 6:1). Yield: 95%. ee: 94%. [α]D
24 = 12.5 (c 0.8, CHCl3) 
[Lit.183 [α]D
25 = 20 (c 1.04, CHCl3) for 96% ee]. ee determination by 
chiral GC analysis, CP-Chirasil-DEX CB column, T = 125 °C, P = 6 psi, 
retention times: tr(R) = 14.5 min (major enantiomer), tr(S) = 15.9 min. 
 (R,E)-4-Phenylbut-3-en-2-ol (4i):207 Obtained as a 
white solid after column chromatography (Hex/EtOAc 
5:1). Yield: 88%. ee: 82%. [α]D
24 = 35 (c 0.6, 
CHCl3) [Lit.
187 [α]D
20 = 23 (c 1.0, CH2Cl2) for 99% ee]. 
ee determination by chiral HPLC analysis, Lux 5u 
Cellulose 3 column, Hex/iPrOH 97:3 flow = 1 mL/min, retention times: 
tr(S) = 14.2 min, tr(R) = 15.3 min (major enantiomer). 
 (R)-1-Phenylpropan-2-ol (4m):192 Obtained as a 
colourless oil after column chromatography 
(Hex/EtOAc 9:1). Yield: 93%. ee: 85%. [α]D
25 = 
35.4 (c 0.7, CHCl3) [Lit.
193 [α]D
28 = 35.4 (c 0.8, CHCl3) for 99% ee]. ee 
determination by chiral GC analysis, Cyclosil β column, T = 85 °C, P = 
15.9 psi, retention times: tr(S) = 76.0 min, tr(R) = 78.2 min (major 
enantiomer). 
 (R)-2-Nonanol (4n):194 Obtained as a colourless oil. 
Conversion: 99%. ee: 90%. IR (ATR) 3340, 2924, 
2855, 1464, 1375, 1114. ee was determined by chiral GC 
analysis on derivative 23. 
 (R)-1-Cyclohexylethan-1-ol (4p):196 This product was 
volatile and could not be isolated. Conversion: 99%. ee: 
94%. ee was determined by chiral GC analysis on 
derivative 24. 
 (R)-4-Methylpentan-2-ol (4q):83, 197 This product 
was volatile and could not be isolated. Conversion: 
77%. ee: 90%. ee was determined by chiral GC analysis 
on derivative 25. 
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 (R)-3,3-Dimethylbutan-2-ol (4o):195 This product was 
volatile and could not be isolated. Conversion: 78%. ee: 
93%. ee determination by chiral GC analysis, CP Chirasil-DEX 
CB column, T = 35 °C, P = 6 psi, retention times: tr(R) = 96.3 min (major 
enantiomer), tr(S) = 97.0 min. 
General procedure for the synthesis of acetates derivatives: In a 
flame dried Schlenk tube, the corresponding aliphatic alcohol [4n, 4p, or 
4q] (0.20 mmol) was dissolved in anhydrous DCM (2 mL, 0.1 M) at 0 °C 
and Et3N (56 µL, 0.40 mmol, 2.0 eq.), DMAP (2.6 mg, 0.02 mmol, 0.1 eq.) 
and acetic anhydride (44 µL, 0.40 mmol, 2.0 eq.) were added sequentially. 
The reaction mixture was stirred at RT for 12 h. The reaction was 
quenched with water (2 mL), extracted with Et2O (3 × 5 mL) and the 
combined organic layers were dried over MgSO4 and concentrated under 
vacuum. The crude product was purified by chromatographic column to 
provide the desired products 23-25. 
 (R)-Nonan-2-yl acetate (23):203 Obtained as a 
colourless oil after purification by column chromatography 
(eluent Hex/EtOAc 97:3). Yield: 95%. ee: 90%. [α]D
25 = 
5.6 (c 0.9, CHCl3). [Lit.
178 [α]D
25 = 3.8 (c 5.3, CHCl3) for 
91% ee]. IR (ATR) 2926, 2856, 1736, 1371, 1239. 1H NMR (400 MHz, 
CDCl3) δ 4.94–4.82 (m, 1H), 2.03 (s, 3H), 1.64–1.40 (m, 2H), 1.38–1.14 
(m, 10H), 1.20 (d, J = 6.4 Hz, 3H), 0.88 (t, J = 7.2 Hz, 3H). 13C NMR 
(100.6 MHz, CDCl3) δ 170.8, 71.1, 35.9, 31.8, 29.4, 29.2, 25.4, 22.6, 21.4, 
19.9, 14.1. ee determination by chiral GC analysis, CP Chirasil-DEX CB 
column, T = 125 °C, P = 6 psi, retention times: tr(S) = 10.6 min, tr(R) = 
11.9 min (major enantiomer). 
 (R)-1-Cyclohexylethyl acetate (24):204 This product 
was volatile and could not be isolated. ee: 94%. 1H 
NMR (400 MHz, CDCl3) δ 4.72 (quint, J = 6.4 Hz, 1H), 
2.04 (s, 3H), 1.80–1.61 (m, 5H), 1.43 (m, 1H), 1.27–
1.09 (m, 3H), 1.16 (d, J = 6.4 Hz, 3H), 1.07–0.90 (m, 2H). 13C NMR 
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(100.6 MHz, CDCl3) δ 171.0, 74.7, 42.5, 28.4, 26.3, 26.0, 25.9, 20.92, 
17.0. ee determination by chiral GC analysis, CP-Chirasil-DEX CB column, 
T = 100 °C, P = 6 psi, retention time: tr(S) = 27.7 min, tr(R) = 34.3 min 
(major enantiomer). 
 (R)-4-Methylpentan-2-yl acetate (25):205 This 
product was volatile and could not be isolated. ee 
determination by chiral GC analysis, CP-Chirasil-DEX CB 
column, T = 100 °C, P = 6 psi, retention time: tr(S) = 
4.9 min, tr(R) = 5.3 min (major enantiomer). 
2.4.3.4. Catalytic enantioselective 1,2-addition of alkenes to 
aldehydes 
General procedure for the catalytic enantioselective 1,2-addition 
of alkenes to aldehydes: To a stirred suspension of Cp2ZrHCl (77 mg, 
0.30 mmol, 2.0 eq.) in dry DCM (0.3 mL) at RT, the corresponding alkene 
(0.33 mmol, 2.2 eq.) was added dropwise and the solution was stirred at 
RT for 30 min. The mixture turned into a clear yellow solution, which 
indicates the successful formation of the organozirconium reagent. Next, 
flame dried ZnBr2 (0.08 mmol, 0.5 eq.) was added into the solution and 
the mixture was stirred at RT for 2 min. Subsequently, a solution of 
Ti(OiPr)4 (0.23 mmol, 1.5 eq.) and (Ra,S)-L14 (20 mol%) in dry DCM (0.1 
mL) was added into the schlenk flask and stirred for further 2 min at RT. 
Finally, the aldehyde (0.15 mmol) was added and the solution was stirred 
at 35 °C for 18 h. 
In cases where the aldehyde was a liquid, this was previously distilled 
before its addition. Whereas with the solid ones, the aldehyde was 
dissolved in dry DCM (0.1 or 0.2 mL depending on its solubility) and added 
to the solution. 
The reaction was quenched by the addition of water (1 mL). The layers 
were separated, and the aqueous layer was extracted with Et2O (3  10 
mL). The combined organic layers were dried with anhydrous MgSO4, 
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filtered and concentrated under vacuum. The crude reaction product was 
purified by flash silica gel chromatography. 
(R)-1-phenylheptanol (6):208, 209 Obtained as a 
colourless oil after purification by column 
chromatography (Hex/EtOAc 95:5). Yield: 87%. 
ee: 91%. [α]D
25 = +16.7 (c 8.4, CHCl3). [lit.
212 [α]D
25 = +31.8 (c 1.1, 
CHCl3) for 99% ee]. 
1H NMR (400 MHz, CDCl3) δ 7.46–7.24 (m, 5H), 
4.68–4.55 (m, 1H), 2.76 (s, 1H), 1.95–1.65 (m, 2H), 1.48–1.25 (m, 8H), 
0.95 (t, J = 7.1 Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 145.1, 128.4, 
127.4, 126.0, 74.6, 39.2, 31.9, 29.3, 25.8, 22.7, 14.1. ee determination by 
chiral GC analysis, Cyclosil β column, T = 150 °C, P = 15.9 psi, retention 
times: tr(S) = 28.7 min, tr(R) = 31.2 min (major enantiomer). 
 (R)-1-p-tolylheptan-1-ol (8a):210 Obtained as 
a white solid after purification by column 
chromatography (Hex/EtOAc 95:5). Yield: 74%. 
ee: 91%. Mp = 34–37 °C. [α]D
25 = +18.7 (c 7.5, CHCl3). [lit.
210 [α]D
26 = 
+27.7 (c 1.1, CHCl3) for 89% ee]. IR (ATR) 3344, 2924, 2855, 1456, 
1041, 816. 1H NMR (400 MHz, CDCl3) δ 7.25–7.10 (m, 4H), 4.65–4.58 
(m, 1H), 2.34 (s, 3H), 1.80–1.60 (m, 2H), 1.45–1.28 (m, 8H), 0.86 (t, J = 
7.6 Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 142.0, 137.1, 129.1, 125.8, 
74.5, 39.0, 31.7, 29.2, 25.8, 22.6, 21.1, 14.1. ee determination by chiral 
GC analysis, CP Chirasil-DEX CB column, T = 140 °C, P = 6 psi, retention 
times: tr(R) = 73.3 min (major enantiomer), tr(S) = 75.7 min. 
 (R)-1-m-tolylheptan-1-ol (8b): Obtained as a 
yellowish oil after purification by column 
chromatography (Hex/EtOAc 95:5). Yield: 34%. 
ee: 88%. [α]D
25 = +19.3 (c 5.7, CHCl3). IR (ATR) 
3348, 2925, 2856, 1457, 784, 702. 1H NMR (400 MHz, CDCl3) δ 7.30–
7.05 (m, 4H), 4.65–4.57 (m, 1H), 2.35 (s, 3H), 1.85 (s broad, 1H), 1.83–
1.60 (m, 2H), 1.45–1.20 (m, 8H), 0.87 (t, J = 6.8 Hz, 3H). 13C NMR 
(100.6 MHz, CDCl3) δ 145.1, 138.2, 128.4, 128.3, 126.7, 123.1, 74.9, 
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39.2, 31.9, 29.3, 26.0, 22.7, 21.6, 14.2. HRMS (+ESI): m/z calculated for 
C14H22ONa [M+Na]
+: 229.1563. Found: 229.1562. ee determination by 
chiral HPLC analysis, Phenomenex® Lux Cellulose-1, Hex/i-PrOH 95:5 
flow = 1 mL/min, retention times: tr(R) = 7.9 min (major enantiomer), 
tr(S) = 8.9 min. 
(R)-1-o-tolylheptan-1-ol (8c):211 Obtained as a 
yellowish oil after purification by column 
chromatography (Hex/EtOAc 95:5). Yield: 49%. 
ee: 75%. [α]D
25 = +28.6 (c 4.9, CHCl3). IR (ATR) 3347, 2925, 2855, 
1459, 1043, 754. 1H NMR (400 MHz, CDCl3) δ 7.50–7.10 (m, 4H), 4.95–
4.88 (m, 1H), 2.33 (s, 3H), 1.78 (s broad, 1H), 1.75–1.60 (m, 2H), 1.55–
1.22 (m, 8H), 0.87 (t, J = 6.8 Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 
143.2, 134.6, 130.5, 127.2, 126.4, 125.2, 70.9, 38.3, 31.9, 29.4, 26.2, 
22.8, 19.2, 14.2. ee determination by chiral HPLC analysis, 
Phenomenex® Lux Cellulose-1, Hex/i-PrOH 95:5 flow = 1 mL/min, 
retention times: tr(R) = 8.9 min (major enantiomer), tr(S) = 9.5 min. 
(R)-1-(4-bromophenyl)heptan-1-ol (8d):211 
Obtained as a white solid after purification by 
column chromatography (Hex/EtOAc 95:5). 
Yield: 56%. ee: 91%. Mp = 35–37 °C. [α]D
25 = +18.6 (c 7.5, CHCl3). 
[lit.212 [α]D
25 = +23.3 (c 0.6, CHCl3) for 99% ee]. IR (ATR) 3299, 2920, 
2851, 1483, 1404, 1007. 1H NMR (400 MHz, CDCl3) δ 7.50–7.16 (m, 4H), 
4.66–4.58 (m, 1H), 1.91 (s broad, 1H), 1.82–1.58 (m, 2H), 1.45–1.15 (m, 
8H), 0.87 (t, J = 7.2 Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 144.0, 
131.6, 127.8, 121.3, 74.2, 39.2, 31.9, 29.3, 25.8, 22.7, 14.2. ee 
determination by chiral HPLC analysis, Phenomenex® Lux Cellulose-1, 
Hex/i-PrOH 95:5 flow = 1 mL/min, retention times: tr(R) = 8.9 min (major 
enantiomer), tr(S) = 9.5 min. 
(R)-1-(4-chlorophenyl)heptan-1-ol (8e):210 
Obtained as a white solid after purification by 
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column chromatography (Hex/EtOAc 95:5 to 90:10). Yield: 59%. ee: 
90%. Mp = 33–35 °C. [α]D
25 = +18.1 (c 6.6, CHCl3). [lit.
212 [α]D
25 = 
+26.1 (c 0.3, CHCl3) for 99% ee]. IR (ATR) 3280, 2923, 2854, 1466, 
1089, 827. 1H NMR (400 MHz, CDCl3) δ 7.35–7.22 (m, 4H), 4.68–4.60 
(m, 1H), 1.89 (s broad, 1H), 1.82–1.58 (m, 2H), 1.44–1.18 (m, 8H), 0.87 
(t, J = 6.8 Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 143.5, 133.2, 128.7, 
127.4, 74.1, 39.3, 31.9, 29.3, 25.8, 22.7, 14.2. ee determination by chiral 
HPLC analysis, Phenomenex® Lux Cellulose-1, Hex/i-PrOH 95:5 flow = 1 
mL/min, retention times: tr(R) = 7.3 min (major enantiomer), tr(S) = 7.8 
min. 
 (R)-1-[4-(1-
oxidanylheptyl)phenyl]ethanone (8f): 
Obtained as a white solid after purification by 
column chromatography (Hex/EtOAc 80:20). 
Yield: 32%. ee: 91%. Mp = 37–39 °C. [α]D
25 = +15.8 (c 3.8, CHCl3). IR 
(ATR) 3283, 2925, 2854, 1678, 1606, 1266. 1H NMR (400 MHz, CDCl3) δ 
7.94 (d, J = 8.4 Hz, 2H), 7.44 (d, J = 8.4 Hz, 2H), 4.78–4.70 (m, 1H), 
2.60 (s, 3H), 1.98 (s broad, 1H), 1.85–1.64 (m, 2H), 1.46–1.18 (m, 8H), 
0.87 (t, J = 7.2 Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 198.0, 150.4, 
136.5, 128.7, 126.1, 74.3, 39.4, 31.9, 29.3, 26.8, 25.7, 22.7, 14.2. HRMS 
(+ESI): m/z calculated for C15H23O2 [M+H]
+: 235.1693. Found: 235.1693. 
ee determination by chiral HPLC analysis, Phenomenex® Lux Cellulose-1, 
Hex/i-PrOH 95:5 flow = 1 mL/min, retention times: tr(R) = 18.4 min 
(major enantiomer), tr(S) = 19.5 min. 
 (R)-4-(hydroxyheptyl)-benzonitrile 
(8g):213  Obtained as a colourless oil after 
purification by column chromatography 
(Hex/EtOAc 95:5 to 80:20). Yield: 58%. ee: 87%. [α]D
25 = +17.5 (c 6.3, 
CHCl3). IR (ATR) 3433, 2927, 2856, 2228, 1609, 839, 732. 
1H NMR (400 
MHz, CDCl3) δ 7.63 (d, J = 8.4 Hz, 2H), 7.46 (d, J = 8.4 Hz, 2H), 4.78–
4.70 (m, 1H), 2.07 (s broad, 1H), 1.82–1.58 (m, 2H), 1.46–1.18 (m, 8H), 
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0.87 (t, J = 6.8 Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 150.3, 132.3, 
126.5, 118.9, 111.1, 73.8, 39.3, 31.7, 29.1, 25.5, 25.6, 14.0. ee 
determination by chiral HPLC analysis, Phenomenex® Lux Cellulose-1, 
Hex/i-PrOH 95:5 flow = 0.5 mL/min, retention times: tr(R) = 30.9 min 
(major enantiomer), tr(S) = 32.8 min. 
 (R)-1-[4-(trifluoromethyl)phenyl]heptan-
1-ol (8h):214 Obtained as a yellowish oil after 
purification by column chromatography 
(Hex/EtOAc 95:5). Conversion: 69%. ee: 87%. ee was determined by 
chiral HPLC analysis on derivative 27. IR (ATR) 3336, 2929, 2858, 1620, 
1323, 1122. 1H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 8.0 Hz, 2H), 7.46 
(d, J = 8.0 Hz, 2H), 4.78–4.70 (m, 1H), 1.95 (s broad, 1H), 1.84–1.64 (m, 
2H), 1.48–1.20 (m, 8H), 0.87 (t, J = 6.8 Hz, 3H). 13C NMR (100.6 MHz, 
CDCl3) δ 148.9, 129.6 (q, J = 128.8 Hz), 126.1, 125.4 (q, J = 14.8 Hz), 
122.8, 74.0, 39.3, 31.7, 29.1, 25.6, 22.6, 14.1. 
(R)-1,5-Diphenyl-pentan-1-ol (10a):215 
Obtained as a colourless oil after purification by 
column chromatography (Hex/EtOAc 90:10). Yield: 
93%. ee: 77%. [α]D
25 = +5.4 (c 11.2, CHCl3). IR (ATR) 3381, 2931, 
2856, 1494, 1452, 696. 1H NMR (400 MHz, CDCl3) δ 7.38–7.13 (m, 10H), 
4.72–4.62 (m, 1H), 2.59 (t, J = 8.0 Hz, 2H), 1.89–1.60 (m, 4H), 1.53–1.43 
(m, 1H), 1.40–1.25 (m, 1H). 13C NMR (100.6 MHz, CDCl3) δ 144.8, 142.6, 
128.5, 128.4, 128.3, 127.5, 125.9, 125.6, 74.6, 38.9, 35.8, 31.4, 25.5. ee 
determination by chiral GC analysis, Cyclosil β column, T = 180 °C, P = 
15.9 psi, retention times: tr(S) = 20.0 min, tr(R) = 20.5 min (major 
enantiomer). 
(R)-5-(tert-butyl-dimethyl-silanyloxy)-1-
phenyl-pentan-1-ol (10b):216, 217 Obtained as a 
yellowish oil after purification by column 
chromatography (Hex/EtOAc 95:5). Yield: 42%. ee: 88%. [α]D
25 = 
+13.3 (c 6.0, CHCl3). IR (ATR) 3376, 2927, 2856, 1253, 1096, 833. 
1H 
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NMR (400 MHz, CDCl3) δ 7.36–7.22 (m, 5H), 4.70–4.64 (m, 1H), 3.59 (t, 
J = 6.4 Hz, 2H), 1.95 (s broad, 1H), 1.88–1.26 (m, 6H), 0.87 (s, 9H), 0.03 
(s, 6H). 13C NMR (100.6 MHz, CDCl3) δ 145.0, 128.6, 127.6, 126.0, 74.8, 
63.2, 39.0, 32.7, 29.8, 26.1, 22.3, 18.5, –5.1. ee determination by chiral 
HPLC analysis, Phenomenex® Lux Cellulose-1, Hex/i-PrOH 95:5 flow = 
0.5 mL/min, retention times: tr(R) = 13.3 min (major enantiomer), tr(S) = 
15.0 min. 
 (R)-5-chloro-1-phenylpentanol (10c):218 
Obtained as a colourless oil after purification by 
column chromatography (Hex/EtOAc 95:5 to 90:10). 
Conversion: 75%. ee: 86%. ee was determined by chiral HPLC analysis 
on derivative 10c’. IR (ATR) 3355, 2918, 2863, 1453, 1027, 699. 1H 
NMR (400 MHz, CDCl3) δ 7.40–7.24 (m, 5H), 4.68 (dd, J = 5.6, 7.6 Hz, 
1H), 3.52 (t, J = 6.4 Hz, 2H), 1.89 (s broad, 1H), 1.88–1.36 (m, 6H). 13C 
NMR (100.6 MHz, CDCl3) δ 144.6, 128.5, 127.7, 125.8, 74.4, 44.9, 38.2, 
32.5, 23.2. 
General procedure for the synthesis of acetates derivatives: In a 
flame dried Schlenk tube, the aliphatic alcohol 8h (0.20 mmol) was 
dissolved in anhydrous DCM (2 mL, 0.1 M) at 0 °C and Et3N (56 µL, 0.40 
mmol, 2.0 eq.), DMAP (2.6 mg, 0.02 mmol, 0.1 eq.) and acetic anhydride 
(44 µL, 0.40 mmol, 2.0 eq.) were added sequentially. The reaction mixture 
was stirred at RT for 12 h. The reaction was quenched with water (2 mL), 
extracted with Et2O (3 × 5 mL) and the combined organic layers were 
dried over MgSO4 and concentrated under vacuum. The crude product 
was purified by chromatographic column to provide 27. 
(R)-1-[4-(trifluoromethyl)phenyl]heptan-
1-yl acetate (27): Obtained as a yellowish oil 
after purification by column chromatography 
(Hex/EtOAc 98:2). Yield: 55%. ee: 87%. 
[α]D
25 = +29.5 (c 8.1, CHCl3). IR (ATR) 2930, 2859, 1739, 1622, 1323, 
1123. 1H NMR (400 MHz, CDCl3) δ 7.60 (d, J = 8.0 Hz, 2H), 7.43 (d, J = 
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8.0 Hz, 2H), 5.78–5.70 (m, 1H), 2.08 (s, 3H), 1.98–1.66 (m, 2H), 1.40–
1.16 (m, 8H), 0.87 (t, J = 7.2 Hz, 3H). 13C NMR (100.6 MHz, CDCl3) δ 
170.3, 144.9, 130.0 (q, J = 129.2 Hz), 126.7, 125.4 (q, J = 14.8 Hz), 
122.7, 75.5, 36.3, 31.6, 28.9, 25.3, 22.5, 21.2, 14.0. HRMS (+ESI): m/z 
calculated for C16H25NO2F3 [M+NH4]
+: 320.1839. Found: 320.1837. ee 
determination by chiral HPLC analysis, Phenomenex® Lux Cellulose-1, 
Hexane 100 flow = 0.5 mL/min, retention times: tr(R) = 21.4 min (major 
enantiomer), tr(S) = 22.5 min. 
General procedure for the synthesis of 2-substituted chiral 
tetrahydropyrans: In a flame dried Schlenk tube, the corresponding 
chiral 4-chlorobutyl alcohol 10c (0.15 mmol) was dissolved in anhydrous 
THF (1.5 mL). Then, KOtBu (50 mg, 0.45 mmol, 3 eq.) was added to the 
previous solution and the resulting suspension was stirred at RT for 18 h. 
The reaction was quenched with water (2 mL) and the crude was 
extracted with EtOAc (3 × 5 mL). The combined organic layers were dried 
over MgSO4 and concentrated under vacuum. The crude product was 
purified by chromatographic column to provide 10c’. 
 (R)-2-Phenyltetrahydro-2H-pyran (10c’):219, 220 
Obtained as a yellowish oil after purification by column 
chromatography (Hex/EtOAc 95:5). Yield: 84%. ee: 
86%. [α]D
25 = +21.4 (c 1.4, CHCl3). IR (ATR) 2934, 
2844, 1604, 1451, 1087, 697. 1H NMR (400 MHz, CDCl3) δ 7.36–7.22 (m, 
5H), 4.32 (dd, J = 11.2, 2.2 Hz, 1H), 4.18–3.58 (m, 1H), 3.62 (td, J = 
11.6, 2.4 Hz, 1H), 1.98–1.89 (m, 1H), 1.87–1.78 (m, 1H), 1.76–1.52 (m, 
4H). 13C NMR (100.6 MHz, CDCl3) δ 143.3, 128.2, 127.2, 125.8, 80.1, 
69.0, 34.0, 25.9, 24.0. ee determination by chiral HPLC analysis, 
Chiralcel® OJ-H, Hex/iPrOH 95:5 flow = 0.5 mL/min, retention times: tr(R) 
= 16.4 min (major enantiomer), tr(S) = 17.7 min. 
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2.4.3.5. Attempted enantioselective synthesis of fluoxetine 
General procedure for the catalytic addition of allylmagnesium 
bromide to benzaldehyde: In a flame dried Schlenk tube, (Ra,S)-L14, 
L15 or L17 (7.5 mg, 0.02 mmol, 0.2 eq.) were dissolved in dry toluene or 
Et2O (1.6 mL, 0.06 M). The solution was then cooled down to the 
corresponding temperature (–40 or –20 °C) and Ti(OiPr)4 (0.44 mL, 1.50 
mmol, 15.0 eq., unless stated differently in the corresponding table) was 
added into the mixture. Five minutes later, allylmagnesium bromide (0.38 
mL, 0.38 mmol, 3.8 eq. 1 M in Et2O, unless stated differently in the 
corresponding table) was added. After stirring the mixture for additional 
10 min, benzaldehyde (1) (10 µL, 0.10 mmol) was added and the reaction 
mixture was stirred for 4 h at the same temperature. 
The reaction was quenched by the addition of water (1 mL). The layers 
were separated, and the aqueous layer was extracted with EtOAc (3  10 
mL). The combined organic layers were neutralised with aq. saturated 
NaHCO3 solution (5 mL), dried with anhydrous MgSO4, filtered and 
concentrated under vacuum. The crude reaction product was purified by 
flash silica gel chromatography to provide 11. 
 1-Phenyl-3-buten-1-ol (11):221 Obtained as a 
colourless oil after purification by column 
chromatography (Hex/EtOAc 90:10). IR (ATR) 3371, 
3064, 2906, 1604, 913, 698. 1H NMR (400 MHz, CDCl3) δ 7.42–7.20 (m, 
5H), 5.88–5.72 (m, 1H), 5.20–5.07 (m, 2H), 4.72 (t, J = 6.4 Hz, 1H), 
2.58–2.42 (m, 2H), 2.18 (s, 1H). 13C NMR (100.6 MHz, CDCl3) δ 143.8, 
134.4, 128.4, 127.5, 125.8, 118.4, 73.2, 43.8. ee was determined by chiral 
GC analysis on derivative 28. 
General procedure for the synthesis of acetates derivatives: In a 
flame dried Schlenk tube, the aliphatic alcohol 11 (0.36 mmol) was 
dissolved in anhydrous DCM (3.6 mL, 0.1 M) at 0 °C and Et3N (101 µL, 
0.73 mmol, 2.0 eq.), DMAP (4.5 mg, 0.04 mmol, 0.1 eq.) and acetic 
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anhydride (68 µL, 0.73 mmol, 2.0 eq.) were added sequentially. The 
reaction mixture was stirred at RT for 12 h. The reaction was quenched 
with water (4 mL), extracted with Et2O (3 × 10 mL) and the combined 
organic layers were dried over MgSO4 and concentrated under vacuum. 
The crude product was purified by column chromatography to provide 29. 
1-phenylbut-3-enyl acetate (29):222 Obtained as a 
colourless oil after purification by column 
chromatography (Hexane 100% to Hex/EtOAc 90:10). IR 
(ATR) 3081, 2919, 1733, 1643, 1229, 1020. 1H NMR 
(400 MHz, CDCl3) δ 7.40–7.25 (m, 5H), 5.80 (dd, J = 6.0, 7.2 Hz, 1H), 
5.78–6.62 (m, 1H), 5.12–5.02 (m, 2H), 2.72–2.50 (m, 2H), 2.07 (s, 3H). 
13C NMR (100.6 MHz, CDCl3) δ 170.3, 140.0, 133.3, 128.4, 127.9, 126.5, 
118.0, 75.1, 40.7, 21.2. ee determination by chiral GC analysis, CP 
Chirasil-DEX CB column, T = 100 °C, P = 6 psi, retention times: tr = 56.9 
and 58.9 min. 
General procedure for the attempted preparation of the Grignard 
reagent 3-dimethylaminopropylmagnesium chloride (21) and its 
addition to benzaldehyde (1):  
 Preparation of the free amine (20’): A solution of NaOH (14.8 g, 
370 mmol, 7.4 eq.) in H2O (25 mL) was cooled down to 0 °C and 
was added to a stirred solution of the hydrochloride salt 20 (7.2 g, 
50 mmol) in H2O at 0 °C. The resulting mixture was stirred for 15 
min at 0 °C. The formation of the free amine (20’) was easily 
appreciated on top the aqueous solution. 
 Preparation of the Grignard reagent 21 from 20’: In a triple-neck 
round-bottom flask, magnesium powder (1.0 or 3.0 eq.) was 
activated with I2 (tip of a spatula) by the use of a heat gun. Next, 
the corresponding dry solvent (Et2O, THF or 
tBuOMe) was added 
and the suspension was heated to reflux. The free amine 20’ was 
added dropwise to the stirred solution and the mixture was heated 
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to reflux overnight. The suspension was allowed to cool down 
before its addition to a solution of benzaldehyde (1, see below). 
 Preparation of the Grignard reagent 21 from 20: The hydrochloride 
salt 20 (1.5 mmol) was dissolved in dry Et2O or THF (12.5 mL, 1 M) 
in a triple-neck round-bottom flask and the mixture was cooled 
down to 0 °C. Next, nBuLi or NaH (1.0 eq.) were added at 0 °C, 
followed by magnesium turnings (1.5 eq.). The suspension was 
stirred for 2 h at room temperature and heated to reflux overnight. 
The suspension was allowed to cool down before its addition to 
benzaldehyde (1, see below). 
 Addition of the attempted Grignard reagent 21 to benzaldehyde 
(1): In a flame dried Schlenk tube, benzaldehyde (0.5 mmol) was 
dissolved in dry Et2O (7.5 mL, 0.07 M) and the solution was cooled 
down to 0 °C. The attempted Grignard reagent (2.5 mmol, 5 eq.) 
was added dropwise and the mixture was stirred at room 
temperature overnight. The reaction was quenched with water (1 
mL) and the organic layer analysed by GC-MS to determine the 
formation of the product 15. 
General procedure for the addition of (1,3-dioxolan-2-
ylmethyl)magnesium bromide to benzaldehyde: In a flame dried 
Schlenk tube, (Ra,S)-L14 (7.5 mg, 0.02 mmol, 0.2 eq.) was dissolved in dry 
THF, toluene or Et2O (1.6 mL, 0.06 M). The solution was then cooled 
down to the corresponding temperature (–40 or –20 °C) and Ti(OiPr)4 
(0.44 mL, 1.50 mmol, 15.0 eq.) was added into the mixture. Five minutes 
later, 1,3-dioxolan-2-ylmethyl)magnesium bromide (0.38 mL, 0.38 mmol, 
3.8 eq. 0.5 M in THF) was added. After stirring the mixture for an 
additional 10 min, benzaldehyde (1) (10 µL, 0.10 mmol) was added and 
the reaction mixture was stirred overnight at the corresponding 
temperature. The reaction was quenched with water (1 mL). The layers 
were separated, and the aqueous layer was extracted with EtOAc (3  10 
mL). The combined organic layers were neutralised with aq. saturated 
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NaHCO3 solution, dried with anhydrous MgSO4, filtered and concentrated. 
The crude reaction product was purified by flash silica gel chromatography 
to provide 17. 
2-(2'-hydroxy-2'-phenyl)ethyl-1,3-dioxolane 
(17):223 Was obtained as a yellowish oil after 
purification by column chromatography (Hex/EtOAc 
80:20 to 60:40). IR (ATR) 3443, 2957, 2886, 1603, 1411, 1023, 699. 1H 
NMR (400 MHz, CDCl3) δ 7.46–7.22 (m, 5H), 5.10–4.98 (m, 2H), 4.12–
4.00 (m, 2H), 4.00–3.85 (m, 2H), 3.33 (s, 1H), 2.20–2.04 (m, 2H). 13C 
NMR (100.6 MHz, CDCl3) δ 143.8, 128.4, 127.4, 125.7, 103.2, 70.3, 65.0, 
64.8, 42.3. ee determination by chiral GC analysis, CP Chirasil-DEX CB 
column, T = 150 °C, P = 6 psi, retention times: tr = 54.5 and 56.9 min.  
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